Back to GetFilings.com
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
|
|
|
(Mark One) |
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
|
|
For the fiscal year ended March 31, 2005 |
|
or |
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
|
|
For the transition period
from to |
Commission file number 000-26124
IXYS Corporation
(Exact name of Registrant as specified in its charter)
|
|
|
Delaware |
|
77-0140882 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
3540 Bassett Street
Santa Clara, California 95054-2704
(Address of principal executive offices and zip code)
(408) 982-0700
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Act:
None
(Title of Class)
Securities registered pursuant to Section 12(g) of the
Act:
Common stock, par value $.01 per share
(Title of Class)
Indicate by check mark whether the Registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the Registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K is not
contained herein, and will not be contained, to the best of
Registrants knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this
Annual Report on Form 10-K or any amendment to this Annual
Report on
Form 10-K. Yes o No þ
Indicate by check mark whether the Registrant is an accelerated
filer (as defined in Rule 12b-2 of the
Act). Yes þ No o
The aggregate market value of the voting stock held by
non-affiliates of the Registrant, computed by reference to the
last sale price on the Nasdaq National Market on
September 30, 2004, was approximately $188,753,476. The
number of shares of the Registrants Common Stock
outstanding as of May 16, 2005 was 33,360,205.
Documents Incorporated
by Reference
Portions of the Registrants proxy statement relating to
its annual meeting of stockholders to follow its fiscal year
ended March 31, 2005, to be filed subsequently
Part III.
IXYS CORPORATION
ANNUAL REPORT ON FORM 10-K
FOR THE FISCAL YEAR ENDED MARCH 31, 2005
TABLE OF CONTENTS
2
FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking
statements that include, but are not limited to, statements
concerning projected revenues, expenses, gross profit and
income, the need for additional capital and the outcome of
pending litigation. These forward-looking statements are based
on our current expectations, estimates and projections about our
industry, managements beliefs, and certain assumptions
made by us. In some cases, these statements may be identified by
terminology such as may, will,
should, expects, plans,
anticipates, believes,
estimates, predicts,
potential, or continue or the negative
of such terms and other comparable expressions. These statements
involve known and unknown risks and uncertainties that may cause
our results, levels of activity, performance or achievements or
our industry to be materially different than those expressed or
implied by the forward-looking statements. Factors that may
cause or contribute to such differences include, but are not
limited to, our ability to compete successfully in our industry,
to continue to develop new products on a timely basis,
cancellation of customer orders, and other factors discussed
below and under the caption Risk Factors in
Item 7. We disclaim any obligation to update any of the
forward-looking statements contained in this report to reflect
any future events or developments.
PART I
We are a multi-market integrated semiconductor company. We
specialize in the development, manufacture and marketing of high
performance power semiconductors, advanced mixed signal
integrated circuits, or ICs, and radio frequency, or RF, power
transistors and systems. Our power semiconductors improve system
efficiency and reliability by converting electricity at
relatively high voltage and current levels into the finely
regulated power required by electronic products. We focus on the
market for power semiconductors that are capable of processing
greater than 200 watts of power.
Our power semiconductor products have historically been divided
into two primary categories, power MOS, or metal oxide silicon,
and power bipolar products. Our power semiconductors are sold as
individual units and are also packaged in high power modules
that frequently consist of multiple semiconductor die. In fiscal
2005, power semiconductors constituted approximately 74.2% of
our revenues, which included 38.3% from power MOS transistors
and 35.9% from bipolar products.
We design and sell integrated circuits, or ICs, that have
applications in telecommunications, display products, and power
management. In our fiscal year ended March 31, 2005, or
fiscal 2005, ICs constituted approximately 15.9% of our revenues.
We also design and sell RF power devices that switch electricity
at the high rates required by circuitry that generates radio
frequencies.
IXYSs power semiconductor products are used primarily to
control electricity in:
|
|
|
|
|
power conversion systems, including uninterruptible power
supplies, or UPS, and switch mode power supplies, or SMPS, for
communications infrastructure applications such as wireless base
stations, network servers and telecommunication switching
stations; |
|
|
|
motor drives for industrial applications such as industrial
transportation, robotics, automation, and process control
equipment; |
|
|
|
plasma display panels; |
|
|
|
medical electronics for sophisticated applications, such as
defibrillators and MRI and CT equipment; and |
|
|
|
renewable energy sources like wind turbines and solar systems. |
Our mixed signal ICs are used in telecommunications products,
central office switching equipment, customer premises equipment,
set top boxes, remote meter reading equipment, security systems,
advanced flat
3
displays, medical electronics and defense aerospace systems. Our
RF power devices are used in wireless infrastructure, industrial
RF applications, medical systems and defense and space
electronics.
We design our products primarily for industrial and business
applications, rather than for use in personal computers or
mobile phones. In fiscal 2005, we sold our products to over
2,000 customers worldwide. Our major customers include ABB,
Astec, Delta Electronics, Eupec, General Electric, Guidant,
Huawei, LG, Medtronics, Samsung, Siemens and Still. In many
cases, our customers incorporate our products into systems sold
to their own customers, which include Ericsson, General
Electric, Hewlett-Packard, IBM, Motorola and Sun Microsystems.
We are organized as a Delaware corporation. Our predecessor was
incorporated in 1983.
Background
The worldwide demand for electrical energy is currently
increasing due to:
|
|
|
|
|
proliferation of technology-driven products that require
electricity, including computers, telecommunications equipment
and the infrastructure to support portable electronics; |
|
|
|
increased use of electronic content in traditional products such
as airplanes, automobiles and home appliances; |
|
|
|
increased use of automation and electrical processes in industry
and mass transit systems; |
|
|
|
the growth of the Internet and mobile telecommunications
demand; and |
|
|
|
penetration of technology into developing countries. |
Not only is demand increasing, but the requirements for
electricity are also changing. Electronic products in all
markets are becoming increasingly sophisticated, offering more
intelligence through the use of microprocessors and
additional solid-state components. The increasing complexity of
such products requires more precisely regulated power quality
and greater power reliability. In addition, the increasing costs
of electricity, coupled with governmental regulations and
environmental concerns, have caused an increased demand for
energy efficiency.
Power semiconductors are used to provide the precisely regulated
power required by sophisticated electronic products and
equipment and address the growing demand for energy efficiency.
In most cases, power semiconductors:
|
|
|
|
|
convert or rectify alternating current, or AC, power
delivered by electrical utilities to the direct current, or DC,
power that is required by most electronic equipment; |
|
|
|
convert DC power at a certain voltage level to DC power at a
different voltage level to meet the specific voltage requirement
for an application; |
|
|
|
invert DC power to high frequency AC power to permit the
processing of power using substantially smaller electronic
components; or |
|
|
|
rectify high frequency AC power from switch mode power supplies
to meet the specific DC voltage required by an application. |
The more sophisticated the end product, the greater the need for
specially formatted, finely regulated power, and the greater the
need for a high performance power semiconductor.
Power semiconductors improve system efficiency and reliability
by processing and converting electrical energy into more usable,
higher quality power. Specifically, power semiconductors are
used primarily in controlling energy in power conversion
systems, including switch-mode power supplies or uninterruptible
power supplies, and motor drive controls. Switch-mode power
supplies efficiently convert power to meet the specific voltage
requirements of an application, such as communications
equipment. Uninterruptible power supplies provide a short-term
backup of electricity in the event of power failure. Motor drive
controls regulate the voltage, current and frequency of power to
a motor.
4
With the growth in telecommunications, data communications and
wireless communications, the demand for analog and mixed signal
ICs and RF power semiconductors has grown. Our mixed signal ICs
address the interface between telecommunication and data
communication components, both in the central office and in
gateway applications, especially with the increased use of the
Internet protocol, or IP. Our RF power semiconductors are used
in wireless infrastructure and in other microwave communication
applications. Technical advancement in the communication
industries is expected to drive the demand for higher
performance semiconductors.
Market Size and Trends
The primary markets we serve are characterized by complex
technological development and higher power level requirements.
We believe the following key trends are driving the demand for
our products:
Growth in communications devices and infrastructure. The
worldwide communications industry has experienced rapid growth
in the last decade, fueled largely by growth in the Internet and
in wireless communication, deregulation, competition,
privatization and technological advances, including the
convergence of voice, video and data communication. The
proliferation of electronic devices and the infrastructure to
support them is resulting in increasing power level requirements
and the demand for greater power reliability, as well as the
need for efficient solid state analog and mixed signal devices
that address the interface between telecommunication and data
communication components.
Increased demand for energy efficiency in motor drives.
Electric motors consume approximately one-half of the
worlds electricity. Due to costs and complexity, motor
controls that permit variable speed operation, which in turn
reduce energy consumption, have been predominantly used only in
higher-end applications. However, recent advancements in power
management enable more cost-effective, variable speed motor
controls, which enhance energy efficiency and improve
performance in a wide range of industrial and commercial
applications, such as heating, ventilation and air conditioning
systems.
Emergence of new applications in medical electronics.
Continued advancements in medical technologies are resulting in
more sophisticated medical electronic devices. Power
semiconductors can greatly reduce the size of equipment and
improve the precision of medical measurements and functionality.
They have enabled cardiac defibrillators to become much smaller
and more portable, improving the ability to install these
devices in more non-medical establishments, such as airplanes
and office buildings. Medical imaging systems, such as
ultrasound and MRI, require high performance mixed signal ICs
and RF power semiconductors to meet the technical requirements
of the marketplace.
Development of new technologies for power management. New
technologies, such as the use of RF for nontraditional power
applications, are opening new markets for power semiconductors.
For example, RF-based semiconductor production equipment is
migrating to high frequency power MOS transistors from
traditional RF tubes. Additionally, material science
developments, such as gallium arsenide, are enabling the
production of power management products with higher power
density, such as those required for wireless base stations.
Demand for increasing power density. The need for higher
levels of power in end use applications is causing purchasers of
power semiconductors to demand more power for their applications
from the same physical space. In the communications industry,
the growth in bandwidth demands is requiring communications
equipment providers to add more equipment or more powerful
equipment to confined spaces in highly populated areas. As a
result, power semiconductor manufacturers are being required to
design and produce products that enable their customers to
expand power levels without expanding product footprints, or
maintaining levels of power while shrinking product footprints.
Demand for new display technologies. The demand for flat
and large televisions with better contrast ratio than that of
LCD technology drives the demand for plasma display televisions,
which demand high voltage power MOSFETs for plasma display
control. Brighter and energy efficient flat panel displays for
portable telephones and PDAs drive the demand for new ICs that
control electronic ink-based displays.
5
IXYSs Strategy
We focus on meeting the needs of the high power, high
performance segment of the power semiconductor market, serving
it with our advanced power and IC technologies. We have
diversified our business to introduce products into new markets,
with an objective to achieve faster revenue growth than our
competitors, while stabilizing the business and providing
sustained growth. We intend to continue building a leading
position within our targeted segments of these markets by
pursuing the following strategies:
Maintain technological focus on high power, high performance
markets. Our technological expertise enables us to focus on
the high power, high performance markets. Due to technological
complexities, fewer industry players compete in these markets,
resulting in a more favorable competitive environment for us. We
believe our technological expertise differentiates us from most
of our competitors. This expertise encompasses a wide range of
scientific disciplines and technical capabilities, including
physics, mechanical engineering, chemistry, circuit design,
material science and packaging. Using our technological
expertise, we continually strive to introduce innovative
products.
Target rapid growth. We select the specific markets where
we intend to compete by evaluating their potential growth, our
ability to establish an advantage based upon our technological
capabilities and the performance of competing products.
Focus on niche markets. We focus on niche markets that
are not adequately addressed by our larger competitors. Our
larger competitors are often not flexible enough to address
niche markets and smaller customers. We focus on these markets
and customers, providing them with products configured to meet
their specific needs.
Continue to diversify markets, customers and products. We
believe that diversifying the markets and customers we serve and
the products we produce enables us to reduce the traditional
cyclical effects of the semiconductor industry on our business.
We have a significant market presence in Europe, North America
and Asia, the three principal geographic markets for high
performance power semiconductors. Moreover, our products are
used in a broad range of applications, from communications
infrastructure to industrial automation to medical electronics,
thereby reducing our reliance on customers from any particular
industry. Our product line spans a broad range of functionality
and price, which allows us to provide an appropriate solution to
most of our customers power semiconductor needs.
Pursue selective acquisition and investment strategy. We
seek to access additional technological capabilities and
complementary product lines through selective acquisitions and
strategic investments, with the goal of integrating acquisitions
into our business. For example, through the acquisition of
Clare, Inc., we expanded our product offerings into the
semiconductor segment of the market that replaces
electromagnetic relays, or EMRs, with solid-state relays, or
SSRs. The semiconductor products acquired with Clare are capable
of integrating a number of functions previously provided by
discrete components into one package and include product
applications such as modem interfaces to the Internet, cable set
top boxes, and voice over Internet protocol, or VOIP,
applications, as well as mixed signal ASICs for the medical,
flat display and military markets. Through another acquisition,
we substantially increased our RF power products, by acquiring a
product line of gallium arsenide devices that are useful in the
amplification or reception of RF in wireless, medical, defense
and space applications.
Collaborate with select companies on product development.
We seek to enter into collaborative arrangements with existing
and potential customers in attractive end user markets in order
to optimize our products for their use. For example, we
partnered with manufacturers of portable defibrillators at an
early stage in the development of this market, and we have
become a leading supplier of power semiconductors for these
devices.
Optimize mix between internal and external manufacturing.
We intend to continue using both internal wafer fabrication
facilities and our external foundry relationships. We also seek
to balance our product assembly through multiple sourcing
relationships. We believe these strategies enable us to maximize
our manufacturing efficiency and flexibility. We also believe
that our internal manufacturing capabilities enable us to lower
our manufacturing cost with respect to certain products, bring
products to market more quickly than
6
would be possible if we were required to rely exclusively on
external foundries, retain certain proprietary aspects of our
process technology and more quickly introduce new process and
product innovations through close collaboration between our
design and process engineers. Our alliances with external
foundries and assembly subcontractors allow us to substantially
reduce capital spending and manufacturing overhead expenses,
obtain competitive pricing and technologies and expand
manufacturing capacity more rapidly than could be achieved with
internal facilities alone.
Power Semiconductors
Our power semiconductor products have historically been divided
into two primary categories, power MOS transistors and bipolar
products. Our power semiconductors are sold separately and are
also packaged in high power modules that frequently consist of
multiple semiconductor dies. In fiscal year 2005, power
semiconductors constituted approximately 74.2% of our revenues,
which included about 38.3% from power MOS transistors and about
35.9% from bipolar products. In fiscal 2004, power
semiconductors constituted approximately 74.3% of our revenues,
which included about 31.4% from power MOS transistors and about
42.9% from bipolar products. In fiscal 2003, power
semiconductors constituted approximately 78.2% of our revenues,
which included about 29.7% from power MOS transistors and about
48.5% from bipolar products.
Power MOS transistors operate at much greater switching speeds,
allowing the design of smaller and less costly end products.
Power MOS transistors are activated by voltage rather than
current, so they require less external circuitry to operate,
making them more compatible with ICs controls. Power MOS
transistors also offer more reliable long-term performance and
are more rugged than traditional bipolar transistors, permitting
them to better withstand adverse operating conditions. Our power
MOS transistors consist of power MOSFETs and IGBTs.
A power MOSFET, or metal oxide silicon field effect transistor,
is a switch controlled by voltage at the gate. Power MOSFETs are
used in combination with passive components to vary the amperage
and frequency of electricity by switching on and off at high
frequency.
Our power MOSFETs are used primarily in power conversion systems
and are focused on higher voltage applications ranging from 60
to 1,700 volts. Our power MOSFETs have on-state resistance among
the lowest available for a given die size and voltage. Lower
on-state resistance results in increased efficiency in a power
device. We believe that as the power requirements of servers,
base stations and other computers increase as the result of
larger and more powerful processors and memory systems, the
designers of power supplies will increasingly demand higher
power density. MOSFETs accommodate this need by providing higher
power with higher efficiency and by reducing the physical size
of the power supplies incorporated into such equipment.
IGBTs, or insulated gate bipolar transistors, also are used as
switches. IGBTs have achieved many of the advantages of power
MOSFETs and of traditional bipolar technology by combining the
voltage controlled switching features of power MOSFETs with the
superior conductivity and energy efficiency of bipolar
transistors. For a given semiconductor die size, IGBTs can
operate at higher currents and voltages, making them a more
cost-effective device for high energy applications than power
MOSFETs.
Since inception, we have developed IGBTs for high voltage
applications. Our current products are focused on voltage
applications ranging from 300 volts to 2,500 volts. Our IGBTs
are used principally in AC motor drives, power systems and
defibrillators.
7
Bipolar products are also used to process electricity, but are
activated by current rather than voltage. Bipolar products are
capable of switching electricity at substantially higher power
levels than power MOS transistors. However, switching speeds of
bipolar products are slower than those of power MOS transistors
and, as a result, bipolar products are preferred where very high
power is required. Our bipolar products consist of rectifiers
and thyristors.
Rectifiers convert AC power to DC power and are used primarily
in input and output rectification and inverters. Our rectifiers
are used in DC and AC motor drives, power supplies, lighting and
heating controls and welding equipment.
A subset of our rectifier product group is a very fast switching
device known as a FRED, or fast recovery epitaxial diode. FREDs
limit spikes in voltage across the power switch to reduce power
dissipation and electromagnetic interference. Our FREDs are used
principally in AC motor drives and power supplies.
Thyristors are switches that can be turned on by a controlled
signal and turned off only when the output current is reduced to
zero, which occurs in the flow of AC power. Thyristors are
preferred over power MOSFETs and IGBTs in high voltage, low
frequency AC applications because their on-state resistance is
lower than the on state resistance of power MOSFETs and IGBTs.
Our thyristors are used in motor drives, defibrillators, power
supplies, lighting and heating controls and welding.
Integrated Circuits
Our integrated circuits address the demand for analog and mixed
signal interface solutions in the communication and other
industries, mixed signal application specific ICs designed for
specific customers as well as standard products, and power
management and control. ICs accounted for 15.9% of our revenues
in fiscal 2005, 17.6% in fiscal 2004 and 19.3% in fiscal 2003.
We manufacture solid-state relays, or SSRs, that isolate the low
current communication signal from the higher power circuit,
while also switching to control the flow of current. Our SSRs,
which include high voltage analog components, optocouplers and
integrated packages, are utilized principally in
telecommunication and video and data communication applications,
as well as instrumentation, industrial control, and aerospace
and automotive applications.
|
|
|
LCAS and DAA integrated products. |
A line card access switch, or LCAS, is a solid-state solution
for a switching function traditionally performed by
electromagnetic devices. Our LCAS products are used in central
office switching applications to enable data and voice
telephony. Data access arrangements, or DAAs, integrate a number
of discrete components and are principally used in analog data
communications that interface with telephone network
applications. Our
Litelinktm
products are DAAs for applications such as VOIP, wired
communication lines and set top boxes.
|
|
|
Application Specific Integrated Circuits. |
We design high voltage, analog and mixed signal application
specific integrated circuits, or ASICs, for a variety of
applications. Applying our technological expertise in ASICs, we
also design and sell application specific standard products. In
this regard, we have developed a line of source and gate drivers
for E Ink and liquid crystal displays.
8
|
|
|
Power Management and Control ICs. |
We also design and sell power management and control ICs, such
as current regulators, motion controllers, digital power
modulators and drivers for power MOSFETs and IGBTs. These ICs
typically manage, control or regulate power semiconductors and
the circuits and subassemblies that incorporate them.
RF Power Semiconductors
Our RF power devices switch electricity at the high rates
necessary to enable the amplification or reception of radio
frequencies. Our products include field effect transistors, or
FETs, pseudomorphic high electron mobility transistors, or
PHEMTs and Gunn diodes. These products are principally gallium
arsenide devices, which remain efficient at the high heat and
energy levels inherent in RF applications.
Other Products
We manufacture our proprietary direct copper bond, or DCB,
substrates for use in our own semiconductor products as well as
for sale to a variety of customers, including those in the power
semiconductor industry. DCB technology cost effectively provides
excellent thermal transfer while maintaining high electrical
isolation. Additionally, we manufacture and sell laser diode
drivers, high voltage pulse generators and modulators, and high
power subsystems that are principally based on our high power
semiconductor devices.
Products and Applications
Our power semiconductors are used primarily to control
electricity in power conversion systems, motor drives, plasma
display panels and medical electronics. Our ICs are used mainly
to interface with telecommunication lines, to control power
semiconductors and to drive medical equipment and displays. Our
RF power semiconductors enable the amplification and reception
of radio frequencies in telecommunication, industrial, defense
and space applications. The following table summarizes the
primary categories of uses for our products, some products used
within the categories and some of the applications served within
the categories.
|
|
|
|
|
|
|
Category |
|
IXYS Products | |
|
End User Applications |
|
|
| |
|
|
Power Conversion Systems
|
|
|
FRED |
|
|
SMPS and UPS for: |
|
|
|
IGBT |
|
|
Wireless base stations |
|
|
|
Module |
|
|
Internet facilities |
|
|
|
MOSFET |
|
|
Storage Area Networks |
|
|
|
Rectifier |
|
|
RF Generators |
|
|
|
IC Driver |
|
|
|
Motor Drives
|
|
|
FRED |
|
|
Automation |
|
|
|
IGBT |
|
|
Robotics |
|
|
|
Module |
|
|
Process control equipment |
|
|
|
MOSFET |
|
|
Machine tools |
|
|
|
Thyristor |
|
|
Electric trains |
|
|
|
IC Driver |
|
|
|
Medical Electronics
|
|
|
IGBT |
|
|
Defibrillators |
|
|
|
MOSFET |
|
|
Medical imaging devices |
|
|
|
Thyristor |
|
|
Laser power supplies |
|
|
|
IC |
|
|
Ultrasound |
|
|
|
GaAs FET |
|
|
Hearing aids |
Telecommunication
|
|
|
SSR |
|
|
Point of sale terminals |
|
|
|
LCAS |
|
|
Modems |
|
|
|
GaAs FET |
|
|
Set top boxes |
|
|
|
DAA |
|
|
Wireless base stations |
|
|
|
|
|
|
Central office |
Display
|
|
|
MOSFET |
|
|
Plasma display panels |
|
|
|
IC driver |
|
|
E-books |
9
We also sell our power semiconductor chips and DCB substrates to
other power semiconductor companies for use in their modules.
Sales and Marketing
We sell our products through a worldwide selling organization
that includes direct sales personnel, independent
representatives and distributors. As of March 31, 2005, we
employed 56 people in sales and marketing and customer support
and service and used 18 sales representative organizations and 6
distributors in North and South America and 47 sales
representative organizations and distributors in the rest of the
world. Sales to distributors accounted for approximately 36% of
net revenues in fiscal 2005, 37% of net revenues in fiscal 2004
and 36% of net revenues in fiscal 2003.
In fiscal year 2005, United States sales represented
approximately 28.2%, and international sales represented
approximately 71.8%, of our net revenues. Of our international
sales in fiscal year 2005, approximately 46.3% were derived from
sales in Europe and the Middle East, approximately 49.4% were
derived from sales in Asia and approximately 4.3% were derived
from sales in Canada and the rest of the world. One customer,
Samsung SDI Co., Ltd., accounted for more than 10% of our net
revenues in fiscal year 2005. For financial information about
geographic areas for each of our last three fiscal years, see
our Audited Consolidated Financial Statements, Note 15,
Segment and Geographic Information provided elsewhere in this
Annual Report on Form 10-K. For a discussion of the risks
attendant to our foreign operations, see Managements
Discussion and Analysis of Financial Condition and Results of
Operations-Risk Factors-Our international operations expose us
to material risks, provided elsewhere in this Annual
Report on Form 10-K, which information is incorporated by
reference into this Item 1.
We market our products through advertisements, technical
articles and press releases that appear regularly in a variety
of trade publications, as well as through the dissemination of
brochures, data sheets and technical manuals. Additionally, we
participate in industry trade shows on a regular basis. We also
have a presence on the Internet through a worldwide web page
that enables engineers to access and download technical
information and data sheets.
Research and Development
We believe that we successfully compete in our markets because
of our ability to design, develop and introduce to the market on
a timely basis new products offering technological improvements.
We are a pioneer in technology with respect to higher power
MOSFETs, IGBTs, SSRs, E Ink and cholesteric driver ICs and
direct-bonded substrates. While the time from initiation of
design to volume production of new semiconductors often takes
18 months or longer, our power semiconductors typically
have a product lifetime of years. Our research and development
expenses were approximately $18.6 million in fiscal 2005,
$15.8 million in fiscal 2004 and $12.8 million in
fiscal 2003. As of March 31, 2005, we employed 91 people in
engineering and research and development activities.
We are engaged in ongoing research and development efforts
focused on enhancements to existing products and the development
of new products. Currently, we are pursuing research and
development projects with respect to:
|
|
|
|
|
developing RF power MOSFETs and GaAs FETs; |
|
|
|
increasing the operating range of our MOS and bipolar products; |
|
|
|
developing new gallium arsenide products; |
|
|
|
developing high efficiency solar cells; |
|
|
|
developing higher power IGBT modules; |
|
|
|
developing power solid state relays; and |
|
|
|
developing power management ICs based on our HVIC technology. |
10
Research and development activities are conducted in
collaboration with manufacturing activities to help expedite new
products from the development phase to manufacturing and to more
quickly implement new process technologies.
Our research and development efforts also include participation
in technology collaborations with universities and research
institutions. These technology collaborations allow research and
development activities that would otherwise require potentially
cost-prohibitive capital expenditures since the necessary
capital equipment is often available at research institutes and
universities. Through these technology collaborations, we
believe we are able to maximize our range of research and
development activities without diffusing the focus of our
internal research and development work.
Patents and Other Intellectual Property Rights
As of March 31, 2005, we held 137 issued patents, of which
102 were issued in the U.S. and 35 were issued in international
jurisdictions. We rely on a combination of patent rights,
copyrights and trade secrets to protect the proprietary elements
of our products. Our policy is to file patent applications to
protect technology, inventions and improvements that are
important to our business. We also seek to protect our trade
secrets and proprietary technology, in part, through
confidentiality agreements with employees, consultants and other
parties.
While we believe that our intellectual property rights are
valuable, we also believe that other factors, such as innovative
skills, technical expertise, the ability to adapt quickly to new
technologies and evolving customer requirements, product support
and customer relations, are of greater competitive significance.
Manufacturing and Facilities
The production of our products is a highly complex and precise
process. We manufacture our products in our own manufacturing
facilities and by utilizing external wafer foundries and
subcontract assembly facilities. We divide our manufacturing
operations into three key areas: wafer fabrication, assembly and
test.
We own an approximately 170,000 square-foot facility in
Lampertheim, Germany at which we fabricate all of our bipolar
products and an approximately 83,000 square-foot facility
in Beverly, Massachusetts, capable of manufacturing high voltage
silicon on insulator ICs, where we fabricate our SSR, DAA and
LCAS products. We also lease an approximately
100,000 square foot facility in Chippenham, England, where
we fabricate the majority of our very high power devices, and an
approximately 30,000 square foot facility in Fremont,
California, where we manufacture our gallium arsenide RF power
semiconductors. We believe that our internal fabrication
capabilities enable us to lower our manufacturing cost with
respect to certain products, bring products to the market more
quickly than would be possible if we were required to rely
exclusively on external foundries, retain certain proprietary
aspects of our process technology and more quickly introduce new
process innovations.
In addition to maintaining our own fabrication facilities, we
have established alliances with selected foundries for wafer
fabrication. This approach allows us to reduce substantial
capital spending and manufacturing overhead expenses, obtain
competitive pricing and technologies and expand manufacturing
capacity more rapidly than could be achieved with internal
foundries alone. We retain the flexibility to shift the
production of our products to different or additional foundries
for cost or performance reasons. Our product designs enable the
production of our devices at multiple foundries using
well-established and cost-effective processes.
Measured in dollars, we relied on external foundries for
approximately 43% of our wafer fabrication requirements in
fiscal year 2005, and our utilization of external foundries is
expected to grow. We have arrangements with a number of external
wafer foundries, three of which provide the wafers for power
semiconductors that we purchase from external foundries. Our
principal external foundry is Samsung Electronics facility
located in Kiheung, South Korea. Our relationship with Samsung
Electronics extends for
11
two decades. We provide our foundries forecasts for wafer
fabrication six months in advance and make firm purchase
commitments one to two months in advance of delivery. Other than
these firm commitments, we do not have any obligations to order
any minimum quantities. In addition, we periodically jointly
purchase equipment for manufacturing.
Wafer fabrication of power semiconductors generally employs
process technology and equipment already proven in IC
manufacturing. Power semiconductors are manufactured using
fabrication equipment that is one or more generations behind the
equipment used to fabricate leading edge ICs. Used fabrication
equipment can be obtained at prices substantially less than the
original cost of such equipment or the cost of current equipment
applying the latest technology. Consequently, the fabrication of
power semiconductors is less capital intensive than the
fabrication of leading edge ICs.
For a discussion of risks attendant to our acquisition of wafers
prior to fabrication, see Managements Discussion and
Analysis of Financial Condition and Results of Operations-Risk
Factors-We depend upon a limited number of suppliers for our
wafers, provided elsewhere in this Annual Report on
Form 10-K, which information is incorporated by
reference into this Item 1. For a discussion of
environmental risks attendant to our business, see
Managements Discussion and Analysis of Financial
Condition and Results of Operations-Risk Factors-We may be
affected by environmental laws and regulations, provided
elsewhere in this Annual Report on Form 10-K, which
information is incorporated by reference into this Item 1.
Packaging or assembly refers to the sequence of production steps
that divide the wafer into individual chips and enclose the
chips in external structures, called packages, which make them
useable in a circuit. Discrete manufacturing involves the
assembly and packaging of single semiconductor, or die, devices.
Module manufacturing involves the assembly of multiple devices
within a single package. SSR products involve multiple chip
assembly on a specialized lead frame. The resulting packages
vary in configuration, but all have leads that are used to mount
the package through holes in the customers printed circuit
boards.
Most of our wafers are sent to independent subcontract assembly
facilities. We use assembly subcontractors located in Asia and
Europe in order to take advantage of low assembly costs.
Measured in dollars, approximately 54% of our products are
assembled at external assembly facilities, and the rest are
assembled in our Lampertheim, Chippenham and Fremont facilities.
Generally, each die on our wafers is electrically tested for
performance after wafer fabrication. Following assembly, our
products are typically returned to our facilities for testing
and final inspection prior to shipment to customers.
Competition
The semiconductor industry is intensely competitive and is
characterized by price competition, technological change,
limited fabrication capacity, international competition and
manufacturing yield problems. The competitive factors in the
market for our products include:
|
|
|
|
|
proper new product definition; |
|
|
|
product quality, reliability and performance; |
|
|
|
product features; |
|
|
|
timely delivery of products; |
|
|
|
price; |
|
|
|
timely delivery of products; |
|
|
|
breadth of product line; |
12
|
|
|
|
|
design and introduction of new products; |
|
|
|
market acceptance of our products and those of our
customers; and |
|
|
|
technical support and service. |
We believe that we are one of a limited group of companies
focused on the development and marketing of high power, high
performance semiconductors capable of performing all of the
basic functions of power semiconductor design and manufacture.
Our primary power semiconductor competitors include Advanced
Power Technology, Fairchild Semiconductor, Fuji, Infineon,
International Rectifier, On Semiconductor, Powerex, Renesas
Technology, Semikron International, STMicroelectronics, Siemens
and Toshiba. Our IC products compete principally with those of
Agere Systems, Legerity, NEC and Silicon Labs. Our RF power
semiconductor competitors include RF Micro Devices and RF
Monolithics.
Backlog
Our trade sales are made primarily pursuant to standard purchase
orders that are booked months in advance of delivery. Generally,
prices and quantities are fixed at the time of booking. Backlog
as of a given date consists of existing orders from our
customers. Backlog is influenced by several factors including
market demand, pricing and customer order patterns in reaction
to product lead times.
In the semiconductor industry, backlog quantities and shipment
schedules under outstanding purchase orders are frequently
revised to reflect changes in customer needs. Agreements calling
for the sale of specific quantities are either contractually
subject to quantity revisions or, as a matter of industry
practice, are often not enforced. Therefore, a significant
portion of our order backlog may be cancelable. For these
reasons, the amount of backlog as of any particular date may not
be an accurate indicator of future results.
We sell products to key customers pursuant to contracts that
allow us to schedule production capacity in advance and allow
the customers to manage their inventory levels consistent with
just-in-time principles while shortening the cycle times
required to produce ordered product. However, these contracts
are typically amended to reflect changes in customer demands and
periodic price renegotiations.
At March 31, 2005, our backlog of orders was approximately
$78.9 million, as compared with $77.3 million at
March 31, 2004. Backlog represents firm orders expected to
be shipped within the 12 months following March 31,
2005.
Employees
At March 31, 2005, we employed 858 employees, of whom 91
were primarily engaged in engineering and research and
development activities, 56 in marketing, sales and customer
support, 653 in manufacturing and 58 in administration and
finance. Of these employees, 112 hold engineering or science
degrees, including 19 Ph.D.s. Certain employees at our
Lampertheim and Chippenham facilities are subject to collective
bargaining agreements. There have been no work stoppages at any
of our facilities to date. We believe that our employee
relations are good.
Available Information
We currently make available through our website at
http://www.IXYS.com, free of charge, copies of our annual report
on Form 10-K, our quarterly reports on Form 10-Q and
our current reports on Form 8-K, and amendments to those
reports, as soon as reasonably practicable after submitting the
information to the SEC. None of the information posted on our
website is incorporated by reference into this Annual Report.
You can also request free copies of such documents by contacting
us at 408-982-0700 or by sending an e-mail to
investorrelations@IXYS.net.
13
Our principal facilities are described below:
|
|
|
|
|
|
|
|
|
|
|
|
|
Approximate | |
|
|
|
|
|
|
Square | |
|
|
|
|
Principal Facilities |
|
Footage | |
|
Lease Expiration | |
|
Use |
|
|
| |
|
| |
|
|
Aliso Viejo, California
|
|
|
27,000 |
|
|
|
April 2006(1) |
|
|
Research and development, sales and distribution |
Beverly, Massachusetts
|
|
|
83,000 |
|
|
|
(2) |
|
|
Research and development, manufacturing, sales and distribution |
Chippenham, England
|
|
|
100,000 |
|
|
|
December 2022 |
|
|
Research and development, manufacturing, sales and distribution |
Fremont, California
|
|
|
30,000 |
|
|
|
November 2008 |
|
|
Research and development, manufacturing, sales and distribution |
Lampertheim, Germany
|
|
|
170,000 |
|
|
|
(3) |
|
|
European headquarters, research and development, manufacturing,
sales and distribution |
Santa Clara, California
|
|
|
20,000 |
|
|
|
January 2009 |
|
|
Corporate headquarters, research and development, sales and
distribution |
|
|
(1) |
Under contract for acquisition at a purchase price of
$5.1 million. |
|
(2) |
Owned, not leased. Acquired on May 6, 2005 for
$9.0 million. |
|
(3) |
Owned, not leased. |
We believe that our current facilities are suitable to our needs
and will be adequate through at least fiscal year 2006 and that
suitable additional or replacement space will be available in
the future as needed on commercially reasonably terms.
|
|
Item 3. |
Legal Proceedings |
We currently are involved in a variety of legal matters that
arise in the normal course of business. Were an unfavorable
ruling to occur, there could be a material adverse impact on our
financial condition, results of operations or cash flows.
On June 22, 2000, International Rectifier Corporation filed
an action for patent infringement against IXYS in the United
States District Court for the Central District of California,
alleging that certain of IXYSs products sold in the United
States infringe U.S. patents owned by International
Rectifier. International Rectifiers complaint against IXYS
contended that IXYSs alleged infringement of International
Rectifiers patents has been and continues to be willful
and deliberate. Subsequently, the U.S. District Court
decided that certain of IXYSs power MOSFETs and IGBTs
infringe certain claims of each of three International Rectifier
U.S. patents.
In 2002, the U.S. District Court entered a permanent
injunction barring IXYS from making, using, offering to sell or
selling in, or importing into, the United States, MOSFETs
(including IGBTs) covered by the subject patents and ruled that
International Rectifier should be awarded damages of
$9.1 million for IXYSs alleged infringement of
International Rectifiers patents. In addition, the
U.S. District Court ruled that IXYS had been guilty of
willful infringement. Subsequently, the U.S. District Court
increased the damages to a total of $27.2 million, plus
attorney fees.
IXYS appealed and on March 19, 2004 the United States Court
of Appeals for the Federal Circuit reversed or vacated all
findings of patent infringement previously issued against IXYS
by the U.S. District Court, and vacated the permanent
injunction. On August 9, 2004, the Federal Circuit Court
vacated the damages award. The case was remanded to the
U.S. District Court for further proceedings. The case has
been set for trial to commence on August 2, 2005.
14
There can be no assurance of a favorable outcome in the
International Rectifier suit. In the event of an adverse
outcome, damages or injunctions awarded by the
U.S. District Court would be materially adverse to
IXYSs financial condition, results of operations and cash
flows. Management has not accrued any amounts for damages in the
accompanying balance sheets for the International Rectifier
matter described above.
On April 10, 2003, LoJack Corporation (LoJack)
filed a suit against Clare, Inc. in the Superior Court of
Norfolk County, Massachusetts claiming breach of contract,
unjust enrichment, breach of the implied covenant of good faith
and fair dealing, failure to perform services and violation of a
Massachusetts statute prohibiting unfair and deceptive acts and
practices, all purportedly resulting from Clares alleged
breach of a contract to develop custom integrated circuits and a
module assembly.
In its complaint, LoJack sought damages in an amount to be
determined at trial, an $890,000 refund of payments it made
under the contract, all work product resulting from any work
prepared by Clare and its attorneys fees in the suit.
LoJack also sought to have its damages trebled under the
Massachusetts statute.
Clare answered the complaint denying any liability and
counterclaiming for breach of contract, unjust enrichment,
breach of the implied covenant of good faith and fair dealing,
violation of the Massachusetts statute, promissory estoppel and
negligent misrepresentation. Discovery in the litigation is
largely complete. Motions for summary judgment have been briefed
but not yet heard. A trial date of October 11, 2005 has
been set.
There can be no assurance of a favorable outcome in the LoJack
suit. In the event of an adverse outcome, damages awarded by the
court could be materially adverse to our financial condition,
results of operations or cash flows. Management has not accrued
any amounts for damages in the accompanying balance sheets for
the LoJack matter described above.
We do not provide any product or similar guarantees or
warranties. However, we provide in the normal course of business
indemnification to officers, directors and selected parties.
|
|
Item 4. |
Submission of Matters to a Vote of Security Holders |
The Annual Meeting of the Stockholders of the Company following
the fiscal year ended March 31, 2004 (the Annual
Meeting) was held on March 31, 2005.
At the Annual Meeting, the stockholders elected each of the
persons identified below to serve as a director of the Company
until the next Annual Meeting of the Stockholders or until such
persons successor is elected (the Director
Proposal) and ratified the appointment of BDO Seidman, LLP
as the independent auditors of the Company for the fiscal year
ending March 31, 2005 (the Auditor Proposal).
The votes on the two proposals were as follows:
|
|
|
Proposal 1: The Director Proposal |
|
|
|
|
|
|
|
|
|
Director |
|
Votes For | |
|
Votes Withheld | |
|
|
| |
|
| |
Donald Feucht
|
|
|
29,710,433 |
|
|
|
1,038,560 |
|
Samuel Kory
|
|
|
25,502,923 |
|
|
|
5,246,070 |
|
S. Joon Lee
|
|
|
29,778,399 |
|
|
|
970,594 |
|
Kenneth D. Wong
|
|
|
29,846,818 |
|
|
|
902,175 |
|
Nathan Zommer
|
|
|
29,772,232 |
|
|
|
976,761 |
|
|
|
|
Proposal 2: The Auditor Proposal |
|
|
|
|
|
Votes in Favor:
|
|
|
30,378,361 |
|
Votes Against:
|
|
|
365,074 |
|
Abstentions:
|
|
|
5,558 |
|
Broker Non-Votes:
|
|
|
|
|
15
Executive Officers of the Registrant
The executive officers, their ages and positions at IXYS, as
well as certain biographical information of these individuals,
are set forth below. The ages of the individuals are provided as
of March 31, 2005.
|
|
|
|
|
|
|
Name |
|
Age | |
|
Position(s) |
|
|
| |
|
|
Nathan Zommer
|
|
|
57 |
|
|
Chairman of the Board, President and Chief Executive Officer |
Uzi Sasson
|
|
|
42 |
|
|
Vice President of Finance, Chief Financial Officer and Secretary |
Peter H. Ingram
|
|
|
56 |
|
|
President of European Operations |
Kevin McDonough
|
|
|
53 |
|
|
President of U.S. Operations |
There are no family relationships among our directors and
executive officers.
Nathan Zommer. Dr. Zommer, our founder, has served
as a Director since our inception in 1983, and has served as
Chairman of the Board, President and Chief Executive Officer
since 1993. From 1984 to 1993, Dr. Zommer served as our
Executive Vice President. Prior to founding IXYS,
Dr. Zommer served in a variety of positions with Intersil,
Hewlett-Packard and General Electric, including as a scientist
in the Hewlett-Packard Laboratories and Director of the Power
MOS Division for Intersil/ General Electric. Dr. Zommer
received his B.S. and M.S. degrees in Physical Chemistry from
Tel Aviv University and a Ph.D. in Electrical Engineering from
Carnegie Mellon University.
Uzi Sasson. Mr. Sasson has served as our Vice
President of Finance, Chief Financial Officer and Secretary
since November 2004. From February to November 2004,
Mr. Sasson was the Chief Executive Officer of Sagent
Management, a tax and accounting consulting firm.
Mr. Sasson also served as the interim Chief Financial
Officer for Digital Power Corp., a manufacturer of switching
power supplies, from June 2004 to November 2004. Mr. Sasson
served as Vice President of Tax for Mercury Interactive
Corporation, a provider of software and services for the
business technology optimization marketplace, from 2001 to 2003.
Prior to that, Mr. Sasson was a Senior Manager at
PricewaterhouseCoopers LLP, an accounting firm, from 1992 to
2001. From August to November 2004, Mr. Sasson served as a
director of IXYS. Mr. Sasson has a Masters of Science in
Taxation and Bachelor of Science in Accounting from Golden Gate
University and is a Certified Public Accountant in California.
Peter H. Ingram. Mr. Ingram has served as our
President of European Operations since 2000. From 1994 to 2000,
he served as our Vice President of European Operations. From
1989 to 1994, he served as our Director of Wafer Fab Operations.
Mr. Ingram worked with the semiconductor operations of ABB
from 1982 until we acquired those operations in 1989.
Mr. Ingram received an Honors degree in Chemistry from the
University of Nottingham.
Kevin McDonough. Mr. McDonough has served as our
President of U.S. Operations since 2001. From 1999 to 2000,
he served as our Vice President of U.S. Operations. From
1998 to 1999, he served as our Director of Quality Assurance and
Product Engineering, and from 1990 to 1994, he served as our
Director of Operations and Quality Assurance. From 1995 to 1998,
Mr. McDonough served as Manager of Wafer Fab Foundries for
Advanced Micro Devices. Mr. McDonough received his B.S. in
Zoology from the University of California at Davis and his
M.B.A. from Oregon State University.
16
PART II
|
|
Item 5. |
Market for Registrants Common Equity, Related
Stockholders Matters and Issuer Purchases of Equity
Securities |
The following table presents, for the periods indicated, the
high and low sale prices per share of our common stock as
reported by The Nasdaq National Market:
|
|
|
|
|
|
|
|
|
|
|
|
High | |
|
Low | |
|
|
| |
|
| |
Fiscal year ending March 31, 2005
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$ |
10.81 |
|
|
$ |
7.53 |
|
|
Second Quarter
|
|
$ |
7.98 |
|
|
$ |
6.11 |
|
|
Third Quarter
|
|
$ |
10.61 |
|
|
$ |
6.66 |
|
|
Fourth Quarter
|
|
$ |
11.67 |
|
|
$ |
9.19 |
|
Fiscal year ending March 31, 2004
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$ |
8.70 |
|
|
$ |
5.16 |
|
|
Second Quarter
|
|
$ |
11.44 |
|
|
$ |
6.02 |
|
|
Third Quarter
|
|
$ |
10.55 |
|
|
$ |
7.05 |
|
|
Fourth Quarter
|
|
$ |
11.55 |
|
|
$ |
8.02 |
|
The number of record holders of our common stock as of
May 16, 2005 was 486. To date, we have not declared or paid
cash dividends. We have no plans to do so.
Equity Compensation Plans Information
The information in the following table is as of March 31,
2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) | |
|
|
(a) | |
|
|
|
Number of Securities | |
|
|
Number of Securities | |
|
(b) | |
|
Remaining Available for | |
|
|
to be Issued Upon | |
|
Weighted-Average | |
|
Future Issuance Under | |
|
|
Exercise of | |
|
Exercise Price of | |
|
Equity Compensation Plans | |
|
|
Outstanding Options, | |
|
Outstanding Options, | |
|
(Excluding Securities | |
Plan Category |
|
Warrants and Rights | |
|
Warrants and Rights | |
|
Reflected in Column (a)) | |
|
|
| |
|
| |
|
| |
Equity compensation plans approved by security holders
|
|
|
5,197,075 |
(1)(2) |
|
$ |
6.68 |
|
|
|
3,797,858 |
(2) |
Equity compensation plans not approved by security holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
5,197,075 |
|
|
$ |
6.68 |
|
|
|
3,797,858 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes options to purchase 417,000 shares of our
common stock with a weighted average exercise price of
$12.12 per share that were assumed in business
combinations. It is our understanding that the stockholders of
the acquired companies approved the plans from which these
options were granted. |
|
(2) |
The 1999 Equity Incentive Plan includes a formula that provides
for an annual increase in the number of shares under the plan up
to 1,000,000, upon the determination of the Board of Directors. |
Issuer Purchases of Equity Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number of | |
|
|
|
|
|
|
|
|
Shares Purchased as | |
|
Maximum Number of | |
|
|
|
|
|
|
Part of Publicly | |
|
Shares that may yet | |
|
|
Total Number of | |
|
Average Price | |
|
Announced Plans or | |
|
be Purchased Under | |
Period |
|
Shares Purchased | |
|
Paid per Share | |
|
Programs | |
|
the Plans or Programs | |
|
|
| |
|
| |
|
| |
|
| |
January 1, 2005 - January 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
925,100 |
|
February 1, 2005 - February 28, 2005
|
|
|
56,800 |
|
|
$ |
9.98 |
|
|
|
56,800 |
|
|
|
868,300 |
|
March 1, 2005 - March 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
868,300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
56,800 |
|
|
$ |
9.98 |
|
|
|
56,800 |
|
|
|
|
|
17
The program effective during the period from January 1,
2005 to March 31, 2005 was announced on May 24, 2004
and expired on June 10, 2005. The purchase of up to
1,000,000 shares of common stock was approved. A new
program was announced June 8, 2005 and will expire on
June 3, 2006. The purchase of up to 1,000,000 shares
of common stock was approved.
|
|
Item 6. |
Selected Financial Data |
The following selected consolidated financial information should
be read in conjunction with our Consolidated Financial
Statements and related notes and Managements Discussion
and Analysis of Financial Condition and Results of Operations
included elsewhere in this Annual Report on Form 10-K. The
consolidated statements of operations data for the years ended
March 31, 2005, 2004 and 2003 and the balance sheet data as
of March 31, 2005 and 2004 are derived from our
consolidated financial statements included elsewhere in this
Annual Report on Form 10-K. The statements of operations
data for the years ended March 31, 2002 and 2001 and the
balance sheet data as of March 31, 2003, 2002 and 2001 are
derived from our consolidated financial statements that are not
included in this Annual Report on Form 10-K. Historical
results are not necessarily indicative of results to be expected
in any future period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004(1) | |
|
2003(2) | |
|
2002(3) | |
|
2001 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands, except per share amounts) | |
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenues
|
|
$ |
256,620 |
|
|
$ |
187,442 |
|
|
$ |
136,111 |
|
|
$ |
82,821 |
|
|
$ |
111,389 |
|
Cost of goods sold
|
|
|
176,710 |
|
|
|
143,948 |
|
|
|
107,371 |
|
|
|
56,918 |
|
|
|
69,967 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
79,910 |
|
|
|
43,494 |
|
|
|
28,740 |
|
|
|
25,903 |
|
|
|
41,422 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research, development and engineering
|
|
|
18,574 |
|
|
|
15,811 |
|
|
|
12,846 |
|
|
|
5,728 |
|
|
|
6,081 |
|
|
Selling, general and administrative
|
|
|
35,707 |
|
|
|
32,742 |
|
|
|
32,437 |
|
|
|
17,614 |
|
|
|
17,187 |
|
|
Restructuring charge
|
|
|
|
|
|
|
|
|
|
|
750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
54,281 |
|
|
|
48,553 |
|
|
|
46,033 |
|
|
|
23,342 |
|
|
|
23,268 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
25,629 |
|
|
|
(5,059 |
) |
|
|
(17,293 |
) |
|
|
2,561 |
|
|
|
18,154 |
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income, net
|
|
|
633 |
|
|
|
310 |
|
|
|
720 |
|
|
|
1,318 |
|
|
|
1,030 |
|
|
Other income (expense), net
|
|
|
(481 |
) |
|
|
(1,324 |
) |
|
|
(1,288 |
) |
|
|
(757 |
) |
|
|
2,724 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before provision for income taxes
|
|
|
25,781 |
|
|
|
(6,073 |
) |
|
|
(17,861 |
) |
|
|
3,122 |
|
|
|
21,908 |
|
(Provision for) benefit from income taxes
|
|
|
(9,539 |
) |
|
|
1,641 |
|
|
|
5,716 |
|
|
|
(1,184 |
) |
|
|
(8,321 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
16,242 |
|
|
$ |
(4,432 |
) |
|
$ |
(12,145 |
) |
|
$ |
1,938 |
|
|
$ |
13,587 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share basic
|
|
$ |
0.49 |
|
|
$ |
(0.14 |
) |
|
$ |
(0.39 |
) |
|
$ |
0.07 |
|
|
$ |
0.54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in per share
calculation basic
|
|
|
33,093 |
|
|
|
32,434 |
|
|
|
30,889 |
|
|
|
26,745 |
|
|
|
25,239 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share diluted
|
|
$ |
0.46 |
|
|
$ |
(0.14 |
) |
|
$ |
(0.39 |
) |
|
$ |
0.07 |
|
|
$ |
0.49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in per share
calculation diluted
|
|
|
35,085 |
|
|
|
32,434 |
|
|
|
30,889 |
|
|
|
29,004 |
|
|
|
27,774 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selected Operating Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin
|
|
|
31.1 |
% |
|
|
23.2 |
% |
|
|
21.1 |
% |
|
|
31.3 |
% |
|
|
37.2 |
% |
|
Depreciation and amortization
|
|
$ |
10,639 |
|
|
$ |
11,186 |
|
|
$ |
9,297 |
|
|
$ |
5,835 |
|
|
$ |
3,409 |
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
58,144 |
|
|
|
42,058 |
|
|
|
40,094 |
|
|
|
32,111 |
|
|
|
44,795 |
|
|
Working capital
|
|
|
124,063 |
|
|
|
96,246 |
|
|
|
95,425 |
|
|
|
81,399 |
|
|
|
82,007 |
|
|
Total assets
|
|
|
219,891 |
|
|
|
198,269 |
|
|
|
183,057 |
|
|
|
124,560 |
|
|
|
127,414 |
|
|
Total long-term obligations
|
|
|
16,796 |
|
|
|
15,120 |
|
|
|
14,966 |
|
|
|
12,261 |
|
|
|
8,307 |
|
|
Total stockholders equity
|
|
|
165,277 |
|
|
|
145,531 |
|
|
|
138,809 |
|
|
|
95,219 |
|
|
|
92,724 |
|
|
|
(1) |
During fiscal 2004, we completed our acquisition of Microwave
Technology, Inc. |
|
(2) |
During fiscal 2003, we completed our acquisition of Clare, Inc. |
|
(3) |
During fiscal 2002, we completed our acquisition of Westcode
Semiconductors, Ltd. |
|
|
Item 7. |
Managements Discussion and Analysis of Financial
Condition and Results of Operations |
This discussion contains forward-looking statements, which
are subject to certain risks and uncertainties, including,
without limitation, those described elsewhere in this
Item 7. Actual results may differ materially from the
results discussed in the forward-looking statements. For a
discussion of risks that could affect future results, see
Risk Factors below. All forward-looking statements
included in this document are made as of the date hereof, based
on the information available to us as of the date hereof, and we
assume no obligation to update any forward-looking statement.
Overview
We are a multi-market integrated semiconductor company. Our
three principal product groups are: power semiconductors;
integrated circuits; and systems and RF power semiconductors.
Our power semiconductors improve system efficiency and
reliability by converting electricity at relatively high voltage
and current levels into the finely regulated power required by
electronic products. We focus on the market for power
semiconductors that are capable of processing greater than 200
watts of power.
We also design, manufacture and sell integrated circuits for a
variety of applications. Our analog and mixed signal integrated
circuits, or ICs, are principally used in telecommunications
applications. Our mixed signal application specific ICs, or
ASICs, address the requirements of the medical imaging equipment
and display markets. Our power management and control ICs are
used in conjunction with our power semiconductors.
Our radio frequency, or RF, power semiconductors enable
circuitry that amplifies or receives radio frequencies in
wireless and other microwave communication applications, medical
imaging applications and defense and space applications.
In fiscal year 2005, United States sales represented
approximately 28.2% and international sales represented
approximately 71.8%, of our net revenues. Of our international
sales, approximately 46.3% were derived from sales in Europe and
the Middle East, approximately 49.4% were derived from sales in
Asia and approximately 4.3% were derived from sales in Canada
and the rest of the world. One customer, Samsung SDI Co., Ltd.,
accounted for more than 10% of our net revenues in fiscal year
2005.
During the last fiscal year, we have seen a trend of increasing
growth in revenues from the sale of power semiconductors,
particularly those for inclusion in consumer products. With the
increasing production resulting from these and other sales of
power semiconductors, we have experienced increasing economies
of scale and have been able to lower our unit cost of
production. Since most of our customers that manufacture
consumer products are located in Asia, we have seen a shift
toward Asia in our revenues. Our power semiconductors for the
consumer products market are manufactured at external foundries.
Consequently, we
19
have seen an increase in the proportion of our products that are
fabricated in external foundries rather than in our own
facilities.
Critical Accounting Policies and Significant Management
Estimates
The discussion and analysis of our financial condition and
results of operations are based upon our consolidated financial
statements, which have been prepared in accordance with
accounting principles generally accepted in the United States of
America. The preparation of these financial statements requires
management to make estimates and judgments that affect the
reported amounts of assets, liabilities, revenues and expenses,
and related disclosures of contingent assets and liabilities. On
an ongoing basis, management evaluates the reasonableness of its
estimates. Management bases its estimates on historical
experience and on various assumptions that are believed to be
reasonable under the circumstances, the results of which form
the basis for making judgments about the carrying values of
assets and liabilities that are not readily available from other
sources. Actual results may differ from these estimates under
different assumptions or conditions.
We believe the following critical accounting policies affect our
more significant judgments and estimates used in preparing our
consolidated financial statements.
Revenue recognition. We sell to distributors and original
equipment manufacturers. Approximately 36% of our revenues in
fiscal 2005 and 37% of our revenues in fiscal 2004 were from
distributors. We provide our distributors with the following
programs: stock rotation and ship and debit. Ship and debit is a
form of price protection. We recognize revenue from product
sales upon shipment provided that we have received an executed
purchase order, the price is fixed and determinable, the risk of
loss has transferred, collection of resulting receivables is
reasonably assured, there are no customer acceptance
requirements, and there are no remaining significant
obligations. Reserves for allowances are also recorded at the
time of shipment. Our management must make estimates of
potential future product returns and so called ship and
debit transactions related to current period product
revenue. Our management analyzes historical returns and ship and
debit transactions, current economic trends and changes in
customer demand and acceptance of our products when evaluating
the adequacy of the sales returns and allowances. Significant
management judgments and estimates must be made and used in
connection with establishing the allowances in any accounting
period. Material differences may result in the amount and timing
of our revenue for any period if management made different
judgments or utilized different estimates.
For our nonrecurring engineering, or NRE, related to engineering
work performed by our Clare Micronix division to design chip
prototypes that will later be used to produce required units,
customers enter into arrangements with Clare Micronix to perform
engineering work for a fixed fee. Clare Micronix records
fixed-fee payments during the development phase from customers
in accordance with Statement of Financial Accounting Standards
No. 68, Research and Development Arrangements
Amounts offset against research and development costs totaled
approximately $161,000 in fiscal 2005, $382,000 in fiscal 2004
and $329,000 in fiscal 2003.
Allowance for sales returns. We maintain an allowance for
sales returns for estimated product returns by our customers. We
estimate our allowance for sales returns based on our historical
return experience, current economic trends, changes in customer
demand, known returns we have not received and other
assumptions. If we make different judgments or utilize different
estimates, the amount and timing of our revenue could be
materially different. Given that our revenues consist of a high
volume of relatively similar products, our actual returns and
allowances have not fluctuated significantly from period to
period to date, and our returns provisions have historically
been reasonably accurate. This allowance is included as part of
the accounts receivable allowance on the balance sheet and as a
reduction to gross revenues in the calculation of net revenues
on the statement of operations.
Allowance for stock rotation. We also provide stock
rotation to select distributors. The rotation allows
distributors to return a percentage of the previous six
months sales. In the fiscal years ended March 31,
2005, 2004, and 2003 approximately $1.1 million, $595,000,
and $1.3 million, respectively, of products were returned
to us under the program. This allowance is included as part of
the accounts receivable allowance on the balance sheet and as a
reduction to gross revenues in the calculation of net revenues
on the statement of
20
operations. We establish the allowance based upon maximum
allowable rotations, which is consistent with our historical
experience.
Allowance for doubtful accounts. We maintain an allowance
for doubtful accounts for estimated losses from the inability of
our customers to make required payments. We evaluate our
allowance for doubtful accounts based on the aging of our
accounts receivable, the financial condition of our customers
and their payment history, our historical write-off experience
and other assumptions. If we were to make different judgments of
the financial condition of our customers or the financial
condition of our customers were to deteriorate, resulting in an
impairment of their ability to make payments, additional
allowances may be required. This allowance is reported on the
balance sheet as part of the accounts receivable allowance and
is included on the statement of operations as part of selling,
general and administrative expense. This allowance is based on
historical losses and managements estimates of future
losses.
Allowance for ship and debit. Ship and debit is a program
designed to assist distributors in meeting competitive prices in
the marketplace on sales to their end customers. Ship and debit
requires a request from the distributor for a pricing adjustment
for a specific part for a customer sale to be shipped from the
distributors stock. We have no obligation to accept this
request. However, it is our historical practice to allow some
companies to obtain sales discounts for inventory held. Our
distributors had approximately $4.5 million in inventory of
our products on hand at March 31, 2005. Ship and debit
authorizations may cover current and future distributor activity
for a specific part for sale to the distributors customer.
In accordance with Staff Accounting Bulletin No. 104
Topic 13, Revenue Recognition, at the time we
record sales to the distributors, we provide an allowance for
the estimated future distributor activity related to such sales
since it is probable that such sales to distributors will result
in ship and debit activity. The sales allowance requirement is
based on sales during the period, credits issued to
distributors, distributor inventory levels, historical trends,
market conditions, pricing trends we see in our direct sales
activity with original equipment manufacturers and other
customers, and input from sales, marketing and other key
management. We receive periodic statements regarding our
products held by our distributors. These procedures require the
exercise of significant judgments. We believe that they enable
us to make reliable estimates of future credits under the ship
and debit program. Our actual results to date have approximated
our estimates. At the time the distributor ships the part from
stock, the distributor debits us for the authorized pricing
adjustment. This allowance is included as part of the accounts
receivable allowance on the balance sheet and as a reduction to
gross revenues in the calculation of net revenues on the
statement of operations. If competitive pricing were to decrease
sharply and unexpectedly, our estimates would be insufficient,
which could significantly adversely affect results.
Additions to the ship and debit allowance are estimates of the
amount of expected future ship and debit activity related to
sales during the period and reduce revenues and gross profit in
the period. The following table sets forth the beginning and
ending balances of, additions to, and deductions from, our
allowance for ship and debit during the three years ended
March 31, 2005 (in thousands):
|
|
|
|
|
|
Balance March 31, 2002
|
|
$ |
355 |
|
|
Additions
|
|
|
2,062 |
|
|
Deductions
|
|
|
(1,934 |
) |
|
|
|
|
Balance March 31, 2003
|
|
|
483 |
|
|
Additions
|
|
|
2,189 |
|
|
Deductions
|
|
|
(2,248 |
) |
|
|
|
|
Balance March 31, 2004
|
|
|
424 |
|
|
Additions
|
|
|
2,742 |
|
|
Deductions
|
|
|
(2,613 |
) |
|
|
|
|
Balance March 31, 2005
|
|
$ |
553 |
|
|
|
|
|
Inventories. Inventories are recorded at the lower of
standard cost, which approximates actual cost on a
first-in-first-out basis, or market value. Consistent with
Statement 3 of Accounting Research Bulletin 43, or
21
ARB 43, our accounting for inventory costing is based on the
applicable expenditure incurred, directly or indirectly, in
bringing the inventory to its existing condition. Such
expenditures include acquisition costs, production costs and
other costs incurred to bring the inventory to its use. In
accordance with Statement 4 of ARB 43, as it is impractical
to track inventory from the time of purchase to the time of sale
for the purpose of specifically identifying inventory cost, our
inventory is therefore valued based on a standard cost, given
that the materials purchased are identical and interchangeable
at various production process. We review our standard costs on
an as-needed basis but in any event at least once a year, and
update them as appropriate to approximate actual costs.
We typically plan our production and inventory levels based on
internal forecasts of customer demand, which are highly
unpredictable and can fluctuate substantially. The value of our
inventories is dependent on our estimate of future demand as it
relates to historical sales. If our projected demand is
over-estimated, we may be required to reduce the valuation of
our inventories below cost. We regularly review inventory
quantities on hand and record an estimated provision for excess
inventory based primarily on our historical sales. We perform an
analysis of inventories and compare the sales for the preceding
two years. To the extent we have inventory in excess of the
greater of two years historical sales, twice the most
recent years historical sales or backlog, we recognize a
reserve for excess inventories. However, for new products, we do
not consider whether there is excess inventory until we develop
sufficient sales history or experience a significant change in
expected product demand based on backlog. Actual demand and
market conditions may be different from those projected by our
management. This could have a material effect on our operating
results and financial position. If we make different judgments
or utilize different estimates, the amount and timing of our
write-down of inventories may be materially different.
During the economic downturn of fiscal 2002 and fiscal 2003, we
built inventory beyond demand in our Santa Clara operation.
At the end of fiscal 2003, excess inventory was measured by sets
of related product part numbers rather than by individual
product part numbers. These sets were used because it was
thought that sales of such would be representative of the sales
of the individual part numbers within any such set. The
fiscal 2003 analysis resulted in a write-down of
$7.3 million.
For the fourth quarter of fiscal 2004, we recognized that sales
by sets of related product part numbers were not revealing
individual part numbers that were not selling at a similar rate
and so we refined the calculation to examine excess inventory by
individual part number. This resulted in an additional
$2.1 million write-down during fiscal 2004. The fiscal 2005
charge is the result of the application of our normal policy.
Excess inventory frequently remains saleable. When excess
inventory is sold, it yields a gross profit margin of up to
100%. Sales of excess inventory have the effect of increasing
the gross profit margin beyond that which would otherwise occur,
because of previous write-downs. Once we have written-down
inventory below cost, we do not write it up. We do not
physically segregate excess inventory and assign unique tracking
numbers to it in our accounting systems. Consequently, we cannot
isolate the sales prices of excess inventory from the sales
prices of non-excess inventory. Therefore, we are unable to
report the amount of gross profit resulting from the sale of
excess inventory or quantify the favorable impact of such gross
profit on our gross profit margin.
22
The following table provides information on our excess inventory
at cost (which has been fully reserved in our financial
statements), including the sale of excess inventory valued at
cost (in thousands):
|
|
|
|
|
|
|
Balance at March 31, 2002
|
|
$ |
6,988 |
|
|
|
Sale of excess inventory
|
|
|
(1,917 |
) |
|
|
Scrap of excess inventory
|
|
|
|
|
|
|
|
|
|
Balance of excess inventory
|
|
|
5,071 |
|
|
|
Additional accrual of excess inventory
|
|
|
12,153 |
|
|
|
|
|
Balance at March 31, 2003
|
|
|
17,224 |
|
|
|
Sale of excess inventory
|
|
|
(2,624 |
) |
|
|
Scrap of excess inventory
|
|
|
(504 |
) |
|
|
|
|
|
Balance of excess inventory
|
|
|
14,096 |
|
|
|
Additional accrual of excess inventory
|
|
|
10,536 |
|
|
|
|
|
Balance at March 31, 2004
|
|
|
24,632 |
|
|
|
Sale of excess inventory
|
|
|
(3,685 |
) |
|
|
Scrap of excess inventory
|
|
|
(2,555 |
) |
|
|
|
|
|
Balance of excess inventory
|
|
|
18,392 |
|
|
|
Additional accrual of excess inventory
|
|
|
2,849 |
|
|
|
|
|
Balance at March 31, 2005
|
|
$ |
21,241 |
|
|
|
|
|
The practical efficiencies of wafer fabrication require the
manufacture of semiconductor wafers in minimum lot sizes. Often,
when manufactured, we do not know whether or when all the
semiconductors resulting from a lot of wafers will sell. With
more than 9,000 different part numbers for semiconductors,
excess inventory resulting from the manufacture of some of those
semiconductors will be continual and ordinary. Because the cost
of storage is minimal when compared to potential value and
because our products do not quickly become obsolete, we expect
to hold excess inventory for potential future sale for years.
Consequently, we have no set time line for the sale or scrapping
of excess inventory.
In addition, in accordance with the guidance in
Statements 6 and 7 of ARB 43, our inventory is also being
written down to lower of cost or market or net realizable value.
We review our inventory listing on a quarterly basis for an
indication of losses being sustained for costs that exceed
selling prices less direct costs to sell. When it is evident
that our selling price is lower than current cost, the inventory
is marked down accordingly. At March 31, 2005, our lower of
cost or market reserve was $1.4 million.
Furthermore, we perform an annual inventory count and periodic
cycle counts for specific parts that have a high turnover. We
also periodically consider any inventory that is no longer
usable and write it off as scrap.
Valuation of property, plant, equipment, and intangible
assets. We regularly evaluate the recoverability of our
property, plant, equipment and intangible assets in accordance
with Statement of Financial Accounting Standards No. 144,
or SFAS No. 144, Accounting for the Impairment
or Disposal of Long-Lived Assets. Actual useful lives and
cash flows could be different from those estimated by our
management. This could have a material effect on our operating
results and financial position. Reviews are regularly performed
to determine whether facts and circumstances exist indicating
that the carrying amount of assets may not be recoverable or
that the useful life is shorter than originally estimated. We
assess the recoverability of our assets by comparing the
projected undiscounted net cash flows associated with the
related asset or group of assets over their remaining lives
against their respective carrying amounts. Impairment, if any,
is based on the excess of the carrying amount over the fair
value of those assets. If assets are determined to be
recoverable, but the useful lives are shorter than originally
estimated, the net book value of the assets is depreciated over
the newly determined remaining useful lives.
23
Legal contingencies. We are subject to various legal
proceedings and claims, the outcomes of which are subject to
significant uncertainty. SFAS No. 5, Accounting
for Contingencies, requires that an estimated loss from a
loss contingency should be accrued by a charge to income if it
is probable that an asset has been impaired or a liability has
been incurred and the amount of the loss can be reasonably
estimated. Disclosure of a contingency is required if there is
at least a reasonable possibility that a loss has been incurred.
We evaluate, among other factors, the degree of probability of
an unfavorable outcome and the ability to make a reasonable
estimate of the amount of loss. Changes in these factors could
materially impact our financial position, results of operations
or cash flows.
Goodwill. We regularly evaluate whether events and
circumstances have occurred that indicate a possible impairment
of goodwill and, in any event, we conduct such evaluation at
least annually as of December 31. In determining whether
there is an impairment of goodwill, we calculate the estimated
implied fair value of our company by comparing the fair value of
the reporting unit with its carrying amount, including goodwill.
Then, if the carrying amount of the reporting unit exceeds its
fair value, we perform the second step of the goodwill
impairment test to measure the amount of impairment loss, if
any. We believe that we operate as a single business unit. We
have one reporting unit. The second step of the goodwill
impairment test, used to measure the amount of impairment loss,
compares the implied fair value of the reporting unit goodwill
with the carrying amount of that goodwill. We determine the
implied fair value of goodwill by allocating the fair value of
the reporting unit to all of the assets and liabilities of that
unit (including any unrecognized intangible assets) as if the
reporting unit had been acquired in a business combination and
the fair value of the reporting unit was the price paid to
acquire the reporting unit. The excess of the fair value of a
reporting unit over the amounts assigned to its assets and
liabilities is the implied fair value of goodwill. If the
carrying amount of the reporting unit goodwill exceeds the
implied fair value of that goodwill, we report the excess as an
impairment loss. We believe the methodology we use in testing
impairment of goodwill provides us with a reasonable basis in
determining whether an impairment charge should be taken. To
date, our goodwill has not been considered to be impaired based
on the results of our analysis.
Income tax. As part of the process of preparing our
consolidated financial statements, we are required to estimate
our income taxes in each of the jurisdictions in which we
operate. This process involves estimating our actual current tax
exposure together with assessing temporary differences resulting
from differing treatment of items for tax and accounting
purposes. These differences result in deferred tax assets and
liabilities, which are included within our consolidated balance
sheet. We then assess the likelihood that our deferred tax
assets will be recovered from future taxable income and, to the
extent we believe that recovery is not likely, we establish a
valuation allowance. A valuation allowance reduces our deferred
tax assets to the amount that is more likely than not to be
realized. In determining the amount of the valuation allowance,
we consider estimated future taxable income as well as feasible
tax planning strategies in each taxing jurisdiction in which we
operate. If we determine that we will not realize all or a
portion of our remaining deferred tax assets, we will increase
our valuation allowance with a charge to income tax expense.
Conversely, if we determine that we will ultimately be able to
utilize all or a portion of the deferred tax assets for which a
valuation allowance has been provided, the related portion of
the valuation allowance will be released to income as a credit
to income tax expense. Significant management judgment is
required in determining our provision for income taxes and
potential tax exposures, our deferred tax assets and liabilities
and any valuation allowance recorded against our net deferred
tax assets. In the event that actual results differ from these
estimates or we adjust these estimates in future periods, we may
need to establish a valuation allowance, which could materially
impact our financial position and results of operations. Our
ability to utilize our deferred tax assets and the need for a
related valuation allowance are monitored on an ongoing basis.
Defined benefit plans. We maintain pension plans covering
certain of our employees in foreign locations. For financial
reporting purposes, net periodic pension costs are calculated
based upon a number of actuarial assumptions, including a
discount rate for plan obligations, assumed rate of return on
pension plan assets and assumed rate of compensation increase
for plan employees. Our assumptions are derived from actuarial
projections and actual market data. All of these assumptions are
based upon managements judgment, considering all known
trends and uncertainties. Actual results that differ from these
assumptions would impact the future expense recognition and cash
funding requirements of our pension plans.
24
Recent Accounting Developments
In December 2004, the FASB issued SFAS No. 123R,
Share-Based Payment, which addresses the accounting
for share-based payment transactions. SFAS No. 123R
eliminates the ability to account for share-based compensation
transactions using APB No. 25, and generally requires
instead that such transactions be accounted and recognized in
the statement of income based on their fair value.
SFAS No. 123R will be effective for public companies
as of the first fiscal year that begins after June 15,
2005. We will adopt SFAS No. 123R for our fiscal year
beginning April 1, 2006. SFAS No. 123R offers us
alternative methods of adopting this standard. At the present
time, we have not yet determined which alternative method we
will use and the resulting impact on our financial position or
results of operations. We do not expect this accounting change
to materially affect our liquidity, as equity-based compensation
is a non-cash expense. The effect of expensing stock options on
our results of operations and earnings per share using the
Black-Scholes model is presented on a pro forma basis in the
accompanying Note 2 to Consolidated Financial Statements.
In December 2004, the FASB issued FASB Staff Position
(FSP) No. FAS 109-1, Application of
FASB Statement No. 109, Accounting for Income
Taxes, to the Tax Deduction on Qualified Production
Activities Provided by the American Jobs Creation Act of
2004. The American Jobs Creation Act, or AJCA, introduces
a special tax deduction on qualified production activities. FSP
109-1 clarifies that this tax deduction should be accounted for
as a special tax deduction in accordance with
Statement 109. Pursuant to AJCA, we are examining if we
will be entitled to this special deduction in 2005. We do not
expect the adoption of these new tax provisions to have a
material impact on our consolidated financial position, results
of operations or cash flows.
In December 2004, the FASB Staff Position No. 109-2,
Accounting and Disclosure Guidance for the Foreign
Earnings Repatriation Provision within the American Jobs
Creation Act of 2004. The American Jobs Creation Act
introduces a special one-time dividends received deduction on
the repatriation of certain foreign earnings to
U.S. companies, provided certain criteria are met. FSP
No. 109-2 provides accounting and disclosure guidance on
the impact of the repatriation provision on a companys
income tax expense and deferred tax liability. We are currently
studying the impact of the one-time favorable foreign dividend
provision and intend to complete the analysis by the end of
fiscal 2006. Accordingly, we have not adjusted our income tax
expense or deferred tax liability to reflect the tax impact of
any repatriation of non-U.S. earnings we may make.
In November 2004, the FASB issued SFAS No. 151,
Inventory Costs an amendment of ARB
No. 43, Chapter 4. This Statement amends the
guidance in ARB No. 43, Chapter 4, Inventory
Pricing, to clarify the accounting for idle facility
expense, double freight, rehandling costs, and excessive
spoilage. ARB 43 previously stated that such costs may be
so abnormal as to require treatment as current period charges.
SFAS No. 151 requires that those items be recognized
as current-period charges regardless of whether they are
abnormal. In addition, this Statement requires that
allocation of fixed production overheads to the costs of
conversion be based on the normal capacity of the production
facilities. The provisions of this Statement are effective for
inventory costs incurred during fiscal years beginning after
June 15, 2005. Earlier application is permitted for
inventory costs incurred during fiscal years beginning after
November 2004. The provisions of this Statement should be
applied prospectively. We will adopt SFAS No. 151 for
our fiscal year beginning April 1, 2006. We are currently
considering but have not yet determined what impact the adoption
of this standard will have on our financial position and results
of operations.
25
Results of Operations
The following table sets forth selected consolidated statements
of operations data for the fiscal years indicated and the
percentage change in such data from year to year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended March 31, | |
|
|
| |
|
|
|
|
% Increase | |
|
|
|
% Increase | |
|
|
|
|
|
|
from | |
|
|
|
from | |
|
|
|
|
2005 | |
|
2004 to 2005 | |
|
2004 | |
|
2003 to 2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Net revenues
|
|
$ |
256,620 |
|
|
|
36.9 |
|
|
$ |
187,442 |
|
|
|
37.7 |
|
|
$ |
136,111 |
|
Cost of goods sold
|
|
|
176,710 |
|
|
|
22.8 |
|
|
|
143,948 |
|
|
|
34.1 |
|
|
|
107,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
79,910 |
|
|
|
83.7 |
|
|
|
43,494 |
|
|
|
51.3 |
|
|
|
28,740 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research, development and engineering
|
|
|
18,574 |
|
|
|
17.5 |
|
|
|
15,811 |
|
|
|
23.1 |
|
|
|
12,846 |
|
|
Selling, general and administrative
|
|
|
35,707 |
|
|
|
9.1 |
|
|
|
32,742 |
|
|
|
0.9 |
|
|
|
32,437 |
|
|
Restructuring charge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(100.0 |
) |
|
|
750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
54,281 |
|
|
|
11.8 |
|
|
|
48,553 |
|
|
|
5.5 |
|
|
|
46,033 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth certain financial data as a
percentage of net revenues for the fiscal years indicated. These
historical operating results may not be indicative of the
results for any future period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ending March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
% of Net | |
|
% of Net | |
|
% of Net | |
|
|
Revenues | |
|
Revenues | |
|
Revenues | |
|
|
| |
|
| |
|
| |
Net revenues
|
|
|
100.0 |
|
|
|
100.0 |
|
|
|
100.0 |
|
Cost of goods sold
|
|
|
68.9 |
|
|
|
76.8 |
|
|
|
78.9 |
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
31.1 |
|
|
|
23.2 |
|
|
|
21.1 |
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research, development and engineering
|
|
|
7.2 |
|
|
|
8.4 |
|
|
|
9.4 |
|
|
Selling, general and administrative
|
|
|
13.9 |
|
|
|
17.5 |
|
|
|
23.8 |
|
|
Restructuring charge
|
|
|
|
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
21.1 |
|
|
|
25.9 |
|
|
|
33.8 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
10.0 |
|
|
|
(2.7 |
) |
|
|
(12.7 |
) |
Other income (expense), net
|
|
|
0.0 |
|
|
|
(0.5 |
) |
|
|
(0.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before provision for (benefit from) income tax
|
|
|
10.0 |
|
|
|
(3.2 |
) |
|
|
(13.1 |
) |
Provision for (benefit from) income tax
|
|
|
3.7 |
|
|
|
(0.9 |
) |
|
|
(4.2 |
) |
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
6.3 |
|
|
|
(2.3 |
) |
|
|
(8.9 |
) |
|
|
|
|
|
|
|
|
|
|
The 37% increase in net revenues from fiscal 2004 to fiscal 2005
reflects increased unit sales of power semiconductors,
integrated circuits and systems and RF power semiconductors. The
largest component of the increase in revenues was a
$51.0 million increase in sales of power semiconductors.
The increase in the power semiconductor group was due
principally to an increase of $32.1 million in sales of
semiconductors for the consumer products market, which also
drove a shift in our product mix toward applications for the
consumer products market. Revenues from the sale of integrated
circuits increased in fiscal 2005 as compared to fiscal 2004 by
$7.7 million as a result of a general strengthening in the
IC business. The $10.5 million increase in
26
systems and RF power semiconductor revenues was principally
related to the Microwave Technology acquisition, which provided
$4.5 million of the increase in revenues in part because it
was owned for a full year during fiscal 2005, while only about
seven months during fiscal 2004.
The following table sets forth the units and average selling
price, or ASP, and revenues for each of our product groups for
fiscal 2005 and compares such revenues against those of fiscal
2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 | |
|
|
|
|
|
|
| |
|
% Change in | |
|
2004 | |
|
|
Units | |
|
ASP | |
|
Revenues | |
|
Revenues from | |
|
Revenues | |
|
|
(000) | |
|
$ | |
|
($000) | |
|
2004 to 2005 | |
|
($000) | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Power Semiconductors
|
|
|
87,689 |
|
|
|
2.17 |
|
|
|
190,338 |
|
|
|
36.6 |
|
|
|
139,312 |
|
Integrated Circuits
|
|
|
47,054 |
|
|
|
0.87 |
|
|
|
40,759 |
|
|
|
23.3 |
|
|
|
33,058 |
|
Systems and RF Power Semiconductors
|
|
|
1,416 |
|
|
|
18.02 |
|
|
|
25,523 |
|
|
|
69.3 |
|
|
|
15,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
136,159 |
|
|
|
1.88 |
|
|
|
256,620 |
|
|
|
|
|
|
|
187,442 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The $51.3 million increase in net revenues from fiscal 2003
to fiscal 2004 is primarily related to increased sales to
traditional markets, the inclusion of revenues from acquired
entities and the addition of revenues from new markets,
including the plasma display panel market. The growth in
revenues includes an approximate 27.0% increase in units shipped
in fiscal 2004 in our traditional markets as compared to fiscal
2003, offset in part by an approximate 3.2% decrease in average
selling prices across our traditional markets. The increase in
revenues from fiscal 2003 to fiscal 2004 included the impact of
two acquisitions. We acquired Microwave Technology in September
2003. Our fiscal 2004 revenues from Microwave Technology were
$6.7 million. We acquired Clare in June 2002. In fiscal
2004, in part because we owned Clare for a full year, our
revenues from Clare were $6.3 million greater than our
revenues from Clare in fiscal 2003.
Over the three year period, our revenues have shifted towards
Asia. Of our net revenues, 35.5% were in Asia in fiscal 2005, as
compared to 23.6% in fiscal 2004 and 17.0% in fiscal 2003. The
increase in revenues from sales to Asian customers is, in part,
related to our increasing sales of semiconductors for inclusion
in consumer products, as most of our customers for these
applications are located in Asia.
In each of the three fiscal years, our revenues were reduced by
allowances for sales returns, stock rotations and ship and
debit. See Critical Accounting Policies and Significant
Management Estimates elsewhere in this Managements
Discussion and Analysis of Financial Condition and Results of
Operations.
The $36.4 million increase in gross profit expressed in
dollars from fiscal 2004 to fiscal 2005 is primarily the result
of increased revenues and related improvements in economies of
scale in production. Of the increase in gross profit,
$8.3 million was caused by the increase in our sales to the
consumer products market. The acquisition of Microwave
Technology in September 2003 resulted in a $2.3 million
increase in gross profit in fiscal 2005 as compared to fiscal
2004. Gross profit margin increased to 31.1% during fiscal 2005
as compared to 23.2% in fiscal 2004 principally because of
reductions in the cost to manufacture our products related to
increasing economies of scale, as well as a decrease from
$10.5 million in fiscal 2004 to $2.8 million in fiscal
2005 in the additional provision for excess inventory, combined
with an increase in the sales of excess inventory. The addition
for the full period of higher margin RF power product lines from
the Microwave Technology acquisition also favorably affected
gross profit margin.
The $14.8 million increase in gross profit expressed in
dollars from fiscal 2003 to fiscal 2004 is primarily the result
of increased revenues. The acquisition of Microwave Technology
resulted in a $3.2 million increase in gross profit in
fiscal 2004 as compared to fiscal 2003. Gross profit margin
increased to 23.2% during fiscal 2004 as compared to 21.1% in
fiscal 2003, principally because of the addition of higher
margin RF power product lines from the Microwave Technology
acquisition, partially offset by provisions for excess and
obsolete inventory and scrap. In addition, the fiscal 2004 gross
profit margin was negatively impacted by changes in the
27
product mix. During fiscal 2004, we commenced significant sales
of semiconductors for inclusion in consumer products, which
carry lower gross profit margins than our other products.
In each of the three years, our gross profit and gross profit
margin were increased by the sale of excess inventory, which had
previously been written-down. See Critical Accounting
Policies and Significant Management Estimates
Inventories elsewhere in the Managements Discussion
and Analysis of Financial Condition and Results of Operations.
|
|
|
Research, Development and Engineering. |
From fiscal 2004 to fiscal 2005, research, development and
engineering expenses increased due to an increase in the number
of projects underway, including projects for gallium arsenide
devices and devices for the consumer products market, and
Microwave Technology having been a part of our business for a
full year, but declined as a percentage of revenues due to our
revenue growth. Although we expect an increase in research,
development and engineering expenses as we fund more development
projects, we do not expect a material increase in such expenses
when expressed as a percentage of revenues. In fiscal 2004 as
compared to fiscal 2003, the dollar and percentage increases
were due to additional funded development projects to support
our growth in revenues and the Microwave Technology acquisition
during fiscal 2004, but declined as a percentage of revenues due
to our revenue growth.
|
|
|
Selling, General and Administrative. |
In fiscal 2005, the amount spent on selling, general and
administrative expenses increased principally due to an increase
of $2.0 million in professional fees for regulatory
compliance. Selling, general and administrative expenses
declined as a percentage of revenues in fiscal 2005 as compared
to fiscal 2004, mainly due to economies of scale and our cost
control efforts. While selling, general and administrative
expenses may increase in future periods, we do not expect a
material increase in such expenses when expressed as a
percentage of revenue. In fiscal 2004 as compared to fiscal
2003, our selling, general and administrative expenses
increased, principally due to an increase in sales commissions
corresponding to our growth in revenues, expenses associated
with the implementation of mandated internal controls and
writeoffs of $642,000 for offices vacated when we moved our
Clare sales function from Belgium to Germany. Selling, general
and administrative expenses declined as a percentage of revenues
from fiscal 2003 to fiscal 2004 principally as a result of our
efforts to control costs, combined with the impact of our growth
in revenues.
In June 2002, we adopted a corporate restructuring program to
reduce expenses and preserve our cash. The restructuring mainly
related to a reduction in the workforce designed to eliminate
redundant positions at Clare. The restructuring charge, which
consists mainly of involuntary employee separation costs of
$750,000, was recorded in operating expense during fiscal 2003.
The separation cost was for 33 employees worldwide: 5 in sales
and marketing, 7 in research and development, 3 in general and
administrative and 9 in operations functions in the United
States; and 8 in sales and marketing and 1 in general and
administrative outside the United States.
|
|
|
Other Income (Expense), Net. |
Other income, net, including loss on foreign currency
transactions and interest income, net, in fiscal 2005 was
$152,000, as compared to other expense of $1.0 million in
fiscal 2004 and $568,000 in fiscal 2003. Other income (expense),
net improved in fiscal 2005 as compared to fiscal 2004 because
of a decrease in foreign currency transaction losses and an
increase in interest income, net. Other expense, net increased
in fiscal 2004 as compared to fiscal 2003 due to reduced
interest income, net.
Interest income, net was $633,000 in fiscal 2005 as compared to
$310,000 in fiscal 2004. Interest income, net grew because of an
increase in short-term interest rates and our increasing cash
balances. Interest income, net declined in fiscal 2004, as
compared to $720,000 in fiscal 2003 because of reduced
short-term interest rates.
28
|
|
|
(Provision for) Benefit from Income Taxes. |
In fiscal 2005, the provision for income taxes reflected an
effective tax rate of 37%, as compared to a benefit from income
taxes reflecting an effective tax rate of 27% in fiscal 2004 and
32% in fiscal 2003. The fiscal 2005 rate, as compared to fiscal
2004, was primarily higher because of valuation allowances
booked against deferred tax assets offset by research and
development credits. The higher valuation allowance in fiscal
2005 was based on our assessment that a portion of our foreign
net operating losses would not be realizable. The lower tax
benefit rate for fiscal 2004, as compared to fiscal 2003, was
primarily due to lower net operating loss carryforwards for
state income taxes.
|
|
|
Liquidity and Capital Resources |
As of March 31, 2005, cash and cash equivalents were
$58.1 million, as compared to $42.1 million at
March 31, 2004 and $40.1 million at March 31,
2003. The increase in cash and cash equivalents during fiscal
2005 and fiscal 2004 was primarily due to cash generated by
operations. Over the past three fiscal years, the cash generated
by our operations has provided sufficient liquidity for our
needs.
Net cash provided by operating activities in fiscal 2005 was
$23.3 million, as compared to $5.7 million in fiscal
2004 and $2.4 million in fiscal 2003. During fiscal 2005,
the principal working capital use of cash was to fund accounts
receivable. Accounts receivable increased from March 31,
2004 to March 31, 2005 by 24.9%, primarily due to higher
revenues. No one customer accounted for more than 10% of our
receivables at March 31, 2005. Our net inventory at
March 31, 2005 increased from March 31, 2004 by 7.0%,
principally because of increased production to meet expected
sales. Accrued expenses and other liabilities increased from
March 31, 2004 to March 31, 2005 principally because
of an increase in liabilities for income taxes. During fiscal
2004 and fiscal 2003, working capital was principally used to
fund accounts receivable in connection with the growth in
revenues.
We used $4.9 million in net cash for investing activities
during fiscal 2005, as compared to $1.9 million used for
investing activities in fiscal 2004 and $5.0 million
provided by investing activities in fiscal 2003. During fiscal
2005, we spent $5.8 million in capital expenditures, as
compared to $3.7 million in 2004 and $2.5 million in
2003. We expect capital expenditures during fiscal 2006 to
continue at about the same level as fiscal 2005. Our fiscal 2004
use of cash for investing activities reflected the purchase of
plant and equipment, while our fiscal 2003 cash flows provided
by investing activities reflected the cash acquired with Clare.
For 2005, net cash used in financing activities was
$2.7 million, as compared to net cash used in financing
activities of $2.3 million in fiscal 2004 and $284,000 in
fiscal 2003. During the three years, we used cash from financing
activities principally to pay capital lease obligations. In
addition, in fiscal 2005 we used $1.1 million to purchase
our common stock and $800,000 to repay our note payable to the
bank. In fiscal 2005, the principal sources of cash from
financing activities were proceeds from the exercise of stock
options and from the payment of notes receivable. In fiscal
2004, the principal sources of cash from financing activities
were proceeds from the exercise of stock options and from
purchases under the employee stock purchase plan. In fiscal
2003, the principal sources of cash from financing activities
were proceeds from loans and from the exercise of stock options.
Another potential source of liquidity is available borrowings
under existing lines of credit. At March 31, 2005, we had
available credit aggregating $6.6 million.
At March 31, 2005, our debt, consisting of capital lease
obligations and loan payable, was $7.3 million,
representing 12.6% of our cash and cash equivalents and 4.4% of
our stockholders equity. Over the past three fiscal years,
satisfying our payment obligations for debt has not materially
affected our ability to fund our operating needs.
At March 31, 2005, we maintain two defined benefit pension
plans: one for the United Kingdom employees and one for German
employees. These plans cover most of the employees in the United
Kingdom and Germany. Benefits are based on years of service and
the employees compensation. The Company deposits funds for
these plans, consistent with the requirements of local law, with
investment management companies, insurance companies, trustees,
and/or accrues for the unfunded portion of the obligations. See
Note 12
29
Pension Plans of the Consolidated Financial Statements for a
discussion of the investment return assumptions, the underlying
estimates and the expected future cash flows associated with the
pension plans.
As of March 31, 2005, we had $58.1 million in cash and
cash equivalents. Since March 31, 2005, we have spent or
committed to spend $14.1 million to purchase two of our
facilities. To substantially cover the cash spent or to be spent
to purchase those facilities, we have borrowed Euro
10.0 million, or about $12.1 million, from a German
bank, repayable over 15 years. We believe that our cash,
combined with interest to be earned thereon and borrowings
available under our credit facilities, will be sufficient to
fund our working and other capital requirements, including
potential investments in other companies and other assets to
support the strategic growth of our business, over the next
twelve months. In the ordinary course of business, we evaluate
opportunities to acquire businesses, products and technologies
and we expect to use our cash to fund these types of activities
in the future. In the event additional needs for cash arise, we
may raise additional funds from a combination of sources
including the potential issuance of debt or equity securities.
Additional financing might not be available on terms favorable
to us, or at all, particularly in light of the recent decline in
the capital markets. If adequate funds were not available or
were not available on acceptable terms, our ability to take
advantage of unanticipated opportunities or respond to
competitive pressures could be limited.
On May 4, 2005, we accelerated the vesting of the right to
purchase 128,250 shares of our common stock pursuant
to previously granted stock options. The accelerated options
were at exercise prices in excess of our closing price on
May 4, 2005 of $10.28. The vesting was accelerated to avoid
future accounting charges under SFAS No. 123R.
Disclosures about Contractual Obligations and Commercial
Commitments
Details of our contractual obligations and commitments as of
March 31, 2005 to make future payments under contracts are
set forth below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period | |
|
|
| |
|
|
|
|
Less | |
|
|
|
|
|
|
Than | |
|
|
|
After | |
Contractual Obligations |
|
Total | |
|
1 Year | |
|
1-3 Years | |
|
3-5 Years | |
|
5 Years | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Capital Lease Obligations(1)
|
|
$ |
8,083 |
|
|
$ |
3,524 |
|
|
$ |
3,682 |
|
|
$ |
877 |
|
|
$ |
|
|
Operating Lease Obligations
|
|
|
19,864 |
|
|
|
3,331 |
|
|
|
4,664 |
|
|
|
3,652 |
|
|
|
8,217 |
|
Pension Obligations
|
|
|
12,230 |
|
|
|
1,172 |
|
|
|
2,190 |
|
|
|
2,530 |
|
|
|
6,338 |
|
Inventory Purchase Obligations
|
|
|
11,814 |
|
|
|
11,814 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Liabilities
|
|
|
157 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
157 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
52,148 |
|
|
$ |
19,841 |
|
|
$ |
10,536 |
|
|
$ |
7,059 |
|
|
$ |
14,712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes anticipated interest payments totaling $941,000. |
RISK FACTORS
In addition to the other information in this Annual Report on
Form 10-K, the following risk factors should be considered
carefully in evaluating us and our business. Additional risks
not presently known to us or that we currently believe are not
serious may also impair our business and its financial condition.
|
|
|
Our operating results fluctuate significantly because of a
number of factors, many of which are beyond our control. |
Given the nature of the markets in which we participate, we
cannot reliably predict future revenues and profitability, and
unexpected changes may cause us to adjust our operations. Large
portions of our costs are fixed, due in part to our significant
sales, research and development and manufacturing costs. Thus,
small declines in revenues could negatively affect our operating
results in any given quarter. Our operating results
30
may fluctuate significantly. For example, in comparing fiscal
2002 to fiscal 2001, net revenues fell by 25.6% and net income
fell by 85.7%. Some of the factors that may affect our quarterly
and annual results are:
|
|
|
|
|
the reduction, rescheduling or cancellation of orders by
customers; |
|
|
|
fluctuations in timing and amount of customer requests for
product shipments; |
|
|
|
changes in the mix of products that our customers purchase; |
|
|
|
loss of key customers; |
|
|
|
the cyclical nature of the semiconductor industry; |
|
|
|
competitive pressures on selling prices; |
|
|
|
market acceptance of our products and the products of our
customers; |
|
|
|
fluctuations in our manufacturing yields and significant yield
losses; |
|
|
|
difficulties in forecasting demand for our products and the
planning and managing of inventory levels; |
|
|
|
the availability of production capacity; |
|
|
|
the amount and timing of investments in research and development; |
|
|
|
changes in our product distribution channels and the timeliness
of receipt of distributor resale information; |
|
|
|
the impact of vacation schedules and holidays, largely during
the second and third fiscal quarters of our fiscal year; and |
|
|
|
the amount and timing of costs associated with product returns. |
As a result of these factors, many of which are difficult to
control or predict, as well as the other risk factors discussed
in this Annual Report on Form 10-K, we may experience
materially adverse fluctuations in our future operating results
on a quarterly or annual basis.
|
|
|
The semiconductor industry is cyclical, and an industry
downturn could adversely affect our operating results. |
Business conditions in the semiconductor industry may rapidly
change from periods of strong demand and insufficient production
to periods of weakened demand and overcapacity. The industry is
characterized by:
|
|
|
|
|
alternating periods of overcapacity and production shortages; |
|
|
|
cyclical demand for semiconductors; |
|
|
|
changes in product mix in response to changes in demand; |
|
|
|
significant price erosion; |
|
|
|
variations in manufacturing costs and yields; |
|
|
|
rapid technological change and the introduction of new
products; and |
|
|
|
significant expenditures for capital equipment and product
development. |
These factors could harm our business and cause our operating
results to suffer.
|
|
|
Our gross margin is dependent on a number of factors,
including our level of capacity utilization. |
Semiconductor manufacturing requires significant capital
investment, leading to high fixed costs, including depreciation
expense. We are limited in our ability to reduce fixed costs
quickly in response to any shortfall in revenues. If we are
unable to utilize our manufacturing and testing facilities at a
high level, the fixed costs associated with these facilities
will not be fully absorbed, resulting in higher average unit
costs and
31
lower gross margins. Increased competition and other factors may
lead to price erosion, lower revenues and lower gross margins
for us in the future.
|
|
|
IXYS could be harmed by litigation involving patents and
other intellectual property rights. |
As a general matter, the semiconductor industry is characterized
by substantial litigation regarding patent and other
intellectual property rights. We have been sued on occasion for
purported patent infringement and are currently defending
against a number of such claims. For example, we have been sued
by International Rectifier for purportedly infringing some of
its patents covering power MOSFETs. After trial, the
U.S. District Court awarded damages to International
Rectifier of $27.2 million plus attorney fees and issued a
permanent injunction against IXYS, effectively barring us from
selling or distributing the allegedly infringing products. The
United States Court of Appeals for the Federal Circuit vacated
those rulings and remanded the litigation to the
U.S. District Court for further action consistent with the
opinion of the Federal Circuit. The litigation is expected to
continue at the U.S. District Court and could result in
another damages award and injunction. We continue to contest
International Rectifiers claims vigorously but the outcome
of this litigation remains uncertain. See Item 3.
Legal Proceedings provided elsewhere in this Annual Report
on Form 10-K.
Additionally, in the future, we could be accused of infringing
the intellectual property rights of International Rectifier or
other third parties. We also have certain indemnification
obligations to customers and suppliers with respect to the
infringement of third party intellectual property rights by our
products. We could incur substantial costs defending ourselves
and our customers and suppliers from any such claim.
Infringement claims or claims for indemnification, whether or
not proven to be true, could harm our business.
In the event of any adverse ruling in any intellectual property
litigation, including the pending power MOSFET litigation with
International Rectifier, we could be required to pay substantial
damages, cease the development, manufacturing, use and sale of
infringing products, discontinue the use of certain processes or
obtain a license from the third party claiming infringement with
royalty payment obligations by us. An adverse decision in the
International Rectifier power MOSFET litigation would, and in
any other infringement action could, materially and adversely
affect our financial condition, results of operations or cash
flows.
Any litigation relating to the intellectual property rights of
third parties, whether or not determined in our favor or settled
by us, is costly and may divert the efforts and attention of our
management and technical personnel from our core business
operations.
|
|
|
We are dependent upon the success of our customers
products. |
Our semiconductors are incorporated into our customers
products, and the demand for our semiconductors is dependent
upon the demand for our customers products. Demand for our
customers products may level or decline due to
technological change in our customers industries, price or
quality of their products or other competitive factors. If sales
of our customers products level or fall, our sales of
semiconductors intended for such products will also likely level
or decline. We have recently sold more semiconductors for
inclusion in consumer products than was our historical practice.
We believe that consumer products are subject to shorter product
life cycles, because of technological change, consumer
preferences, trendiness and other factors, than the products of
many of our other customers. In particular, in recent years we
have sold semiconductors for inclusion in the plasma display
panels of a small number of manufacturers. Plasma display panels
are one of several technologies for visual display in
television. Should competition among the various visual display
technologies for television adversely affect the sales of plasma
display panels, our operating results could be adversely
affected. Moreover, our operating results could be adversely
affected if those plasma display panel manufacturers that have
selected our semiconductors for inclusion in their products are
not successful in their competition against other manufacturers
of plasma display panels.
|
|
|
Our international operations expose us to material
risks. |
During fiscal year 2005, our product sales by region were
approximately 28.2% in the United States, approximately 33.2% in
Europe and the Middle East and approximately 35.5% in Asia and
approximately 3.1% in Canada and the rest of the world. We
expect revenues from foreign markets to continue to represent a
32
significant portion of total revenues. IXYS maintains
significant operations in Germany and the United Kingdom and
contracts with suppliers and manufacturers in South Korea, Japan
and elsewhere in Europe and Asia. Some of the risks inherent in
doing business internationally are:
|
|
|
|
|
foreign currency fluctuations; |
|
|
|
changes in the laws, regulations or policies of the countries in
which we manufacture or sell our products; |
|
|
|
trade restrictions; |
|
|
|
longer payment cycles; |
|
|
|
challenges in collecting accounts receivable; |
|
|
|
cultural and language differences; |
|
|
|
employment regulations; |
|
|
|
limited infrastructure in emerging markets; |
|
|
|
transportation delays; |
|
|
|
seasonal reduction in business activities; |
|
|
|
work stoppages; |
|
|
|
terrorist attack or war; and |
|
|
|
economic or political instability. |
Our sales of products manufactured in our Lampertheim, Germany
facility and our costs at that facility are denominated in
Euros, and sales of products manufactured in our Chippenham,
U.K. facility and our costs at that facility are primarily
denominated in British pounds and Euros. Fluctuations in the
value of the Euro and the British pound against the
U.S. dollar could have a significant impact on our balance
sheet and results of operations. We generally do not enter into
foreign currency hedging transactions to control or minimize
these risks. Fluctuations in currency exchange rates could cause
our products to become more expensive to customers in a
particular country, leading to a reduction in sales or
profitability in that country. If we expand our international
operations or change our pricing practices to denominate prices
in other foreign currencies, we could be exposed to even greater
risks of currency fluctuations.
In addition, the laws of certain foreign countries may not
protect our products or intellectual property rights to the same
extent as do U.S. laws regarding the manufacture and sale
of our products in the U.S. Therefore, the risk of piracy
of our technology and products may be greater when we
manufacture or sell our products in these foreign countries.
|
|
|
We have material weaknesses in our internal control over
financial reporting that could result in a material misstatement
of our financial condition, results of operations or cash
flows. |
Our management assessed our internal control over financial
reporting and concluded that five material weaknesses existed as
of March 31, 2005:
|
|
|
|
|
deficiencies in the number of accounting personnel trained in
applying United States generally accepted accounting principles,
or US GAAP, and in reporting financial information in
accordance with the requirements of the Securities and Exchange
Commission, or SEC; |
|
|
|
deficiencies in our over costing and valuation of inventory; |
|
|
|
deficiencies in our control over the use of spreadsheets in our
operations; |
|
|
|
deficiencies in the review of the consolidation process; and |
|
|
|
inadequate segregation of duties in the purchasing cycle. |
33
The deficiencies in the number of accounting personnel have
resulted in a number of designed controls not operating
properly. The deficiencies in the number of accounting staff
during the initial year of Sarbanes-Oxley compliance placed an
extra burden upon the existing division controllers and their
accounting staff, which led to controls not being performed
properly.
The material weakness related to the costing and valuation of
inventory resulted from the incorrect calculation of inventory
yields and overhead absorption, causing erroneous production
variances, at our facility in Lampertheim, Germany, errors in
capitalized variances at our facilities in Chippenham, England
and Lampertheim, Germany and errors in calculating inventory
reserves in our facility in Fremont, California. The net effect
of the corrections of these errors on our financial statements
for the year ended March 31, 2005 was an increase in cost
of goods sold on our statement of operations of $624,000, a
decrease in inventory of $122,000 and $502,000 distributed over
a number of other accounts.
The material weakness related to spreadsheets occurred when
division controllers made modifications to the template
spreadsheets for periodic reporting sent to them by corporate
accounting personnel, and the modifications and the impact of
the modifications were not identified by corporate accounting
personnel when accounting information was submitted by the
divisions. As a result of these items, reported income taxes and
miscellaneous other matters changed approximately $105,000 and
$332,000, respectively. In addition, the spreadsheets used to
compute key financial statement items did not have adequate
validation controls.
In part because a financial analyst resigned without notice, our
controls relating to review of consolidations, inputs, foreign
currency translations and recurring journal entries did not
function properly. As a consequence of the unexpected departure
of the financial analyst, our senior financial analyst, who is
responsible for our consolidation process, had to do her work as
well as that of the departed financial analyst. Thus, a layer of
control in the consolidation process was eliminated. Due to a
lack of personnel resources, supervisory review of the senior
financial analysts work was inadequate. As a result of
these deficiencies, our auditors found differences in our
reports requiring a reduction in deferred tax assets and income
tax payable of approximately $8.2 million and adjustments
to foreign exchange totaling $145,000. These deficiencies were
assessed to be a material weakness.
We have determined that a number of duties have not been
segregated properly within our cycle of activities whereby we
purchase and pay for goods and services. In particular, at
several of our facilities, the same individual was able to
update vendor files, control purchase orders and process vendor
invoices. These deficiencies in segregation of duties
constituted a material weakness. The material weakness arises
from the limited number of accounting personnel at a number of
our facilities and our historical practice of only having
accounting personnel perform traditional accounting functions.
Existence of these or other material weaknesses in our internal
control could result in a material misstatement of our financial
condition, results of operations or cash flows. Whether or not a
misstatement occurs, the existence of one or more material
weaknesses could result in an adverse reaction in the financial
marketplace due to a loss of investor confidence in the
reliability of our controls over financial reporting, which
ultimately could negatively impact the market price of our
shares.
Based on its assessment and as set forth in the Section 404
management report included in this annual report, our management
determined that our internal controls over financial reporting
were ineffective. Our management further determined that our
disclosure controls and procedures were ineffective. See
Item 9A. Controls and Procedures, elsewhere in
this Annual Report on Form 10-K.
Our efforts to correct the deficiencies in our disclosure and
internal controls have required, and will continue to require,
the commitment of significant financial and managerial
resources. In addition, we anticipate the costs associated with
the testing and evaluation of our internal controls will be
significant and material in fiscal year 2006 and may continue to
be material in future fiscal years as these controls are
maintained and continually evaluated and tested.
34
|
|
|
We may not be successful in our acquisitions. |
We have in the past made, and may in the future make,
acquisitions. These acquisitions involve numerous risks,
including:
|
|
|
|
|
diversion of managements attention during the acquisition
process; |
|
|
|
disruption of our ongoing business; |
|
|
|
the potential strain on our financial and managerial controls
and reporting systems and procedures; |
|
|
|
unanticipated expenses and potential delays related to
integration of an acquired business; |
|
|
|
the risk that we will be unable to develop or exploit acquired
technologies; |
|
|
|
failure to successfully integrate the operations of an acquired
company with our own; |
|
|
|
the challenges in achieving strategic objectives, cost savings
and other benefits from acquisitions; |
|
|
|
the risk that our markets do not evolve as anticipated and that
the technologies acquired do not prove to be those needed to be
successful in those markets; |
|
|
|
the risks of entering new markets in which we have limited
experience; |
|
|
|
difficulties in expanding our information technology systems to
accommodate the acquired businesses; |
|
|
|
failure to retain key personnel of the acquired business; |
|
|
|
the challenges inherent in managing an increased number of
employees and facilities and the need to implement appropriate
policies, benefits and compliance programs; |
|
|
|
customer dissatisfaction or performance problems with an
acquired company; |
|
|
|
adverse effects on our relationships with suppliers; |
|
|
|
the reduction in financial stability associated with the
incurrence of debt or the use of a substantial portion of our
available cash; |
|
|
|
the costs associated with acquisitions, including in-process
R&D charges and amortization expense related to intangible
assets, and the integration of acquired operations; and |
|
|
|
assumption of known or unknown liabilities or other
unanticipated events or circumstances. |
We cannot assure you that we will be able to successfully
acquire other businesses or product lines or integrate them into
our operations without substantial expense, delay in
implementation or other operational or financial problems.
In the normal course of business, we frequently engage in
discussions with parties relating to possible acquisitions. As a
result of such transactions, our financial results may differ
from the investment communitys expectations in a given
quarter. Further, if market conditions or other factors lead us
to change our strategic direction, we may not realize the
expected value from such transactions. If we do not realize the
expected benefits or synergies of such transactions, our
consolidated financial position, results of operations, cash
flows, and stock price could be negatively impacted.
|
|
|
We depend on external foundries to manufacture many of our
products. |
Of our revenues in fiscal year 2005, 43% came from wafers
manufactured for us by external foundries. Our dependence on
external foundries may grow. We currently have arrangements with
a number of wafer
35
foundries, three of which produce the wafers for power
semiconductors that we purchase from external foundries. Samsung
Electronicss facility in Kiheung, South Korea is our
principal external foundry.
Our relationships with our external foundries do not guarantee
prices, delivery or lead times, or wafer or product quantities
sufficient to satisfy current or expected demand. These
foundries manufacture our products on a purchase order basis. We
provide these foundries with rolling forecasts of our production
requirements; however, the ability of each foundry to provide
wafers to us is limited by the foundrys available
capacity. At any given time, these foundries could choose to
prioritize capacity for their own use or other customers or
reduce or eliminate deliveries to us on short notice. If growth
in demand for our products occurs, these foundries may be unable
or unwilling to allocate additional capacity to our needs,
thereby limiting our revenue growth. Accordingly, we cannot be
certain that these foundries will allocate sufficient capacity
to satisfy our requirements. In addition, we cannot be certain
that we will continue to do business with these or other
foundries on terms as favorable as our current terms. If we are
not able to obtain additional foundry capacity as required, our
relationships with our customers could be harmed and our
revenues could be reduced or their growth limited. Moreover,
even if we are able to secure additional foundry capacity, we
may be required, either contractually or as a practical business
matter, to utilize all of that capacity or incur penalties or an
adverse effect on the business relationship. The costs related
to maintaining foundry capacity could be expensive and could
harm our operating results. Other risks associated with our
reliance on external foundries include:
|
|
|
|
|
the lack of control over delivery schedules; |
|
|
|
the unavailability of, or delays in obtaining access to, key
process technologies; |
|
|
|
limited control over quality assurance, manufacturing yields and
production costs; and |
|
|
|
potential misappropriation of our intellectual property. |
Our requirements typically represent a small portion of the
total production of the external foundries that manufacture our
wafers and products. We cannot be certain these external
foundries will continue to devote resources to the production of
our wafers and products or continue to advance the process
design technologies on which the manufacturing of our products
is based. These circumstances could harm our ability to deliver
our products on time or increase our costs.
|
|
|
We may not be able to acquire additional production
capacity to meet the present and future demand for our
products. |
The semiconductor industry has been characterized by periodic
limitations on production capacity. Although we may be able to
obtain the capacity necessary to meet present demand, if we are
unable to increase our production capacity to meet possible
future demand, some of our customers may seek other sources of
supply or our future growth may be limited.
|
|
|
Our success depends on our ability to manufacture our
products efficiently. |
We manufacture our products in facilities that are owned and
operated by us, as well as in external wafer foundries and
independent subcontract assembly facilities. The fabrication of
semiconductors is a highly complex and precise process, and a
substantial percentage of wafers could be rejected or numerous
die on each wafer could be nonfunctional as a result of, among
other factors:
|
|
|
|
|
contaminants in the manufacturing environment; |
|
|
|
defects in the masks used to print circuits on a wafer; |
|
|
|
manufacturing equipment failure; or |
|
|
|
wafer breakage. |
36
For these and other reasons, we could experience a decrease in
manufacturing yields. Additionally, as we increase our
manufacturing output, we may also experience a decrease in
manufacturing yields. As a result, we may not be able to cost
effectively expand our production capacity in a timely manner.
|
|
|
Our markets are subject to technological change and our
success depends on our ability to develop and introduce new
products. |
The markets for our products are characterized by:
|
|
|
|
|
changing technologies; |
|
|
|
changing customer needs; |
|
|
|
frequent new product introductions and enhancements; |
|
|
|
increased integration with other functions; and |
|
|
|
product obsolescence. |
To develop new products for our target markets, we must develop,
gain access to and use leading technologies in a cost-effective
and timely manner and continue to expand our technical and
design expertise. Failure to do so could cause us to lose our
competitive position and seriously impact our future revenues.
Products or technologies developed by others may render our
products or technologies obsolete or noncompetitive. A
fundamental shift in technologies in our product markets would
have a material adverse effect on our competitive position
within the industry.
|
|
|
We may not be able to protect our intellectual property
rights adequately. |
Our ability to compete is affected by our ability to protect our
intellectual property rights. We rely on a combination of
patents, trademarks, copyrights, trade secrets, confidentiality
procedures and non-disclosure and licensing arrangements to
protect our intellectual property rights. Despite these efforts,
we cannot be certain that the steps we take to protect our
proprietary information will be adequate to prevent
misappropriation of our technology, or that our competitors will
not independently develop technology that is substantially
similar or superior to our technology. More specifically, we
cannot assure you that our pending patent applications or any
future applications will be approved, or that any issued patents
will provide us with competitive advantages or will not be
challenged by third parties. Nor can we assure you that, if
challenged, our patents will be found to be valid or
enforceable, or that the patents of others will not have an
adverse effect on our ability to do business. We may also become
subject to or initiate interference proceedings in the
U.S. Patent and Trademark office, which can demand
significant financial and management resources and could harm
our financial results. Also, others may independently develop
similar products or processes, duplicate our products or
processes or design their products around any patents that may
be issued to us. See Item 3. Legal Proceedings
in Part I of this Annual Report on Form 10-K.
|
|
|
Our revenues are dependent upon our products being
designed into our customers products. |
Many of our products are incorporated into customers
products or systems at the design stage. The value of any design
win largely depends upon the customers decision to
manufacture the designed product in production quantities, the
commercial success of the customers product and the extent
to which the design of the customers electronic system
also accommodates incorporation of components manufactured by
our competitors. In addition, our customers could subsequently
redesign their products or systems so that they no longer
require our products. We may not achieve design wins or our
design wins may not result in future revenues.
37
|
|
|
Because our products typically have lengthy sales cycles,
we may experience substantial delays between incurring expenses
related to research and development and the generation of
revenues. |
The time from initiation of design to volume production of new
semiconductors often takes 18 months or longer. We first
work with customers to achieve a design win, which may take nine
months or longer. Our customers then complete the design,
testing and evaluation process and begin to ramp up production,
a period which may last an additional nine months or longer. As
a result, a significant period of time may elapse between our
research and development efforts and our realization of
revenues, if any, from volume purchasing of our products by our
customers.
|
|
|
Our backlog may not result in future revenues. |
Customer orders typically can be cancelled or rescheduled
without penalty to the customer. As a result, our backlog at any
particular date is not necessarily indicative of actual revenues
for any succeeding period. A reduction of backlog during any
particular period, or the failure of our backlog to result in
future revenues, could harm our results of operations.
|
|
|
The markets in which we participate are intensely
competitive. |
Certain of our target markets are intensely competitive. Our
ability to compete successfully in our target markets depends on
the following factors:
|
|
|
|
|
proper new product definition; |
|
|
|
product quality, reliability and performance; |
|
|
|
product features; |
|
|
|
price; |
|
|
|
timely delivery of products; |
|
|
|
breadth of product line; |
|
|
|
design and introduction of new products; |
|
|
|
market acceptance of our products and those of our
customers; and |
|
|
|
technical support and service. |
In addition, our competitors or customers may offer new products
based on new technologies, industry standards or end-user or
customer requirements, including products that have the
potential to replace our products or provide lower cost or
higher performance alternatives to our products. The
introduction of new products by our competitors or customers
could render our existing and future products obsolete or
unmarketable.
Our primary power semiconductor competitors include Advanced
Power Technology, Fairchild Semiconductor, Fuji, Infineon,
International Rectifier, On Semiconductor, Powerex, Renesas
Technology, Semikron International, STMicroelectronics, Siemens
and Toshiba. Our IC products compete principally with those of
Agere Systems, Legerity, NEC and Silicon Labs. Our RF power
semiconductor competitors include RF Micro Devices and RF
Monolithics. Many of our competitors have greater financial,
technical, marketing and management resources than we have. Some
of these competitors may be able to sell their products at
prices below which it would be profitable for us to sell our
products or benefit from established customer relationships that
provide them with a competitive advantage. We cannot assure you
that we will be able to compete successfully in the future
against existing or new competitors or that our operating
results will not be adversely affected by increased price
competition.
38
|
|
|
We rely on our distributors and sales representatives to
sell many of our products. |
A substantial majority of our products are sold to distributors
and through sales representatives. Our distributors and sales
representatives could reduce or discontinue sales of our
products. They may not devote the resources necessary to sell
our products in the volumes and within the time frames that we
expect. In addition, we depend upon the continued viability and
financial resources of these distributors and sales
representatives, some of which are small organizations with
limited working capital. These distributors and sales
representatives, in turn, depend substantially on general
economic conditions and conditions within the semiconductor
industry. We believe that our success will continue to depend
upon these distributors and sales representatives.
At March 31, 2005, no distributor accounted for greater
than 10% of our outstanding receivables. Nonetheless, if any
significant distributor or sales representative experiences
financial difficulties, or otherwise becomes unable or unwilling
to promote and sell our products, our business could be harmed.
|
|
|
Our future success depends on the continued service of
management and key engineering personnel and our ability to
identify, hire and retain additional personnel. |
Our success depends upon our ability to attract and retain
highly-skilled technical, managerial, marketing and finance
personnel, and, to a significant extent, upon the efforts and
abilities of Nathan Zommer, Ph.D., our president and chief
executive officer, and other members of senior management. The
loss of the services of one or more of our senior management or
other key employees could adversely affect our business. We do
not maintain key person life insurance on any of our officers,
employees or consultants. There is intense competition for
qualified employees in the semiconductor industry, particularly
for highly skilled design, applications and test engineers. We
may not be able to continue to attract and retain engineers or
other qualified personnel necessary for the development of our
business or to replace engineers or other qualified individuals
who could leave us at any time in the future. If we grow, we
expect increased demands on our resources, and growth would
likely require the addition of new management and engineering
staff as well as the development of additional expertise by
existing management employees. If we lose the services of or
fail to recruit key engineers or other technical and management
personnel, our business could be harmed.
|
|
|
Growth and expansion place a significant strain on our
resources, including our information systems and our employee
base. |
Presently, because of past acquisitions, we are operating a
number of different information systems that are not integrated.
In part because of this, we use spreadsheets, which are prepared
by individuals rather than automated systems, in our accounting.
Consequently, in our accounting, we perform many manual
reconciliations and other manual steps, which result in a high
risk of errors. For a further discussion of issues relating to
spreadsheets, see Item 9A Controls and
Procedures.
If we do not adequately manage and evolve our financial
reporting and managerial systems and processes, our ability to
manage and grow our business may be harmed. Our ability to
successfully implement our goals and comply with regulations,
including Sarbanes-Oxley Act of 2002, requires an effective
planning and management system and process. We will need to
continue to improve existing, and implement new operational and
financial systems, procedures and controls to manage our
business effectively in the future.
In improving our operational and financial systems, procedures
and controls, we would expect to periodically implement new
software and other systems that will affect our internal
operations regionally or globally. The conversion process from
one system to another is complex and requires, among other
things, that data from the existing system be made compatible
with the upgraded system. During any transition, we could
experience errors, delays and other inefficiencies, which could
adversely affect our business. Any delay in the implementation
of, or disruption in the transition to, any new or enhanced
systems, procedures or controls, could harm our ability to
forecast sales demand, manage our supply chain, achieve accuracy
in the conversion of electronic data and record and report
financial and management information on a timely and accurate
basis. In addition, as we add additional functionality, new
problems could arise that we have not foreseen. Such problems
could adversely impact our ability to do the following in a
timely manner: provide quotes; take
39
customer orders; ship products; provide services and support to
our customers; bill and track our customers; fulfill contractual
obligations; and otherwise run our business. Failure to properly
or adequately address these issues could result in the diversion
of managements attention and resources, impact our ability
to manage our business and our results of operations, cash
flows, and stock price could be negatively impacted.
Future growth will also require us to successfully hire, train,
motivate and manage our employees. In addition, our continued
growth and the evolution of our business plan will require
significant additional management, technical and administrative
resources. We may not be able to effectively manage the growth
and evolution of our current business.
|
|
|
Our stock price is volatile. |
The market price of our common stock has fluctuated
significantly to date. See Item 5 Market
for Registrants Common Equity and Related Stockholders
Matters provided elsewhere in this Annual Report on
Form 10-K. The future market price of our common stock may
also fluctuate significantly in the event of:
|
|
|
|
|
variations in our actual or expected quarterly operating results; |
|
|
|
announcements or introductions of new products; |
|
|
|
technological innovations by our competitors or development
setbacks by us; |
|
|
|
conditions in the communications and semiconductor markets; |
|
|
|
the commencement or adverse outcome of litigation; |
|
|
|
changes in analysts estimates of our performance or
changes in analysts forecasts regarding our industry,
competitors or customers; |
|
|
|
announcements of merger or acquisition transactions or a failure
to achieve the expected benefits of an acquisition as rapidly or
to the extent anticipated by financial analysts; |
|
|
|
terrorist attack or war; |
|
|
|
sales of our common stock by one or more members of management,
including Nathan Zommer, Ph.D., our President and Chief
Executive Officer; or |
|
|
|
general economic and market conditions. |
In addition, the stock market in recent years has experienced
extreme price and volume fluctuations that have affected the
market prices of many high technology companies, including
semiconductor companies. These fluctuations have often been
unrelated or disproportionate to the operating performance of
companies in our industry, and could harm the market price of
our common stock.
|
|
|
Our dependence on independent subcontractors to assemble
and test our products subject us to a number of risks, including
an inadequate supply of products and higher materials
costs. |
We depend on independent subcontractors for the assembly and
testing of our products. The majority of our products are
assembled by independent subcontractors located outside of the
United States. Our reliance on these subcontractors involves the
following significant risks:
|
|
|
|
|
reduced control over delivery schedules and quality; |
|
|
|
the potential lack of adequate capacity during periods of excess
demand; |
|
|
|
difficulties selecting and integrating new subcontractors; |
|
|
|
limited or no warranties by subcontractors or other vendors on
products supplied to us; |
|
|
|
potential increases in prices due to capacity shortages and
other factors; |
|
|
|
potential misappropriation of our intellectual property; and |
40
|
|
|
|
|
economic or political instability in foreign countries. |
These risks may lead to delayed product delivery or increased
costs, which would harm our profitability and customer
relationships.
In addition, we use a limited number of subcontractors to
assemble a significant portion of our products. If one or more
of these subcontractors experiences financial, operational,
production or quality assurance difficulties, we could
experience a reduction or interruption in supply. Although we
believe alternative subcontractors are available, our operating
results could temporarily suffer until we engage one or more of
those alternative subcontractors.
|
|
|
Our operating expenses are relatively fixed, and we may
order materials in advance of anticipated customer demand.
Therefore, we have limited ability to reduce expenses quickly in
response to any revenue shortfalls. |
Our operating expenses are relatively fixed, and, therefore, we
have limited ability to reduce expenses quickly in response to
any revenue shortfalls. Consequently, our operating results will
be harmed if our revenues do not meet our revenue projections.
We also typically plan our production and inventory levels based
on our own expectations for customer demand. Actual customer
demand, however, can be highly unpredictable and can fluctuate
substantially. From time to time, in response to anticipated
long lead times to obtain inventory and materials from our
external suppliers and foundries, we may order materials or
production in advance of anticipated customer demand. This
advance ordering may result in excess inventory levels or
unanticipated inventory write-downs if expected orders fail to
materialize.
|
|
|
We depend on a limited number of suppliers for our
wafers. |
We purchase the bulk of our silicon wafers from three vendors
with whom we do not have long-term supply agreements. Any of
these suppliers could reduce or terminate our supply of wafers
at any time. Our reliance on a limited number of suppliers
involves several risks, including potential inability to obtain
an adequate supply of silicon wafers and reduced control over
the price, timely delivery, reliability and quality of the
silicon wafers. We cannot assure that problems will not occur in
the future with suppliers.
|
|
|
Our ability to access capital markets could be
limited. |
From time to time we may need to access the capital markets to
obtain long-term financing. Although we believe that we can
continue to access the capital markets on acceptable terms and
conditions, our flexibility with regard to long-term financing
activity could be limited by our existing capital structure, our
credit ratings, and the health of the semiconductor industry. In
addition, many of the factors that affect our ability to access
the capital markets, such as the liquidity of the overall
capital markets and the current state of the economy, are
outside of our control. There can be no assurances that we will
continue to have access to the capital markets on favorable
terms.
|
|
|
Geopolitical instability, war, terrorist attacks,
terrorist threats, and government responses thereto, may
negatively impact all aspects of our operations, revenues, costs
and stock prices. |
Any such event may disrupt our operations or those of our
customers or suppliers. Our markets currently include South
Korea, Taiwan and Israel, which are experiencing political
instability. Additionally, our principal external foundry is
located in South Korea.
|
|
|
Business interruptions may damage our facilities or those
of our suppliers. |
Our operations and those of our suppliers are vulnerable to
interruption by fire, earthquake and other natural disasters, as
well as power loss, telecommunications failure and other events
beyond our control. We do not have a detailed disaster recovery
plan and do not have backup generators. Our facilities in
California are located near major earthquake faults and have
experienced earthquakes in the past. If any of these events
41
occurs, our ability to conduct our operations could be seriously
impaired, which could harm our business, financial condition and
results of operations or cash flows. We cannot be sure that the
insurance we maintain against general business interruptions
will be adequate to cover all our losses.
|
|
|
We may be affected by environmental laws and
regulations. |
We are subject to a variety of laws, rules and regulations in
the United States, England and Germany related to the use,
storage, handling, discharge and disposal of certain chemicals
and gases used in our manufacturing process. Any of those
regulations could require us to acquire expensive equipment or
to incur substantial other expenses to comply with them. If we
incur substantial additional expenses, product costs could
significantly increase. Our failure to comply with present or
future environmental laws, rules and regulations could result in
fines, suspension of production or cessation of operations.
|
|
|
Our tax liability has been in dispute from time to
time. |
From time to time, we have received notices of tax assessments
from certain governments of countries in which we operate. These
governments or other government entities may serve future
notices of assessments on us and the amounts of these
assessments or our failure to favorably resolve such assessments
may have a material adverse effect on our financial condition or
results of operations.
|
|
|
We face the risk of financial exposure to product
liability claims alleging that the use of products that
incorporate our semiconductors resulted in adverse
effects. |
Approximately 10.1% of our net revenues in fiscal year 2005 were
derived from sales of products used in medical devices such as
defibrillators. Product liability risks may exist even for those
medical devices that have received regulatory approval for
commercial sale. We cannot be sure that the insurance that we
maintain against product liability will be adequate to cover our
losses. Any defects in our semiconductors used in these devices,
or in any other product, could result in significant
replacement, recall or product liability costs to us.
|
|
|
Nathan Zommer, Ph.D. owns a significant interest in
our common stock. |
Nathan Zommer, Ph.D., our president and chief executive
officer, beneficially owned, as of May 16, 2005,
approximately 20% of the outstanding shares of our common stock.
As a result, Dr. Zommer can exercise significant control
over all matters requiring stockholder approval, including the
election of the board of directors. His holdings could result in
a delay of, or serve as a deterrent to, possible changes in
control of IXYS, which may reduce the market price of our common
stock.
|
|
|
Regulations may adversely affect our ability to sell our
products. |
Power semiconductors with operating voltages above 40 volts are
subject to regulations intended to address the safety,
reliability and quality of the products. These regulations
relate to processes, design, materials and assembly. For
example, in the United States some high voltage products are
required to pass Underwriters Laboratory recognition for voltage
isolation and fire hazard tests. Sales of power semiconductors
outside of the United States are subject to international
regulatory requirements that vary from country to country. The
process of obtaining and maintaining required regulatory
clearances can be lengthy, expensive and uncertain. The time
required to obtain approval for sale internationally may be
longer than that required for U.S. approval, and the
requirements may differ.
In addition, approximately 10.1% of our revenues in fiscal year
2005 were derived from the sale of products included in medical
devices that are subject to extensive regulation by numerous
governmental authorities in the United States and
internationally, including the U.S. Food and Drug
Administration, or FDA. The FDA and certain foreign regulatory
authorities impose numerous requirements for medical device
manufacturers to meet, including adherence to Good Manufacturing
Practices, or GMP, regulations and similar regulations in other
countries, which include testing, control and documentation
requirements. Ongoing compliance with GMP and other applicable
regulatory requirements is monitored through periodic
inspections by federal and state agencies, including the FDA,
and by comparable agencies in other countries.
42
Our failure to comply with applicable regulatory requirements
could prevent our products from being included in approved
medical devices.
Our business could also be harmed by delays in receiving or the
failure to receive required approvals or clearances, the loss of
previously obtained approvals or clearances or the failure to
comply with existing or future regulatory requirements.
|
|
|
The anti-takeover provisions of our certificate of
incorporation and of the Delaware General Corporation Law may
delay, defer or prevent a change of control. |
Our board of directors has the authority to issue up to
5,000,000 shares of preferred stock and to determine the
price, rights, preferences, privileges and restrictions,
including voting rights, of those shares without any further
vote or action by our stockholders. The rights of the holders of
common stock will be subject to, and may be harmed by, the
rights of the holders of any shares of preferred stock that may
be issued in the future. The issuance of preferred stock may
delay, defer or prevent a change in control because the terms of
any issued preferred stock could potentially prohibit our
consummation of any merger, reorganization, sale of
substantially all of our assets, liquidation or other
extraordinary corporate transaction, without the approval of the
holders of the outstanding shares of preferred stock. In
addition, the issuance of preferred stock could have a dilutive
effect on our stockholders.
Our stockholders must give substantial advance notice prior to
the relevant meeting to nominate a candidate for director or
present a proposal to our stockholders at a meeting. These
notice requirements could inhibit a takeover by delaying
stockholder action. The Delaware anti-takeover law restricts
business combinations with some stockholders once the
stockholder acquires 15% or more of our common stock. The
Delaware statute makes it more difficult for us to be acquired
without the consent of our board of directors and management.
|
|
Item 7A. |
Quantitative and Qualitative Disclosures about Market
Risk |
We are exposed to financial market risks, including changes in
interest rates and foreign currency exchange rates. To mitigate
these risks, we have on occasion utilized derivative financial
instruments. We do not use derivative financial instruments for
speculative or trading purposes.
We currently keep our funds in accounts and instruments that,
for accounting purposes, are cash and cash equivalents and do
not carry interest rate risk to the fair market value of
principal. We may, in the future, choose to place our funds in
investments in high quality debt securities, potentially
consisting of debt instruments of the United States or state or
local governments or investment grade corporate issuers.
Investments in both fixed and floating rate securities have some
degree of interest rate risk. Fixed rate securities may have
their fair market value adversely impacted by increases in
interest rates. Floating rate securities may produce less income
than anticipated if interest rates fall. As a result, changes in
interest rates could cause us to incur losses in principal if we
are forced to sell securities that have declined in market value
or may result in lower than anticipated investment income.
Should we establish one, our investment portfolio would be
categorized as available-for-sale and accordingly presented at
fair value on the balance sheet.
We intend to manage our exposure to interest rate, market and
credit risk in any investment portfolio with investment policies
and procedures that limit such things as term, credit rating and
the amount of credit exposure to any one issue, issuer and type
of instrument. We have not used derivative financial instruments
in any investment portfolio.
We are also exposed to short-term fluctuations in interest rates
as the accounts and instruments in which we invest our cash have
variable interest rates. Although an increase in interest rates
would have an adverse impact on our interest expense, our cash
and cash equivalents greatly exceed the balances that we borrow
through lines of credit and, if necessary to limit the burden of
interest expense, we could reduce our borrowing.
The impact on the fair market value of our cash equivalents and
our earnings from a hypothetical 100 basis point adverse
change in interest rates as of the end each of fiscal 2005 and
2004 would have had the effect of reducing our annual net income
as of the end of each of fiscal 2005 and fiscal 2004 by an
amount less
43
than $1.0 million. As our cash and cash equivalents have
historically been held in accounts and instruments where the
principal is not subject to interest rate risk and our cash and
cash equivalents greatly exceed our variable rate borrowings,
this sensitivity analysis was accomplished by offsetting our
variable rate borrowings against our cash and cash equivalents
and then estimating the impact of a 100 basis point
reduction in interest rates on such adjusted cash balances.
Revenues from our foreign subsidiaries were approximately 38.8%
of total revenues in fiscal year 2005. These revenues come from
our German and UK subsidiaries and are primarily denominated in
Euros and British pounds, respectively. Our foreign subsidiaries
also incur most of their expenses in the local currency. Our
principal foreign subsidiaries use their respective local
currencies as their functional currency.
Although we have entered into a limited number of foreign
exchange forward contracts to help manage foreign currency
exchange risk associated with certain of our operations, we do
not generally hedge foreign currency exchange rates. The foreign
exchange forward contracts we have entered into generally have
original maturities ranging from one to three months. We do not
enter into foreign exchange forward contracts for trading
purposes. We do not expect gains or losses on these contracts to
have a material impact on our financial results.
It is possible that our future financial results could be
directly affected by changes in foreign currency exchange rates.
The prices of our products would become more expensive in a
particular foreign market if the value of the U.S. dollar,
the Euro or the British pound were to rise in comparison to the
local currency, which could make it more difficult to sell our
products in that market. We will continue to face foreign
currency exchange risk in the future. Therefore, our financial
results could be directly affected by weak economic conditions
in foreign markets. In addition, a strengthening of the
U.S. dollar, the Euro or the British pound could make our
products less competitive in foreign markets. Also, since
March 31, 2005, we have borrowed Euro 10 million, or
about $12.1 million. Changing foreign exchange rates could
adversely affect the repayment of this loan. A hypothetical 10%
adverse change in the value of the Euro against the
U.S. dollar and the British pound against the
U.S. dollar would have had the effect of reducing our
annual net income as of the end of each of fiscal 2005 and 2004
by an amount less than $1.0 million.
Because of the operation of our principal foreign units in their
own functional currencies, this sensitivity analysis was
undertaken by examining the net income or loss of the foreign
units incorporated into our statement of operations and testing
the impact of the hypothetical change in exchange rates on such
income or loss. The hypothetically derived net income or loss of
the foreign units was then calculated with our statement of
operations data to derive the hypothetical impact on our net
income.
44
|
|
Item 8. |
Financial Statements and Supplementary Data |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ON
CONSOLIDATED FINANCIAL STATEMENTS
To the Board of Directors and Stockholders,
IXYS Corporation
Santa Clara, California
We have audited the accompanying consolidated balance sheet of
IXYS Corporation as of March 31, 2005, and the related
consolidated statements of operations, stockholders
equity, comprehensive income, and cash flows for the year then
ended. These financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles
used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We
believe that our audit provides a reasonable basis for our
opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of IXYS Corporation as of March 31, 2005, and
the results of its operations and its cash flows for the year
then ended, in conformity with accounting principles generally
accepted in the United States of America.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
effectiveness of IXYS Corporations internal control
over financial reporting as of March 31, 2005, based on the
criteria established in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) and our report
dated June 3, 2005 expressed an unqualified opinion on
managements assessment of the effectiveness of internal
control over financial reporting and an adverse opinion on the
effectiveness of internal control over financial reporting.
|
|
|
BDO Seidman, LLP |
|
San Francisco, California |
June 3, 2005
except for Note 16 which is as of June 23, 2005
45
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors of
IXYS Corporation
In our opinion, the consolidated balance sheet as of
March 31, 2004 and the related consolidated statement of
operations, of comprehensive income (loss), of cash flows and of
changes in stockholders equity for each of the two years
in the period ended March 31, 2004 (appearing in this
Form 10-K) present fairly, in all material respects, the
financial position of IXYS Corporation and its subsidiaries
at March 31, 2004, and the consolidated results of
operations, comprehensive income (loss) and cash flows of IXYS
Corporation and its subsidiaries at March 31, 2004 and for
each of the two years in the period ended March 31, 2004 in
conformity with accounting principles generally accepted in the
United States of America. These financial statements are the
responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audits. We conducted our audits of these
statements in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles
used and significant estimates made by management, and
evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for our
opinion.
PricewaterhouseCoopers LLP
San Jose, CA
May 18, 2004
46
IXYS CORPORATION
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
|
|
(In thousands, except | |
|
|
share data) | |
ASSETS |
Current assets:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
58,144 |
|
|
$ |
42,058 |
|
|
Restricted cash
|
|
|
155 |
|
|
|
1,141 |
|
|
Accounts receivable, net of allowances of $2,629 in 2005 and
$2,654 in 2004
|
|
|
41,388 |
|
|
|
33,131 |
|
|
Inventories
|
|
|
51,411 |
|
|
|
48,055 |
|
|
Prepaid expenses and other current assets
|
|
|
4,134 |
|
|
|
1,710 |
|
|
Deferred income taxes
|
|
|
6,649 |
|
|
|
7,769 |
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
161,881 |
|
|
|
133,864 |
|
Property, plant and equipment, net
|
|
|
27,814 |
|
|
|
26,369 |
|
Other assets
|
|
|
5,907 |
|
|
|
7,310 |
|
Deferred income taxes
|
|
|
2,787 |
|
|
|
9,503 |
|
Goodwill
|
|
|
21,502 |
|
|
|
21,223 |
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
219,891 |
|
|
$ |
198,269 |
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
Current liabilities:
|
|
|
|
|
|
|
|
|
|
Current portion of capitalized lease obligations
|
|
$ |
2,733 |
|
|
$ |
3,447 |
|
|
Notes payable to bank
|
|
|
|
|
|
|
800 |
|
|
Accounts payable
|
|
|
12,962 |
|
|
|
15,277 |
|
|
Accrued expenses and other liabilities
|
|
|
22,123 |
|
|
|
18,094 |
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
37,818 |
|
|
|
37,618 |
|
Capitalized lease obligations, net of current portion
|
|
|
4,409 |
|
|
|
2,904 |
|
Loan payable
|
|
|
157 |
|
|
|
157 |
|
Pension liabilities
|
|
|
12,230 |
|
|
|
12,059 |
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
54,614 |
|
|
|
52,738 |
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 8)
|
|
|
|
|
|
|
|
|
Stockholders Equity
|
|
|
|
|
|
|
|
|
|
Preferred stock, $0.01 par value:
|
|
|
|
|
|
|
|
|
|
|
Authorized: 5,000,000 shares; none issued and outstanding
|
|
|
|
|
|
|
|
|
|
Common stock, $0.01 par value:
|
|
|
|
|
|
|
|
|
|
|
Authorized: 80,000,000 shares; 33,586,196 issued and
33,359,194 outstanding in 2005 and 33,018,675 issued and
32,923,373 outstanding in 2004
|
|
|
336 |
|
|
|
331 |
|
|
Additional paid-in capital
|
|
|
153,376 |
|
|
|
151,074 |
|
|
Deferred compensation
|
|
|
(4 |
) |
|
|
(10 |
) |
|
Notes receivable from stockholders
|
|
|
(355 |
) |
|
|
(1,388 |
) |
|
Retained earnings (accumulated deficit)
|
|
|
5,492 |
|
|
|
(10,750 |
) |
|
Accumulated other comprehensive income
|
|
|
7,984 |
|
|
|
6,721 |
|
|
Treasury stock, at cost: 227,002 and 95,302 common shares in
2005 and 2004
|
|
|
(1,552 |
) |
|
|
(447 |
) |
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
165,277 |
|
|
|
145,531 |
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$ |
219,891 |
|
|
$ |
198,269 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
47
IXYS CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands, except per share data) | |
Net revenues
|
|
$ |
256,620 |
|
|
$ |
187,442 |
|
|
$ |
136,111 |
|
Cost of goods sold
|
|
|
176,710 |
|
|
|
143,948 |
|
|
|
107,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
79,910 |
|
|
|
43,494 |
|
|
|
28,740 |
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research, development and engineering
|
|
|
18,574 |
|
|
|
15,811 |
|
|
|
12,846 |
|
|
Selling, general and administrative
|
|
|
35,707 |
|
|
|
32,742 |
|
|
|
32,437 |
|
|
Restructuring
|
|
|
|
|
|
|
|
|
|
|
750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
54,281 |
|
|
|
48,553 |
|
|
|
46,033 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
25,629 |
|
|
|
(5,059 |
) |
|
|
(17,293 |
) |
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
1,341 |
|
|
|
615 |
|
|
|
910 |
|
|
Interest expense
|
|
|
(708 |
) |
|
|
(305 |
) |
|
|
(190 |
) |
|
Other expense
|
|
|
(481 |
) |
|
|
(1,324 |
) |
|
|
(1,288 |
) |
|
|
|
|
|
|
|
|
|
|
Income (loss) before income tax
|
|
|
25,781 |
|
|
|
(6,073 |
) |
|
|
(17,861 |
) |
(Provision for) benefit from income tax
|
|
|
(9,539 |
) |
|
|
1,641 |
|
|
|
5,716 |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
16,242 |
|
|
$ |
(4,432 |
) |
|
$ |
(12,145 |
) |
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share basic
|
|
$ |
0.49 |
|
|
$ |
(0.14 |
) |
|
$ |
(0.39 |
) |
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in per share
calculation basic
|
|
|
33,093 |
|
|
|
32,434 |
|
|
|
30,889 |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share diluted
|
|
$ |
0.46 |
|
|
$ |
(0.14 |
) |
|
$ |
(0.39 |
) |
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in per share
calculation diluted
|
|
|
35,085 |
|
|
|
32,434 |
|
|
|
30,889 |
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
48
IXYS CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Net income (loss)
|
|
$ |
16,242 |
|
|
$ |
(4,432 |
) |
|
$ |
(12,145 |
) |
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
|
|
1,263 |
|
|
|
5,363 |
|
|
|
3,721 |
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss)
|
|
$ |
17,505 |
|
|
$ |
931 |
|
|
$ |
(8,424 |
) |
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
49
IXYS CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes | |
|
Retained | |
|
|
|
Accumulated | |
|
|
|
|
|
|
|
|
|
|
|
|
Additional | |
|
Receivable | |
|
Earnings | |
|
|
|
Other | |
|
|
|
|
|
Total | |
|
|
|
|
|
|
Paid-In | |
|
from | |
|
(Accumulated | |
|
Deferred | |
|
Comprehensive | |
|
Treasury | |
|
Treasury | |
|
Stockholders | |
|
|
Shares | |
|
Amount | |
|
Capital | |
|
Stockholders | |
|
Deficit) | |
|
Compensation | |
|
Gain (Loss) | |
|
Shares | |
|
Amount | |
|
Equity | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Balances, March 31, 2002
|
|
|
26,902 |
|
|
$ |
270 |
|
|
$ |
92,785 |
|
|
$ |
(853 |
) |
|
$ |
5,827 |
|
|
|
|
|
|
$ |
(2,363 |
) |
|
|
95 |
|
|
$ |
(447 |
) |
|
$ |
95,219 |
|
Exercise of stock options
|
|
|
130 |
|
|
|
1 |
|
|
|
443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
444 |
|
Issuance of common stock under Employee Stock Purchase Plan
|
|
|
31 |
|
|
|
|
|
|
|
207 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
207 |
|
Issuance of common stock for the acquisition of Clare, Inc.
|
|
|
4,894 |
|
|
|
49 |
|
|
|
51,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51,399 |
|
Interest accrued on notes receivable
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(60 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(60 |
) |
Deferred compensation
|
|
|
|
|
|
|
|
|
|
|
50 |
|
|
|
|
|
|
|
|
|
|
|
(50 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24 |
|
Foreign currency translation adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,721 |
|
|
|
|
|
|
|
|
|
|
|
3,721 |
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(12,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2003
|
|
|
31,957 |
|
|
|
320 |
|
|
|
144,835 |
|
|
|
(913 |
) |
|
|
(6,318 |
) |
|
|
(26 |
) |
|
|
1,358 |
|
|
|
95 |
|
|
|
(447 |
) |
|
|
138,809 |
|
Exercise of stock options
|
|
|
233 |
|
|
|
2 |
|
|
|
841 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
843 |
|
Issuance of common stock under Employee Stock Purchase Plan
|
|
|
62 |
|
|
|
1 |
|
|
|
561 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
562 |
|
Issuance of common stock for the acquisition of Microwave
Technology, Inc.
|
|
|
767 |
|
|
|
8 |
|
|
|
4,348 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,356 |
|
Interest accrued on notes receivable
|
|
|
|
|
|
|
|
|
|
|
475 |
|
|
|
(475 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred compensation
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
|
|
|
|
|
|
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
|
Foreign currency translation adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,363 |
|
|
|
|
|
|
|
|
|
|
|
5,363 |
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,432 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,432 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2004
|
|
|
33,019 |
|
|
|
331 |
|
|
|
151,074 |
|
|
|
(1,388 |
) |
|
|
(10,750 |
) |
|
|
(10 |
) |
|
|
6,721 |
|
|
|
95 |
|
|
|
(447 |
) |
|
|
145,531 |
|
Exercise of stock options
|
|
|
480 |
|
|
|
4 |
|
|
|
1,509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,513 |
|
Issuance of common stock under Employee Stock Purchase Plan
|
|
|
87 |
|
|
|
1 |
|
|
|
614 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
615 |
|
Interest accrued on notes receivable
|
|
|
|
|
|
|
|
|
|
|
60 |
|
|
|
(60 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation expense on shareholder loans
|
|
|
|
|
|
|
|
|
|
|
119 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
119 |
|
Repayment of notes receivable
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,039 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,039 |
|
Interest forgiven on notes receivable
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54 |
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
Repurchase of common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
132 |
|
|
|
(1,105 |
) |
|
|
(1,105 |
) |
Foreign currency translation adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,263 |
|
|
|
|
|
|
|
|
|
|
|
1,263 |
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,242 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,242 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2005
|
|
|
33,586 |
|
|
$ |
336 |
|
|
$ |
153,376 |
|
|
$ |
(355 |
) |
|
$ |
5,492 |
|
|
$ |
(4 |
) |
|
$ |
7,984 |
|
|
|
227 |
|
|
$ |
(1,552 |
) |
|
$ |
165,277 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these
consolidated financial statements.
50
IXYS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
16,242 |
|
|
$ |
(4,432 |
) |
|
$ |
(12,145 |
) |
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
10,639 |
|
|
|
11,186 |
|
|
|
9,297 |
|
|
|
Provision for receivables allowances
|
|
|
4,994 |
|
|
|
4,261 |
|
|
|
8,024 |
|
|
|
Write down of inventories
|
|
|
2,917 |
|
|
|
2,057 |
|
|
|
7,258 |
|
|
|
Loss on disposal of fixed assets
|
|
|
225 |
|
|
|
4 |
|
|
|
240 |
|
|
|
Loss (gain) on foreign currency transactions
|
|
|
1,399 |
|
|
|
670 |
|
|
|
(1,713 |
) |
|
|
Deferred income taxes
|
|
|
7,885 |
|
|
|
(4,424 |
) |
|
|
(3,067 |
) |
|
|
Compensation expense for notes from shareholders
|
|
|
119 |
|
|
|
|
|
|
|
|
|
|
|
Interest forgiven on notes from shareholders
|
|
|
54 |
|
|
|
|
|
|
|
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(12,568 |
) |
|
|
(13,262 |
) |
|
|
(6,799 |
) |
|
|
Inventories
|
|
|
(5,286 |
) |
|
|
2,253 |
|
|
|
2,987 |
|
|
|
Prepaid expenses and other current assets
|
|
|
(2,134 |
) |
|
|
144 |
|
|
|
89 |
|
|
|
Other assets
|
|
|
(335 |
) |
|
|
(618 |
) |
|
|
(1,742 |
) |
|
|
Accounts payable
|
|
|
(2,702 |
) |
|
|
2,096 |
|
|
|
(527 |
) |
|
|
Accrued expenses and other liabilities
|
|
|
2,258 |
|
|
|
4,828 |
|
|
|
379 |
|
|
|
Pension liabilities
|
|
|
(337 |
) |
|
|
916 |
|
|
|
123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
23,370 |
|
|
|
5,679 |
|
|
|
2,404 |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted cash decrease (increase)
|
|
|
986 |
|
|
|
1,607 |
|
|
|
(321 |
) |
|
Purchases of plant and equipment
|
|
|
(5,952 |
) |
|
|
(3,679 |
) |
|
|
(2,510 |
) |
|
Acquisition of Microwave Technology, Inc., net of cash acquired
|
|
|
|
|
|
|
143 |
|
|
|
|
|
|
Acquisition of Clare, Inc., net of cash acquired
|
|
|
|
|
|
|
|
|
|
|
7,843 |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities
|
|
|
(4,966 |
) |
|
|
(1,929 |
) |
|
|
5,012 |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal payments on capital lease obligations
|
|
|
(3,996 |
) |
|
|
(3,918 |
) |
|
|
(2,928 |
) |
|
Repayment of notes payable to bank
|
|
|
(800 |
) |
|
|
(10 |
) |
|
|
|
|
|
Collections on stockholder notes receivables
|
|
|
1,039 |
|
|
|
212 |
|
|
|
|
|
|
Proceeds from loans
|
|
|
|
|
|
|
|
|
|
|
1,931 |
|
|
Proceeds from issuance of common stock under the employee stock
purchase plan
|
|
|
615 |
|
|
|
562 |
|
|
|
207 |
|
|
Proceeds from exercise of stock options
|
|
|
1,513 |
|
|
|
843 |
|
|
|
506 |
|
|
Purchase of treasury stock
|
|
|
(1,105 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities
|
|
|
(2,734 |
) |
|
|
(2,311 |
) |
|
|
(284 |
) |
|
|
|
|
|
|
|
|
|
|
Effect of foreign exchange rate fluctuations on cash and cash
equivalents
|
|
|
416 |
|
|
|
525 |
|
|
|
851 |
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
16,086 |
|
|
|
1,964 |
|
|
|
7,983 |
|
Cash and cash equivalents at beginning of year
|
|
|
42,058 |
|
|
|
40,094 |
|
|
|
32,111 |
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$ |
58,144 |
|
|
$ |
42,058 |
|
|
$ |
40,094 |
|
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosures of Cash Flow Information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid during the period for interest
|
|
$ |
149 |
|
|
$ |
138 |
|
|
$ |
164 |
|
|
Cash paid during the period for income taxes
|
|
$ |
721 |
|
|
$ |
108 |
|
|
$ |
1,256 |
|
Supplemental Schedule of Noncash Investing and Financing
Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of fixed assets under capital lease
|
|
$ |
264 |
|
|
$ |
683 |
|
|
$ |
116 |
|
|
Common stock issued for Microwave Technology, Inc. net assets
|
|
$ |
|
|
|
$ |
4,356 |
|
|
$ |
|
|
|
Common stock issued for Clare, Inc. net assets
|
|
$ |
|
|
|
$ |
|
|
|
$ |
51,399 |
|
The accompanying notes are an integral part of these
consolidated financial statements.
51
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
1. |
Formation and Business of IXYS: |
IXYS Corporation (IXYS or the
Company) designs, develops, manufactures and markets
power semiconductors and digital and analog integrated circuits
(ICs). Power semiconductors are used primarily in
controlling energy in motor drives, power conversion (including
uninterruptible power supplies (UPS) and switch mode
power supplies (SMPS)) and medical electronics.
IXYSs power semiconductors convert electricity at
relatively high voltage and current levels to create efficient
power as required by a specific application. IXYSs target
market includes segments of the power semiconductor market that
require medium to high power semiconductors, with a particular
emphasis on high power semiconductors. IXYSs power
semiconductors include power metal oxide silicon field effect
transistors (Power MOSFETs), insulated gate bipolar
transistors (IGBTs), thyristors and rectifiers,
including fast recovery epitaxial diodes (FREDs).
IXYSs ICs include solid-state relays (SSRs)
for telecommunications applications and power management and
control ICs, such as current regulators, motion controllers,
digital power modulators and power MOSFET and IGBT drivers.
IXYS sells products in North America, Europe, and Asia through
an organization that includes direct sales personnel,
independent representatives and distributors. The Company is
headquartered in Northern California with principal
operations in California, Massachusetts, Germany and the United
Kingdom. Each site has manufacturing, research and development
and sales and distribution activities. The Company also makes
use of subcontract manufacturers for fabrication of wafers and
for assembly and test operations.
|
|
2. |
Summary of Significant Accounting Policies: |
|
|
|
Principles of Consolidation: |
The consolidated financial statements include the accounts of
IXYS and its wholly owned subsidiaries after elimination of all
intercompany balances and transactions.
The preparation of financial statements in conformity with
generally accepted accounting principles requires management to
make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting
period. Actual results could materially differ from IXYSs
estimates.
Revenue from power semiconductor and IC product sales is
recognized upon shipment, provided that a signed purchase order
was received, the price is fixed, title has transferred,
collection of resulting receivables is reasonably assured, and
there are no remaining significant obligations. Reserves for
sales returns and allowances, including allowances for so called
ship and debit transactions, are recorded at the
time of shipment, based on historical returns and discounts,
current economic trends and changes in customer demand.
Transactions with sale terms of FOB shipping point are
recognized when the products are shipped and transactions with
sale terms of FOB destination are recognized upon arrival.
IXYS sells to distributors and original equipment manufacturers.
Approximately 36% of the Companys revenues in fiscal 2005
were from distributors. IXYS provides its distributors with the
following programs: stock rotation and ship and debit. Ship and
debit is a form of price protection. IXYS recognizes revenue
from product sales upon shipment provided that it has received
an executed purchase order, the price is fixed and determinable,
the risk of loss has transferred, collection of resulting
receivables is reasonably assured, there are no customer
acceptance requirements, and there are no remaining significant
obligations. Reserves for
52
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
allowances are also recorded at the time of shipment. The
management of IXYS must make estimates of potential future
product returns and so called ship and debit
transactions related to current period product revenue.
Management analyzes historical returns and ship and debit
transactions, current economic trends and changes in customer
demand and acceptance of the Companys products when
evaluating the adequacy of the sales returns and allowances.
Significant management judgments and estimates must be made and
used in connection with establishing the allowances in any
accounting period. Material differences may result in the amount
and timing of the Companys revenue for any period if
management made different judgments or utilized different
estimates.
Allowance for sales returns. IXYS maintains an allowance
for sales returns for estimated product returns by its
customers. The Company estimates its allowance for sales returns
based on its historical return experience, current economic
trends, changes in customer demand, known returns it has not
received and other assumptions. If IXYS makes different
judgments or utilizes different estimates, the amount and timing
of its revenue could be materially different. Given that the
Companys revenues consist of a high volume of relatively
similar products, its actual returns and allowances have not
fluctuated significantly from period to period to date, and its
returns provisions have historically been reasonably accurate.
This allowance is included as part of the accounts receivable
allowance on the balance sheet and as a reduction to gross
revenues in the calculation of net revenues on the statement of
operations.
Allowance for stock rotation. The Company also provides
stock rotation to select distributors. The rotation
allows distributors to return a percentage of the previous six
months sales. In the fiscal years ended March 31,
2005, 2004, and 2003 approximately $1.1 million, $595,000,
and $1.3 million, respectively, of products were returned
to IXYS under the program. This allowance is included as part of
the accounts receivable allowance on the balance sheet and as a
reduction to gross revenues in the calculation of net revenues
on the statement of operations. IXYS establishes the allowance
based upon maximum allowable rotations, which is consistent with
its historical practice.
Trade accounts receivable and allowance for doubtful
accounts. Trade accounts receivable are recorded at the
invoiced amount and do not bear interest. The allowance for
doubtful accounts is IXYSs best estimate of the amount of
probable credit losses in the existing accounts receivable. IXYS
determines the allowance based on the aging of its accounts
receivable, the financial condition of its customers and their
payment history, its historical write-off experience and other
assumptions. The allowance for doubtful accounts is reviewed
quarterly. Past due balances and other specified accounts as
necessary are reviewed individually. Account balances are
charged off against the allowance after all means of collection
have been exhausted and the potential for recovery is considered
remote. This allowance is included as part of the accounts
receivable allowance on the balance sheet and as a selling,
general and administrative expense in the statement of
operations. This allowance is based on historical losses and
managements estimate of future losses.
Allowance for ship and debit. Ship and debit is a program
designed to assist distributors in meeting competitive prices in
the marketplace on sales to their end customers. Ship and debit
requires a request from the distributor for a pricing adjustment
for a specific part for a customer sale to be shipped from the
distributors stock. The Company has no obligation to
accept this request. However, it is the Companys
historical practice to allow some companies to obtain sales
discounts for inventory held. IXYSs distributors had
approximately $4.5 million in inventory of the
Companys products on hand at March 31, 2005. Ship and
debit authorizations may cover current and future distributor
activity for a specific part for sale to the distributors
customer. In accordance with Staff Accounting
Bulletin No. 104 Topic 13, Revenue
Recognition, at the time the Company records sales to the
distributors, it provides an allowance for the estimated future
distributor activity related to such sales since it is probable
that such sales to distributors will result in ship and debit
activity. The sales allowance requirement is based on sales
during the period, credits issued to distributors, distributor
inventory levels, historical trends, market conditions, pricing
trends IXYS sees in its direct sales activity with original
equipment manufacturers and other customers, and input from
sales,
53
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
marketing and other key management. The Company receives
periodic statements regarding its products held by distributors.
These procedures require the exercise of significant judgments.
IXYS believes that they enable the Company to make reliable
estimates of future credits under the ship and debit program.
Actual results to date have approximated the estimates. At the
time the distributor ships the part from stock, the distributor
debits IXYS for the authorized pricing adjustment. This
allowance is included as part of the accounts receivable
allowance on the balance sheet and as a reduction to gross
revenues in the calculation of net revenues on the statement of
operations. If competitive pricing were to decrease sharply and
unexpectedly, estimates would be insufficient, which could
significantly adversely affect results.
Additions to the ship and debit allowance are estimates of the
amount of expected future ship and debit activity related to
sales during the period and reduce revenues and gross profit in
the period. The following table sets forth the beginning and
ending balances of, additions to, and deductions from, the
allowance for ship and debit during the three years ended
March 31, 2005 (in thousands):
|
|
|
|
|
|
Balance March 31, 2002
|
|
$ |
355 |
|
|
Additions
|
|
|
2,062 |
|
|
Deductions
|
|
|
(1,934 |
) |
|
|
|
|
Balance March 31, 2003
|
|
|
483 |
|
|
Additions
|
|
|
2,189 |
|
|
Deductions
|
|
|
(2,248 |
) |
|
|
|
|
Balance March 31, 2004
|
|
|
424 |
|
|
Additions
|
|
|
2,742 |
|
|
Deductions
|
|
|
(2,613 |
) |
|
|
|
|
Balance March 31, 2005
|
|
$ |
553 |
|
|
|
|
|
For nonrecurring engineering, or NRE, related to engineering
work performed by the Clare Micronix division to design chip
prototypes that will later be used to produce required units,
customers enter into arrangements with Clare Micronix to perform
engineering work for a fixed fee. Clare Micronix records
fixed-fee payments during the development phase from customers
in accordance with Statement of Financial Accounting Standards
No. 68, Research and Development Arrangements
Amounts offset against research and development costs totaled
approximately $161,000 in fiscal 2005, $382,000 in fiscal 2004
and $329,000 in fiscal 2003.
|
|
|
Foreign Currency Translation: |
The local currency is considered to be the functional currency
of IXYSs wholly owned international subsidiaries, IXYS
Semiconductor GmbH (IXYS GmbH), IXYS Berlin GmbH
(IXYS Berlin) and Westcode Semiconductors Limited
(Westcode). Accordingly, assets and liabilities are
translated at the exchange rate in effect at year-end and
revenues and expenses are translated at average rates during the
year. Adjustments resulting from the translation of the accounts
of IXYS GmbH, IXYS Berlin and Westcode into U.S. dollars
are included in accumulated other comprehensive income, a
separate component of stockholders equity. The
Companys Swiss subsidiary utilizes the US dollar as its
functional currency. Foreign currency transaction gains and
losses are included as a component of other income or expense.
IXYS considers all highly liquid investments with original
maturities of three months or less at the time of purchase to be
cash equivalents. Cash equivalents include investments in money
market accounts at banks.
54
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A reclassification has been made to the fiscal 2003 and fiscal
2004 consolidated financial statements to conform to the
presentation of fiscal 2005. In the reclassification, litigation
expenses in the amount of $3.0 million and
$4.7 million for the fiscal years 2004 and 2003 were
reclassified from other expense, net to selling, general and
administrative expenses. In addition, proceeds from capital
lease obligations in the amounts of $1.2 million and
$3.0 million were reclassified on the consolidated
statement of cash flows in fiscal 2004 and fiscal 2003,
respectively, to a reduction of purchases of plant and
equipment. Such reclassification had no effect on previously
reported net income or retained earnings.
Inventories, consisting primarily of wafers, bipolar devices,
transistors, diodes and integrated circuits, are recorded at the
lower of a currently adjusted standard cost, which approximates
actual cost on a first-in-first-out basis, or market value.
Consistent with Statement 3 of Accounting Research
Bulletin 43, or ARB 43, the Companys accounting for
inventory costing is based on the applicable expenditure
incurred, directly or indirectly, in bringing the inventory to
its existing condition. Such expenditures include acquisition
costs, production costs and other costs incurred to bring the
inventory to its use. Shipping and handling costs, when
incurred, are included in the cost of inventory and in the cost
of goods sold. In accordance with Statement 4 of ARB 43, as
it is impractical to track inventory from the time of purchase
to the time of sale for the purpose of specifically identifying
inventory cost, the Companys inventory is therefore valued
based on a standard cost, given that the materials purchased are
identical and interchangeable at various production process.
IXYS reviews its standard costs on an as-needed basis but in any
event at least once a year, and updates them as appropriate to
approximate actual costs. Work in process and finished goods
inventory are determined to be saleable based on a demand
forecast within a specific time horizon, generally 12 to
24 months. Inventories in excess of saleable amounts are
not valued.
The Company typically plans its production and inventory levels
based on internal forecasts of customer demand, which are highly
unpredictable and can fluctuate substantially. The value of its
inventories is dependent on its estimate of future demand as it
relates to historical sales. If the Companys projected
demand is over-estimated, IXYS may be required to reduce the
valuation of its inventories below cost. IXYS regularly reviews
inventory quantities on hand and record an estimated provision
for excess inventory based primarily on its historical sales.
IXYS performs an analysis of inventories and compares the sales
for the preceding two years. To the extent the Company has
inventory in excess of the greater of two years historical
sales, twice the most recent years historical sales or
backlog, it recognizes a reserve for excess inventories.
However, for new products, the Company does not consider whether
there is excess inventory until it develops sufficient sales
history or experiences a significant change in expected product
demand, based on backlog. Actual demand and market conditions
may be different from those projected by IXYSs management.
This could have a material effect on the Companys
operating results and financial position. If IXYS makes
different judgments or utilizes different estimates, the amount
and timing of the write-down of inventories may be materially
different.
During the economic downturn of fiscal 2002 and fiscal 2003,
IXYS built inventory beyond demand in its Santa Clara
operation. At the end of fiscal 2003, excess inventory was
measured by sets of related product part numbers rather than by
individual product part numbers. These sets were used because it
was thought that sales of such would be representative of the
sales of the individual part numbers within any such set. For
the fourth quarter of fiscal 2004, IXYS recognized that sales by
sets of related product part numbers were not revealing
individual part numbers that were not selling at a similar rate
and so the Company refined the calculation to examine excess
inventory by individual part number.
Excess inventory frequently remains saleable. When excess
inventory is sold, it yields a gross profit margin of up to
100%. Sales of excess inventory have the effect of increasing
the gross profit margin beyond
55
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
that which would otherwise occur, because of previous
write-downs. Once inventory is written down below cost, it is
not written up. IXYS does not physically segregate excess
inventory and assign unique tracking numbers to it in the
Companys accounting systems. Consequently, IXYS cannot
isolate the sales prices of excess inventory from the sales
prices of non-excess inventory. Therefore, IXYS is unable to
report the amount of gross profit resulting from the sale of
excess inventory or quantify the favorable impact of such gross
profit on its gross profit margin.
The following table provides information on the Companys
excess inventory at cost (which has been fully reserved in the
Companys financial statements), including the sale of
excess inventory valued at cost (in thousands):
|
|
|
|
|
|
|
Balance at March 31, 2002
|
|
$ |
6,988 |
|
|
|
Sale of excess inventory
|
|
|
(1,917 |
) |
|
|
Scrap of excess inventory
|
|
|
|
|
|
|
|
|
|
Balance of excess inventory
|
|
|
5,071 |
|
|
|
Additional accrual of excess inventory
|
|
|
12,153 |
|
|
|
|
|
Balance at March 31, 2003
|
|
|
17,224 |
|
|
|
Sale of excess inventory
|
|
|
(2,624 |
) |
|
|
Scrap of excess inventory
|
|
|
(504 |
) |
|
|
|
|
|
Balance of excess inventory
|
|
|
14,096 |
|
|
|
Additional accrual of excess inventory
|
|
|
10,536 |
|
|
|
|
|
Balance at March 31, 2004
|
|
|
24,632 |
|
|
|
Sale of excess inventory
|
|
|
(3,685 |
) |
|
|
Scrap of excess inventory
|
|
|
(2,555 |
) |
|
|
|
|
|
Balance of excess inventory
|
|
|
18,392 |
|
|
|
Additional accrual of excess inventory
|
|
|
2,849 |
|
|
|
|
|
Balance at March 31, 2005
|
|
$ |
21,241 |
|
|
|
|
|
The practical efficiencies of wafer fabrication require the
manufacture of semiconductor wafers in minimum lot sizes. Often,
when manufactured, the Company does not know whether or when all
the semiconductors resulting from a lot of wafers will sell.
With more than 9,000 different part numbers for semiconductors,
excess inventory resulting from the manufacture of some of those
semiconductors will be continual and ordinary. Because the cost
of storage is minimal when compared to potential value and
because the products of the Company do not quickly become
obsolete, IXYS expects to hold excess inventory for potential
future sale for years. Consequently, IXYS has no set time line
for the sale or scrapping of excess inventory.
In addition, in accordance with the guidance in
Statements 6 and 7 of ARB 43, the inventory of the Company
is also being written down to lower of cost or market or net
realizable value. IXYS reviews its inventory listing on a
quarterly basis for an indication of losses being sustained for
costs that exceed selling prices less direct costs to sell. When
it is evident that the selling price is lower than current cost,
the inventory is marked down accordingly. At March 31, 2005
the Companys lower of cost or market reserve was
$1.4 million.
Furthermore, IXYS performs an annual inventory count and
periodic cycle counts for specific parts that have a high
turnover. The Company also periodically consider any inventory
that is no longer usable and writes it off.
56
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
Property, Plant and Equipment: |
Property, plant and equipment, including equipment under capital
leases, is stated at cost less accumulated depreciation.
Equipment under capital lease are stated at the lower of the
present value of the minimum lease payments at the beginning of
the lease term or the fair value of the leased assets at the
inception of the lease. Depreciation is computed using the
straight-line method over estimated useful lives of three to ten
years for equipment and twenty years for plant. Upon disposal,
the assets and related accumulated depreciation are removed from
IXYSs accounts and the resulting gains or losses are
reflected in the statements of operations. Repairs and
maintenance costs are charged to expense. Depreciation of
leasehold improvements is provided on the straight-line method
over the shorter of the estimated useful life or the term of the
lease.
As required by SFAS No. 144 Accounting for the
Impairment or Disposal of Long-Lived Assets, IXYS
evaluates the recoverability of the carrying amount of its
property, plant and equipment whenever events or changes in
circumstances indicate that the carrying amount of an asset may
not be fully recoverable. Impairment is assessed when the
forecasted undiscounted cash flows derived for the operation to
which the assets relate are less than the carrying amount
including associated intangible assets of the operation. If the
operation is determined to be unable to recover the carrying
amount of its assets, then intangible assets are written down
first, followed by the other long-lived assets of the operation,
to fair value. Fair value is determined based on discounted cash
flows or appraised values, depending on the nature of the
assets. Judgment is used when applying these impairment rules to
determine the timing of the impairment test, the undiscounted
expected cash flows used to assess impairments and the fair
value of an impaired asset. The dynamic economic environment in
which IXYS operates and the resulting assumptions used to
estimate future cash flows impact the outcome of these
impairment tests.
|
|
|
Foreign Exchange Contracts: |
Although the majority of IXYSs transactions are in
U.S. Dollars, IXYS enters into currency forward contracts
to manage foreign currency exchange risk associated with its
operations. From time to time, IXYS purchases short-term,
forward exchange contracts to hedge the impact of foreign
currency fluctuations on certain underlying assets, liabilities
and commitments for operating expenses denominated in foreign
currencies. The purpose of entering into these hedge
transactions is to minimize the impact of foreign currency
fluctuations on the results of operations. The contracts
generally have maturity dates that do not exceed three months.
IXYS does not purchase short-term forward exchange contracts for
trading purposes. The Company elected not to designate these
forward exchange contracts as accounting hedges and any changes
in fair value are marked to market and recorded in the results
of operations in other income. At March 31, 2005, no such
contracts were open.
IXYS maintains pension plans covering certain of its employees.
For financial reporting purposes, net periodic pension costs are
calculated based upon a number of actuarial assumptions,
including a discount rate for plan obligations, assumed rate of
return on pension plan assets and assumed rate of compensation
increases for plan employees. All of these assumptions are based
upon managements judgment, considering all known trends
and uncertainties. Actual results that differ from these
assumptions would impact the future expense recognition and cash
funding requirements of the Companys pension plans.
IXYS expenses advertising as the costs are incurred. Advertising
expense for the years ended March 31, 2005, 2004 and 2003
was $451,000, $408,000 and $657,000, respectively. Advertising
expense is included in selling, general and administrative
expense.
57
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
Research and Development: |
Research and development costs are charged to operations as
incurred.
IXYSs provision for income taxes is comprised of its
current tax liability and the change in deferred tax assets and
liabilities. Deferred tax assets and liabilities are determined
based on differences between financial reporting and tax bases
of assets and liabilities and are measured using the enacted tax
rates and laws that will be in effect when the differences are
expected to reverse. A valuation allowance is required to reduce
the deferred tax assets to the amount that is more likely than
not to be realized. In determining the amount of the valuation
allowance, IXYS considers estimated future taxable income as
well as feasible tax planning strategies in each taxing
jurisdiction in which it operates. If IXYS determines that it
will not realize all or a portion of its remaining deferred tax
assets, it will increase its valuation allowance with a charge
to income tax expense. Conversely, if IXYS determines that it
will ultimately be able to utilize all or a portion of the
deferred tax assets for which a valuation allowance has been
provided, the related portion of the valuation allowance will be
released to income as a credit to income tax expense.
Significant management judgment is required in determining the
provision for income taxes, the deferred tax assets and
liabilities and any valuation allowance recorded against net
deferred tax assets. In the event that actual results differ
from these estimates or IXYS adjusts these estimates in future
periods, IXYS may need to establish a valuation allowance that
could materially impact its financial position and results of
operations. IXYSs ability to utilize its deferred tax
assets and the continuing need for a related valuation allowance
are monitored on an ongoing basis.
On October 22, 2004, the President signed the American Jobs
Creation Act of 2004 (the Act). Incorporated into
the provisions, the Act includes a temporary incentive for
U.S. corporations to repatriate accumulated income earned
overseas. IXYS presently does not intend to repatriate any
foreign income under the Act.
|
|
|
Other Income and Expense: |
Other income and expense primarily consists of gains and losses
on foreign currency transactions and interest income and expense.
The Company does not provide product guarantees or warranties.
On occasion, the Company provides limited indemnification to
customers against intellectual property infringement claims
related to the Companys products. To date, the Company has
not experienced significant activity or claims related to such
indemnifications. The Company does provide in the normal course
of business indemnification to its officers, directors and
selected parties.
The Company is subject to various legal proceedings and claims,
the outcomes of which are subject to significant uncertainty.
SFAS No. 5, Accounting for Contingencies,
requires that an estimated loss from a loss contingency should
be accrued by a charge to income if it is probable that an asset
has been impaired or a liability has been incurred and the
amount of the loss can be reasonably estimated. Disclosure of a
contingency is required if there is at least a reasonable
possibility that a loss has been incurred. IXYS evaluates, among
other factors, the degree of probability of an unfavorable
outcome and the ability to make a reasonable estimate of the
amount of loss. Changes in these factors could materially impact
the Companys financial position, results of operations or
cash flows.
58
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
Net Income (Loss) Per Share: |
Basic earnings per share is computed by dividing net income
(loss) by the weighted-average number of common shares
outstanding for the period. Diluted earnings per share reflects
the potential dilution from the exercise of options into common
stock. The calculation of dilutive net income (loss) per share
excludes potential shares if their effect is anti-dilutive; that
is, when the exercise price of the option exceeds the market
price. Potential shares consist of incremental common shares
issuable upon the exercise of stock options.
|
|
|
Recent Accounting Pronouncements: |
In December 2004, the FASB issued SFAS No. 123R,
Share-Based Payment, which addresses the accounting
for share-based payment transactions. SFAS No. 123R
eliminates the ability to account for share-based compensation
transactions using APB No. 25, and generally requires
instead that such transactions be accounted and recognized in
the statement of income based on their fair value.
SFAS No. 123R will be effective for public companies
as of the first fiscal year that begins after June 15,
2005. IXYS will adopt SFAS No. 123R for the fiscal
year beginning April 1, 2006. SFAS No. 123R
offers IXYS alternative methods of adopting this standard. At
the present time, the Company has not yet determined which
alternative method it will use and the resulting impact on its
financial position or results of operations. IXYS does not
expect this accounting change to materially affect its liquidity
as equity-based compensation is a non-cash expense. The effect
of expensing stock options on the Companys results of
operations and earnings per share using the Black-Scholes model
is presented on a pro forma basis in the accompanying
Note 2 to Consolidated Financial Statements.
In December 2004, the FASB issued FASB Staff Position
(FSP) No. FAS 109-1, Application of
FASB Statement No. 109, Accounting for Income
Taxes, to the Tax Deduction on Qualified Production
Activities Provided by the American Jobs Creation Act of
2004. The American Jobs Creation Act, or AJCA, introduces
a special tax deduction on qualified production activities. FSP
109-1 clarifies that this tax deduction should be accounted for
as a special tax deduction in accordance with
Statement 109. Pursuant to AJCA, IXYS is examining if it
will be entitled to this special deduction in 2005. The Company
does not expect the adoption of these new tax provisions to have
a material impact on its consolidated financial position,
results of operations or cash flows.
In December 2004, the FASB Staff Position No. 109-2,
Accounting and Disclosure Guidance for the Foreign
Earnings Repatriation Provision within the American Jobs
Creation Act of 2004. The American Jobs Creation Act
introduces a special one-time dividends received deduction on
the repatriation of certain foreign earnings to
U.S. companies, provided certain criteria are met. FSP
No. 109-2 provides accounting and disclosure guidance on
the impact of the repatriation provision on a companys
income tax expense and deferred tax liability. The Company is
currently studying the impact of the one-time favorable foreign
dividend provision and intends to complete the analysis by the
end of fiscal 2006. Accordingly, IXYS has not adjusted its
income tax expense or deferred tax liability to reflect the tax
impact of any repatriation of non-U.S. earnings it may make.
In November 2004, the FASB issued SFAS No. 151,
Inventory Costs an amendment of
ARB No. 43, Chapter 4. This Statement
amends the guidance in ARB No. 43, Chapter 4,
Inventory Pricing, to clarify the accounting for
idle facility expense, double freight, rehandling costs, and
excessive spoilage. ARB 43 previously stated that such costs may
be so abnormal as to require treatment as current period
charges. SFAS No. 151 requires that those items be
recognized as current-period charges regardless of whether they
are abnormal. In addition, this Statement requires
that allocation of fixed production overheads to the costs of
conversion be based on the normal capacity of the production
facilities. The provisions of this Statement are effective for
inventory costs incurred during fiscal years beginning after
June 15, 2005. Earlier application is permitted for
inventory costs incurred during fiscal years beginning after
November 2004. The provisions of this Statement should be
applied prospectively. IXYS will adopt
59
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
SFAS No. 151 for the fiscal year beginning
April 1, 2006. The Company is currently considering but
have not yet determined what impact the adoption of this
standard will have on its financial position and results of
operations.
IXYSs foreign currency translation adjustments represent
the only component of comprehensive income that is excluded from
net income (loss) for 2005 and prior years. See Foreign Currency
Translation above for discussion of currency translation
adjustments.
|
|
|
Concentration and Business Risks: |
|
|
|
Dependence on Third Parties for Wafer Fabrication and
Assembly: |
IXYS manufactures approximately 57% of its wafers, an integral
component of its products, in its facilities in Germany, the UK,
Massachusetts and California. IXYS relies on third party
suppliers to provide the remaining 43%. The principal external
foundry is Samsung Electronicss facility in Kiheung, South
Korea. There can be no assurance that material disruptions in
supply will not occur in the future. In such event, IXYS may
have to identify and secure additional foundry capacity and may
be unable to identify or secure sufficient foundry capacity to
meet demand. Even if such capacity is available from another
manufacturer, the qualification process could take six months or
longer. If IXYS were unable to qualify alternative manufacturing
sources for existing or new products in a timely manner or if
such sources were unable to produce semiconductor devices with
acceptable manufacturing yields and at acceptable prices,
IXYSs business, financial condition and results of
operations would be materially and adversely affected.
IXYS purchases silicon wafers from three vendors with whom IXYS
does not have long term supply agreements. Any of these
suppliers could terminate their relationship with IXYS at any
time. IXYSs reliance on a limited number of suppliers
involves several risks, including potential inability to obtain
an adequate supply of silicon wafers and reduced control over
the price, timely delivery, reliability and quality of the
silicon wafers. There can be no assurance that problems will not
occur in the future with suppliers.
|
|
|
Employees Covered by Collective Bargaining Arrangements: |
Approximately 150 IXYS employees in the United Kingdom and 240
in Germany have their annual pay increases negotiated by a labor
union.
|
|
|
Concentration of Credit Risk: |
IXYS invests its excess cash primarily in short-term time
deposit accounts with a major German bank and money market
accounts with a U.S. bank. Additionally, IXYS invests in
commercial paper with financial institutions that management
believes to be creditworthy. These securities mature within
ninety days or less and bear minimal credit risk. IXYS has not
experienced any losses on such investments.
IXYS sells its products primarily to distributors and original
equipment manufacturers. IXYS performs ongoing credit
evaluations of its customers and generally does not require
collateral. An allowance for potential credit losses is
maintained by IXYS and such losses have not been material. See
Note 15 for a discussion of revenues by geography.
During the year ended March 31, 2005, sales to one customer
represented 11.5% of net revenues. At March 31, 2005 and
2004, no customer accounted for greater than 10% of accounts
receivable.
60
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Financial instruments that potentially subject IXYS to credit
risk comprise principally cash and cash equivalents and trade
accounts receivable. IXYS invests its excess cash in accordance
with its investment policy that has been approved by the Board
of Directors and is reviewed periodically by management to
minimize credit risk. The policy authorizes the investment of
excess cash in government securities, tax exempt municipal
securities, Eurodollar notes and bonds, time deposits,
certificates of deposit, commercial paper rated Aa or better and
other specific money market accounts and corporate instruments
of similar liquidity and credit quality.
|
|
|
Fair Value of Financial Instruments: |
Carrying amounts of certain of IXYSs financial instruments
including cash and cash equivalents, accounts receivable and
accounts payable approximate fair value due to their short
maturities. Based on borrowing rates currently available to IXYS
for loans with similar terms, the carrying value of notes
payable to banks, loans payable and notes receivable from
stockholders approximate fair value.
|
|
|
Stock-Based Compensation Plans: |
IXYS accounts for stock-based compensation using the intrinsic
value method prescribed in Accounting Principles Board
(APB) Opinion No. 25, Accounting for
Stock Issued to Employees. Under APB No. 25,
compensation cost is measured as the excess, if any, of the
quoted market price of IXYSs stock at the date of grant
over the exercise price of the option granted. Compensation cost
for stock options, if any, is recognized ratably over the
vesting period. IXYSs policy is to grant options with an
exercise price equal to the quoted market price of IXYSs
stock on the grant date. Accordingly, no compensation has been
recognized for its stock option plans. IXYS provides additional
pro forma disclosures as required under SFAS No. 123,
Accounting for Stock-Based Compensation.
Had compensation cost for its stock plans been determined based
on the fair value at the grant date for awards in fiscal years
2005, 2004 and 2003 consistent with the provisions of
SFAS No. 123, IXYSs net income (loss) and net
income (loss) per share for fiscal years 2005, 2004 and 2003
would have decreased to the pro forma amounts indicated below
(in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
Net income (loss)
|
|
$ |
16,242 |
|
|
$ |
(4,432 |
) |
|
$ |
(12,145 |
) |
Less: Total stock-based compensation determined under fair value
based methods for all awards to employees, net of tax
|
|
|
(1,870 |
) |
|
|
(2,580 |
) |
|
|
(2,366 |
) |
|
|
|
|
|
|
|
|
|
|
Pro forma net income (loss)
|
|
$ |
14,372 |
|
|
$ |
(7,012 |
) |
|
$ |
(14,511 |
) |
|
|
|
|
|
|
|
|
|
|
As reported net income (loss) per share basic
|
|
$ |
0.49 |
|
|
$ |
(0.14 |
) |
|
$ |
(0.39 |
) |
|
|
|
|
|
|
|
|
|
|
Pro forma net income (loss) per share basic
|
|
$ |
0.43 |
|
|
$ |
(0.22 |
) |
|
$ |
(0.47 |
) |
|
|
|
|
|
|
|
|
|
|
As reported net income (loss) per share diluted
|
|
$ |
0.46 |
|
|
$ |
(0.14 |
) |
|
$ |
(0.39 |
) |
|
|
|
|
|
|
|
|
|
|
Pro forma net income (loss) per share diluted
|
|
$ |
0.41 |
|
|
$ |
(0.22 |
) |
|
$ |
(0.47 |
) |
|
|
|
|
|
|
|
|
|
|
The fair value of option grants has been estimated on the date
of grant using the Black-Scholes option pricing model with the
following weighted average assumptions:
|
|
|
|
|
|
|
|
|
Year Ended March 31, |
|
|
|
|
|
2005 |
|
2004 |
|
2003 |
|
|
|
|
|
|
|
Risk-free interest rate
|
|
3.15% to 3.49% |
|
1.72% to 3.22% |
|
2.74% to 4.33% |
Expected term
|
|
4.0 years |
|
4.0 years |
|
4.0 years |
Volatility
|
|
64% |
|
100% |
|
104% |
Dividend yield
|
|
0% |
|
0% |
|
0% |
61
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
Microwave Technology, Inc.: |
On September 5, 2003, IXYS completed its acquisition of
100% of the voting equity interests of Microwave Technology,
Inc. (MwT), a manufacturer of discrete gallium
arsenide field effect transistors (FETS) based in
the United States. The acquisition of MwT expanded the
Companys line of radio frequency, or RF, products by
adding MwTs gallium arsenide semiconductor products and
increased IXYSs presence in RF power semiconductors. The
acquisition was intended to allow the combined organization to
be more competitive and to achieve greater financial strength,
operational efficiencies, access to capital and growth potential
than either company could separately achieve. These factors
contributed to the purchase price in excess of the fair value of
MwTs net tangible and intangible assets acquired, and, as
a result, IXYS has recorded goodwill in connection with this
transaction. The acquisition was a stock-for-stock exchange. As
such, none of the goodwill is expected to be deductible for tax
purposes. MwT has been included in the Companys statement
of operations since September 5, 2003. In connection with
the acquisition, approximately 767,000 shares of IXYS
common stock and options exercisable for approximately
26,000 shares of IXYS common stock were issued. The total
purchase price is as follows (in thousands):
|
|
|
|
|
|
Value of IXYS common stock issued
|
|
$ |
4,189 |
|
Value of IXYS options issued
|
|
|
167 |
|
Direct merger cost
|
|
|
321 |
|
|
|
|
|
|
Total purchase price
|
|
$ |
4,677 |
|
|
|
|
|
The fair value of IXYSs common stock issued was determined
using an average of the closing sales prices of a share of the
common stock on the Nasdaq National Market for the five trading
days before and after the definitive agreement was signed. The
fair value of the options assumed in the transaction was
determined using the Black-Scholes option pricing model using an
expected life of 2-years, risk free rate of 2% and expected
volatility of 66% and no expected dividend rate.
In fiscal 2004 IXYS allocated the purchase price to identifiable
intangible assets, tangible assets, liabilities assumed and
goodwill as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
Fair value of tangible assets acquired:
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
$ |
2,182 |
|
|
|
|
|
|
Deferred tax assets short term
|
|
|
559 |
|
|
|
|
|
|
Plant and equipment
|
|
|
91 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,832 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Useful | |
|
|
|
|
Lives | |
|
|
|
|
| |
Amortizable intangible assets:
|
|
|
|
|
|
|
|
|
|
Core technology
|
|
|
300 |
|
|
|
5 to 6 years |
|
|
Existing technology
|
|
|
1,300 |
|
|
|
5 to 6 years |
|
|
Contract and related customers relationships
|
|
|
400 |
|
|
|
5 to 6 years |
|
|
Tradename
|
|
|
200 |
|
|
|
5 to 6 years |
|
|
Backlog
|
|
|
200 |
|
|
|
3 to 6 months |
|
|
|
|
|
|
|
|
|
|
|
2,400 |
|
|
|
|
|
Total assets acquired
|
|
|
5,232 |
|
|
|
|
|
Fair value of liabilities assumed
|
|
|
(2,415 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net assets acquired
|
|
|
2,817 |
|
|
|
|
|
Goodwill
|
|
|
1,860 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total purchase price
|
|
$ |
4,677 |
|
|
|
|
|
|
|
|
|
|
|
|
62
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company made an adjustment of approximately $279,000 to
Goodwill in fiscal 2005 related to the acquisition of Microwave
Technology.
Pro Forma Disclosure (in thousands, except per share
data):
The following unaudited pro forma combined amounts give effect
to the acquisition of MwT as if the acquisition had occurred on
April 1, 2002. On a pro forma basis, the results of
operations of MwT for the years ended March 31, 2004 and
2003 are consolidated with IXYS results for the same periods.
The pro forma amounts do not purport to be indicative of what
would have occurred had the acquisition been made as of the
beginning of the period, or of results which may occur in the
future.
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(Unaudited) | |
|
(Unaudited) | |
Net revenue
|
|
$ |
189,826 |
|
|
$ |
148,607 |
|
Net loss
|
|
$ |
(6,627 |
) |
|
$ |
(21,215 |
) |
Net loss per share basic
|
|
|
(0.20 |
) |
|
|
(0.65 |
) |
Net loss per share diluted
|
|
$ |
(0.20 |
) |
|
$ |
(0.65 |
) |
Weighted-average shares used in per share
calculation basic
|
|
|
32,753 |
|
|
|
32,612 |
|
Weighted-average shares used in per share
calculation diluted
|
|
|
32,753 |
|
|
|
32,612 |
|
On June 10, 2002, IXYS completed its acquisition of 100% of
the voting equity interests of Clare, Inc. (Clare).
The acquisition of Clare expanded the Companys product
offerings into the semiconductor segment of the market that
replaces electromagnetic relays, or EMRs, with solid state
relays, or SSRs. Clares semiconductor products are capable
of integrating a number of functions previously provided by
discrete components into one package and including product
applications such as modem interfaces to the Internet, cable set
top boxes, and voice over Internet protocol, or VOIP,
applications. The acquisition was intended to allow the combined
organization to be more competitive and to achieve greater
financial strength, operational efficiencies, access to capital
and growth potential than either company could separately
achieve. These factors contributed to the purchase price in
excess of the fair value of Clares net tangible and
intangible assets acquired, and, as a result, IXYS has recorded
goodwill in connection with this transaction. The acquisition
was a stock-for-stock exchange. As such, none of the goodwill is
expected to be deductible for tax purposes. Clare has been
included in the Companys statement of operations since
June 10, 2002. In connection with the acquisition,
approximately 4.9 million shares of IXYS common stock and
options exercisable for approximately 1.0 million shares of
IXYS common stock were issued. In connection with the
acquisition, (a) each outstanding share of Clare common
stock was converted into the right to receive 0.49147 of a share
of IXYS common stock, which resulted in the issuance of
approximately 4.9 million shares of IXYS common stock, and
(b) each option to purchase Clare common stock outstanding
immediately prior to the consummation of the acquisition was
converted into an option to purchase 0.49147 of a share of IXYS
common stock, resulting in the assumption of options exercisable
for approximately 1.0 million shares of IXYS common stock.
The total purchase price is as follows (in thousands):
|
|
|
|
|
|
Value of IXYS common stock issued
|
|
$ |
47,658 |
|
Value of Clares options assumed by IXYS
|
|
|
3,741 |
|
Merger cost
|
|
|
1,676 |
|
|
|
|
|
|
Total purchase price
|
|
$ |
53,075 |
|
|
|
|
|
63
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The fair value of IXYSs common stock issued was determined
using an average of the closing sales prices of a share of the
common stock on Nasdaq National Market for the three days before
and after the announcement date. The fair value of the options
assumed in the transaction was determined using the
Black-Scholes option pricing model using an expected life of two
years, risk free rate of 3.4% and expected volatility of 80% and
no expected dividend rate. IXYS has allocated the purchase price
to identifiable intangible assets, tangible assets, liabilities
assumed and goodwill as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
Fair Value of tangible assets acquired:
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
$ |
24,861 |
|
|
|
|
|
|
Deferred tax assets short term
|
|
|
4,796 |
|
|
|
|
|
|
Plant and equipment
|
|
|
10,271 |
|
|
|
|
|
|
Other assets
|
|
|
111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,039 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Useful | |
|
|
|
|
Lives | |
|
|
|
|
| |
Amortizable intangible assets:
|
|
|
|
|
|
|
|
|
|
Core technology
|
|
|
2,700 |
|
|
|
5 to 6 years |
|
|
Tradename/trademarks
|
|
|
900 |
|
|
|
3 years |
|
|
Other
|
|
|
715 |
|
|
|
3 months to 6 years |
|
|
|
|
|
|
|
|
|
|
|
4,315 |
|
|
|
|
|
Total assets acquired
|
|
|
44,354 |
|
|
|
|
|
Fair value of liabilities assumed
|
|
|
(8,746 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net assets acquired
|
|
|
35,608 |
|
|
|
|
|
Goodwill
|
|
|
17,467 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total purchase price
|
|
$ |
53,075 |
|
|
|
|
|
|
|
|
|
|
|
|
Pro Forma Disclosure (in thousands, except per share
data):
The following unaudited pro forma combined amounts give effect
to the acquisition of Clare as if the acquisition had occurred
on April 1, 2002. On a pro forma basis, the results of
operations of Clare for the year ended March 31, 2003 are
consolidated with IXYS results for the same periods. The pro
forma amounts do not purport to be indicative of what would have
occurred had the acquisition been made as of the beginning of
each period or of results that may occur in the future.
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2003 | |
|
|
| |
|
|
(Unaudited) | |
Net revenue
|
|
$ |
142,568 |
|
Net loss
|
|
$ |
(19,938 |
) |
Net loss per share basic
|
|
$ |
(0.63 |
) |
Net loss per share diluted
|
|
$ |
(0.63 |
) |
Weighted-average shares used in per share calculation
|
|
|
31,845 |
|
In June 2002, the Company adopted a corporate restructuring
program to reduce expenses and preserve the Companys cash.
The restructuring mainly relates to a reduction in the workforce
designed to eliminate redundant positions at Clare. The
restructuring charge, which consisted mainly of involuntary
employee
64
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
separation costs of $750,000, was recorded in operating expense
for the year ended March 31, 2003 and fully paid by
year-end. The separation cost is for 33 employees worldwide: 5
in sales and marketing, 7 in research and development, 3 in
general and administrative and 9 in operations functions in the
United States; and 8 in sales and marketing and 1 in general and
administrative outside the United States.
|
|
5. |
Goodwill and Intangible Assets: |
Goodwill represents the excess of the purchase price over the
estimated fair value of the net assets acquired. IXYS values
goodwill and intangible assets in accordance with
SFAS No. 142, Goodwill and Other Intangible
Assets. The costs of acquired intangible assets are
recorded at fair value at acquisition. Intangible assets with
finite lives are amortized using the straight-line method over
their estimated useful lives, normally three to six years, and
evaluated for impairment in accordance with
SFAS No. 144 Accounting for the Impairment or
Disposal of Long-Lived Assets.
Goodwill and intangible assets with indefinite lives are carried
at fair value and reviewed at least annually for impairment as
of December 31, or more frequently if events and
circumstances indicate that the asset might be impaired, in
accordance with SFAS No. 142. The Company has
determined that it only has one reporting unit as defined by
SFAS 142. An impairment loss would be recognized to the
extent that the carrying amount exceeds the fair value of the
Company (the reporting unit). There are two steps in the
determination. The first step compares the carrying amount of
the net assets to the fair value of the Company. The second
step, if necessary, recognizes an impairment loss to the extent
the carrying amount of the Companys net assets exceed the
fair value of the Company. The implied fair value of goodwill is
determined by allocating the fair value of the Company in a
manner similar to a purchase price allocation, in accordance
with SFAS No. 141, Business Combinations.
The residual fair value after this allocation is the implied
fair value of the Companys goodwill. IXYS has not recorded
an impairment of goodwill or intangible assets.
Recent additions to goodwill are discussed in Note 3
Acquisitions. The Company made an adjustment of approximately
$279,000 to Goodwill in fiscal 2005 related to the acquisition
of Microwave Technology.
|
|
6. |
Balance Sheet Details: |
|
|
|
Allowances Movement (in thousands): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at | |
|
|
|
|
|
|
|
Balance at | |
|
|
Beginning | |
|
|
|
|
|
Translation | |
|
End of | |
|
|
of Year | |
|
Additions | |
|
Deductions | |
|
Adjustments | |
|
Year | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Allowances for accounts receivable and for doubtful accounts
Year ended March 31, 2005
|
|
$ |
2,654 |
|
|
$ |
4,994 |
|
|
$ |
(5,057 |
) |
|
$ |
38 |
|
|
$ |
2,629 |
|
|
Year ended March 31, 2004
|
|
$ |
3,169 |
|
|
$ |
4,261 |
|
|
$ |
(4,849 |
) |
|
$ |
73 |
|
|
$ |
2,654 |
|
|
Year ended March 31, 2003
|
|
$ |
1,045 |
|
|
$ |
8,024 |
|
|
$ |
(5,982 |
) |
|
$ |
82 |
|
|
$ |
3,169 |
|
Inventories consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Raw materials
|
|
$ |
13,386 |
|
|
$ |
12,117 |
|
Work in process
|
|
|
25,304 |
|
|
|
26,729 |
|
Finished goods
|
|
|
12,721 |
|
|
|
9,209 |
|
|
|
|
|
|
|
|
|
|
$ |
51,411 |
|
|
$ |
48,055 |
|
|
|
|
|
|
|
|
65
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
Property, Plant and Equipment: |
Property, plant and equipment consists of the following (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Property and plant
|
|
$ |
6,367 |
|
|
$ |
6,390 |
|
Equipment owned
|
|
|
55,300 |
|
|
|
48,267 |
|
Equipment capital leases
|
|
|
16,102 |
|
|
|
17,679 |
|
Leasehold improvements
|
|
|
2,954 |
|
|
|
2,954 |
|
|
|
|
|
|
|
|
|
|
|
80,723 |
|
|
|
75,290 |
|
Accumulated depreciation owned plant, equipment, and
leasehold improvements
|
|
|
(43,804 |
) |
|
|
(37,599 |
) |
Accumulated amortization capital leases
|
|
|
(9,105 |
) |
|
|
(11,322 |
) |
|
|
|
|
|
|
|
|
|
$ |
27,814 |
|
|
$ |
26,369 |
|
|
|
|
|
|
|
|
Depreciation and amortization expense for fiscal years ended
March 31, 2005, 2004 and 2003 amounted to
$9.3 million, $11.2 million and $9.3 million,
respectively.
IXYS leases certain equipment under capital lease arrangements
expiring through fiscal year 2008 at interest rates of 5.2% to
13.7%.
Other assets consists of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Purchased intangible assets, net (see Note 3
Acquisitions for historic addition activity)
|
|
$ |
2,724 |
|
|
$ |
4,273 |
|
Loans to vendors
|
|
|
1,967 |
|
|
|
1,442 |
|
Other
|
|
|
1,216 |
|
|
|
1,595 |
|
|
|
|
|
|
|
|
|
|
$ |
5,907 |
|
|
$ |
7,310 |
|
|
|
|
|
|
|
|
Amortization of purchased intangible assets was approximately
$1.3 million in fiscal 2005 and is expected to be
approximately $965,000 in fiscal 2006.
|
|
|
Accrued Expenses and Other Liabilities: |
Accrued expenses and other liabilities consist of the following
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Compensation and vacation
|
|
$ |
6,374 |
|
|
$ |
2,834 |
|
Legal, audit and tax preparation
|
|
|
2,449 |
|
|
|
2,101 |
|
Commissions, royalties, deferred revenue and other
|
|
|
2,511 |
|
|
|
3,962 |
|
Income taxes
|
|
|
5,958 |
|
|
|
7,247 |
|
Uninvoiced goods and services
|
|
|
4,831 |
|
|
|
1,950 |
|
|
|
|
|
|
|
|
|
|
$ |
22,123 |
|
|
$ |
18,094 |
|
|
|
|
|
|
|
|
66
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
7. |
Borrowing Arrangements: |
IXYS entered into a loan and security agreement with a
U.S. bank to borrow up to an aggregate amount not to exceed
$5.0 million. The loan bears interest at the banks
prime rate, 5.75% at March 31, 2005, payable monthly, and
matures in September 2005. The loan is collateralized by certain
assets and contains certain general and financial covenants,
including a requirement that IXYS remain solvent and able to pay
its debts as they become due. At March 31, 2005, IXYS had
no outstanding balance under the loan. IXYS has another line of
credit with a U.S. bank that consists of a $100,000
commitment, none of which has been drawn down. The line bears
interest at a rate of 3.25%. The line is collateralized by a
$100,000 certificate of deposit that IXYS has with the bank.
In October of 2004, IXYS Semiconductor GmbH obtained a
$5.0 million line of credit with a German bank that
supports a letter of credit facility. At March 31, 2005,
there were approximately $1.6 million of open letters of
credit to support inventory purchases.
A German bank issued to IXYS a commitment letter for a Euro
3.8 million, or about $4.9 million, equipment lease
facility. The equipment lease facility provides financing at
varying pricing for periods up to 48 months. At
March 31, 2005, IXYS had drawn Euro 2.6 million, or
about $3.4 million, under this commitment. In addition to
the rights to the equipment, the bank holds a security interest
in the general assets of IXYS Semiconductor GmbH and
unrestricted amounts deposited with the bank. Drawings under the
facility are included within the capitalized lease obligations
on the balance sheet.
IXYS entered into a term loan with a Swiss bank in the amount of
Swiss Franc 200,000, or approximately US $157,000. The loan
bears interest of 5.25% and is due in November 2006.
|
|
8. |
Commitments and Contingencies: |
IXYS leases certain equipment under capital lease arrangements
expiring through fiscal year 2008 at interest rates of 5.2% to
13.7%.
IXYS rents certain of its facilities under operating leases that
expire in 2022.
Future minimum lease payments under capital and operating leases
are (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
Capital | |
|
Operating | |
Fiscal Year Ending March 31, |
|
Leases | |
|
Leases | |
|
|
| |
|
| |
|
2006
|
|
$ |
3,524 |
|
|
$ |
3,331 |
|
|
2007
|
|
|
2,247 |
|
|
|
2,518 |
|
|
2008
|
|
|
1,435 |
|
|
|
2,146 |
|
|
2009
|
|
|
872 |
|
|
|
2,008 |
|
|
Thereafter
|
|
|
5 |
|
|
|
9,861 |
|
|
|
|
|
|
|
|
Total Minimum Payments
|
|
|
8,083 |
|
|
$ |
19,864 |
|
|
|
|
|
|
|
|
Less: Interest
|
|
|
(941 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,142 |
|
|
|
|
|
Less: Current Portion
|
|
|
(2,733 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
4,409 |
|
|
|
|
|
|
|
|
|
|
|
|
Rent expense for fiscal years ended March 31, 2005, 2004
and 2003 amounted to $2.8 million, $2.6 million and
$2.1 million, respectively.
67
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
As of March 31, 2005 and 2004, IXYS had cash deposits with
financial institutions of $155,000 and $1.1 million,
respectively, which were restricted as to use and represent
compensating balances for current or future discounted
acceptances and letters of credit. These balances are included
in restricted cash on the Companys balance sheets.
As of March 31, 2005, IXYS is committed to purchase
approximately $11.8 million of inventory from suppliers of
IXYS.
IXYS Corporation guarantees the $5.0 million line of
credit issued by a German bank to IXYS Semiconductor GmbH to
support a letter of credit facility. At March 31, 2005,
there were approximately $1.6 million of open letters of
credit to support inventory purchases.
IXYS currently is involved in a variety of legal matters that
arise in the normal course of business. Were an unfavorable
ruling to occur, there could be a material adverse impact on the
Companys financial condition, results of operations or
cash flows.
On June 22, 2000, International Rectifier Corporation filed
an action for patent infringement against IXYS in the United
States District Court for the Central District of California,
alleging that certain of IXYSs products sold in the United
States infringe U.S. patents owned by International
Rectifier. International Rectifiers complaint against IXYS
contended that IXYSs alleged infringement of International
Rectifiers patents has been and continues to be willful
and deliberate. Subsequently, the U.S. District Court
decided that certain of IXYSs power MOSFETs and IGBTs
infringe certain claims of each of three International Rectifier
U.S. patents.
In 2002, the U.S. District Court entered a permanent
injunction barring IXYS from making, using, offering to sell or
selling in, or importing into, the United States, MOSFETs
(including IGBTs) covered by the subject patents and ruled that
International Rectifier should be awarded damages of
$9.1 million for IXYSs alleged infringement of
International Rectifiers patents. In addition, the
U.S. District Court ruled that IXYS had been guilty of
willful infringement. Subsequently, the U.S. District Court
increased the damages to a total of $27.2 million, plus
attorney fees.
IXYS appealed and on March 19, 2004 the United States Court
of Appeals for the Federal Circuit reversed or vacated all
findings of patent infringement previously issued against IXYS
by the U.S. District Court, and vacated the permanent
injunction. On August 9, 2004, the Federal Circuit Court
vacated the damages award. The case was remanded to the
U.S. District Court for further proceedings. The case has
been set for trial to commence on August 2, 2005.
There can be no assurance of a favorable outcome in the
International Rectifier suit. In the event of an adverse
outcome, damages or injunctions awarded by the
U.S. District Court would be materially adverse to
IXYSs financial condition, results of operations and cash
flows. Management has not accrued any amounts for damages in the
accompanying balance sheets for the International Rectifier
matter described above.
On April 10, 2003, LoJack Corporation (LoJack)
filed a suit against Clare, Inc. in the Superior Court of
Norfolk County, Massachusetts claiming breach of contract,
unjust enrichment, breach of the implied covenant of good faith
and fair dealing, failure to perform services and violation of a
Massachusetts statute prohibiting unfair and deceptive acts and
practices, all purportedly resulting from Clares alleged
breach of a contract to develop custom integrated circuits and a
module assembly.
In its complaint, LoJack sought damages in an amount to be
determined at trial, an $890,000 refund of payments it made
under the contract, all work product resulting from any work
prepared by Clare and its attorneys fees in the suit.
LoJack also sought to have its damages trebled under the
Massachusetts statute.
68
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Clare answered the complaint denying any liability and
counterclaiming for breach of contract, unjust enrichment,
breach of the implied covenant of good faith and fair dealing,
violation of the Massachusetts statute, promissory estoppel and
negligent misrepresentation. Discovery in the litigation is
largely complete. Motions for summary judgment have been briefed
but not yet heard. A trial date of October 11, 2005 has
been set.
There can be no assurance of a favorable outcome in the LoJack
suit. In the event of an adverse outcome, damages awarded by the
court could be materially adverse to the Companys
financial condition, results of operations or cash flows.
Management has not accrued any amounts of damages in the
accompanying balance sheets for the LoJack matter described
above.
|
|
|
Stock Purchase and Stock Option Plans: |
IXYS has the 1999 Equity Incentive Plan and the 1999
Non-Employee Directors Equity Incentive Plan (the
Plans) under which incentive stock options may be
granted for not less than 85% of fair market value at the time
of grant. The options, once granted, expire ten years from the
date of grant. Options granted to employees under the 1999
Incentive Plan typically vest over four years, the initial
option grants under the 1999 Non-Employee Directors Equity
Incentive Plan vests over four years and subsequent annual
grants vest over one year. The Board of Directors has the full
power to determine the provisions of each option issued under
the Plans. The 1994 Stock Option Plan was terminated in May
1999. No options have been granted below fair market value.
Since inception, the cumulative shares authorized for the 1999
Equity Incentive Plan were approximately 8.6 million
shares. The Plan has an evergreen feature that adds up to
1,000,000 shares to the total shares authorized each year
at the discretion of the board. The 1999 Non-Employee
Directors Equity Incentive Plan had a total of
500,000 shares authorized at its inception date.
69
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Stock option activity under the Plans is summarized below (in
thousands, except share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding | |
|
Weighted | |
|
|
Shares | |
|
| |
|
Average | |
|
|
Available for | |
|
Number of | |
|
|
|
Exercise | |
|
|
Grant | |
|
Shares | |
|
Exercise Price | |
|
Total | |
|
Price | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Balances, March 31, 2002
|
|
|
2,749,276 |
|
|
|
3,820,694 |
|
|
|
|
|
|
$ |
19,595 |
|
|
$ |
5.13 |
|
|
Options assumed
|
|
|
|
|
|
|
992,128 |
|
|
$ |
1.91-$50.10 |
|
|
$ |
14,127 |
|
|
$ |
14.24 |
|
|
New authorized
|
|
|
899,991 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
(888,750 |
) |
|
|
888,750 |
|
|
$ |
4.64-$7.79 |
|
|
$ |
4,992 |
|
|
$ |
5.62 |
|
|
Options exercised
|
|
|
|
|
|
|
(130,224 |
) |
|
$ |
0.08-$5.23 |
|
|
$ |
(506 |
) |
|
$ |
3.89 |
|
|
Options cancelled
|
|
|
(58,725 |
) |
|
|
(584,462 |
) |
|
$ |
3.625-$50.10 |
|
|
$ |
(7,713 |
) |
|
$ |
13.20 |
|
|
Options expired
|
|
|
|
|
|
|
(1,875 |
) |
|
$ |
17.35 |
|
|
$ |
(33 |
) |
|
$ |
17.60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2003
|
|
|
2,701,792 |
|
|
|
4,985,011 |
|
|
|
|
|
|
$ |
30,462 |
|
|
$ |
6.11 |
|
|
Options assumed
|
|
|
|
|
|
|
25,741 |
|
|
$ |
1.83-$3.66 |
|
|
$ |
87 |
|
|
$ |
3.38 |
|
|
New authorized
|
|
|
1,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
(746,000 |
) |
|
|
746,000 |
|
|
$ |
6.75-$10.63 |
|
|
$ |
6,313 |
|
|
$ |
8.46 |
|
|
Options exercised
|
|
|
|
|
|
|
(232,862 |
) |
|
$ |
1.02-$7.73 |
|
|
$ |
(843 |
) |
|
$ |
3.62 |
|
|
Options cancelled
|
|
|
185,676 |
|
|
|
(185,676 |
) |
|
$ |
3.63-$31.54 |
|
|
$ |
(2,314 |
) |
|
$ |
12.46 |
|
|
Options expired
|
|
|
27,650 |
|
|
|
(27,650 |
) |
|
$ |
3.63-$29.50 |
|
|
$ |
(309 |
) |
|
$ |
11.18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2004
|
|
|
3,169,118 |
|
|
|
5,310,564 |
|
|
|
|
|
|
$ |
33,396 |
|
|
$ |
6.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options assumed
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New authorized
|
|
|
1,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
(453,000 |
) |
|
|
453,000 |
|
|
$ |
6.65-$9.15 |
|
|
$ |
3,687 |
|
|
$ |
8.14 |
|
|
Options exercised
|
|
|
|
|
|
|
(480,751 |
) |
|
$ |
1.69-$7.38 |
|
|
$ |
(1,551 |
) |
|
$ |
3.23 |
|
|
Options cancelled
|
|
|
61,640 |
|
|
|
(61,640 |
) |
|
$ |
4.64-$31.54 |
|
|
$ |
(560 |
) |
|
$ |
9.09 |
|
|
Options expired
|
|
|
20,100 |
|
|
|
(24,098 |
) |
|
$ |
2.16-$19.00 |
|
|
$ |
(247 |
) |
|
$ |
10.25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances, March 31, 2005
|
|
|
3,797,858 |
|
|
|
5,197,075 |
|
|
|
|
|
|
$ |
34,725 |
|
|
$ |
6.68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table summarizes information about stock options
outstanding at March 31, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Exercisable | |
Options Outstanding | |
|
| |
| |
|
|
|
Weighted | |
|
|
Number of | |
|
Weighted Average | |
|
Weighted Average | |
|
|
|
Average | |
Exercise Price |
|
Shares | |
|
Contractual Life | |
|
Exercise Price | |
|
Number of Shares | |
|
Exercise Price | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
$1.69-2.34
|
|
|
807,058 |
|
|
|
4.5 |
|
|
$ |
2.20 |
|
|
|
804,993 |
|
|
$ |
2.20 |
|
$3.46-4.88
|
|
|
1,547,180 |
|
|
|
4.5 |
|
|
$ |
3.82 |
|
|
|
1,453,363 |
|
|
$ |
3.77 |
|
$5.23-7.79
|
|
|
1,532,162 |
|
|
|
7.5 |
|
|
$ |
7.02 |
|
|
|
817,250 |
|
|
$ |
7.01 |
|
$8.01-11.70
|
|
|
857,591 |
|
|
|
8.7 |
|
|
$ |
9.11 |
|
|
|
222,266 |
|
|
$ |
8.81 |
|
$12.21-18.25
|
|
|
239,511 |
|
|
|
4.5 |
|
|
$ |
13.63 |
|
|
|
238,011 |
|
|
$ |
13.62 |
|
$18.44-21.36
|
|
|
115,499 |
|
|
|
4.9 |
|
|
$ |
19.17 |
|
|
|
115,499 |
|
|
$ |
19.17 |
|
$28.49-36.24
|
|
|
98,074 |
|
|
|
4.7 |
|
|
$ |
30.46 |
|
|
|
98,074 |
|
|
$ |
30.46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,197,075 |
|
|
|
6.1 |
|
|
$ |
6.68 |
|
|
|
3,749,456 |
|
|
$ |
6.23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The fair value of option grants has been estimated on the date
of grant using the Black-Scholes option pricing model with the
following weighted average assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
Risk-free interest rate
|
|
|
3.15% to 3.49% |
|
|
|
1.72% to 3.22% |
|
|
|
2.74% to 4.33% |
|
Expected term
|
|
|
4 years |
|
|
|
4 years |
|
|
|
4 years |
|
Volatility
|
|
|
64% |
|
|
|
100% |
|
|
|
104% |
|
Dividend yield
|
|
|
0% |
|
|
|
0% |
|
|
|
0% |
|
No dividend yield is assumed as IXYS has not paid dividends and
has no plans to do so.
The weighted average expected term was calculated based on the
vesting period and the expected life of the grant using historic
experience. The risk free interest rate was calculated based on
rates prevailing during grant periods and the expected life of
the options at the date of grants. The weighted average fair
values of options granted to employees during the fiscal years
ended March 31, 2005, 2004 and 2003 were $3.81, $8.46 and
$4.41, respectively.
In November 1995 IXYS sold 6,750,395 shares of common stock
to certain members of IXYSs management. The shares were
purchased through recourse promissory notes at a purchase price
of $0.11 per share. Interest is due on the notes at a rate
of 5.79% per annum through September 15, 2000 and
6.25% per annum after that date, with the balance
outstanding due in full September 2005. At March 31, 2005,
approximately $299,000 was receivable on these notes.
In August 2001 IXYS sold 8,250 shares of common stock to a
director. The shares were purchased through a recourse
promissory note at a purchase price of $3.625 per share.
Interest is due on the note at a rate of 6.75% per annum,
with the balance outstanding due in full in August 2006. At
March 31, 2005, $56,000 was receivable on this note.
In May 1999, IXYS approved the 1999 Employee Stock Purchase Plan
(Purchase Plan) and reserved 500,000 shares of
common stock for issuance under the Purchase Plan and terminated
all prior Paradigm employee stock purchase plans. Under the
Purchase Plan, substantially all employees may purchase the
Companys common stock at a price equal to 85.0% of the
lower of the fair market value at the beginning or the end of
each specified six-month offering period. Stock purchases are
limited to 15.0% of an employees eligible compensation.
During the year ended March 31, 2005, there were
approximately 87,000 shares purchased under the Purchase
Plan leaving 221,000 shares available for purchase under
the plan in the future.
The fair value for the purchase rights issued under the Purchase
Plan using the Black-Scholes valuation model with the following
weighted average assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
Risk-free interest rate
|
|
|
1.28% |
|
|
|
1.02% |
|
|
|
1.22% |
|
Expected life
|
|
|
0.5 years |
|
|
|
0.5 years |
|
|
|
0.5 years |
|
Volatility
|
|
|
57% |
|
|
|
100% |
|
|
|
104% |
|
Dividend yield
|
|
|
0% |
|
|
|
0% |
|
|
|
0% |
|
The weighted average fair value per share of those purchase
rights granted in 2005, 2004 and 2003 was $2.66, $6.16 and
$2.70, respectively.
On May 4, 2005, IXYS accelerated the vesting of the right
to purchase 128,250 shares of its common stock
pursuant to previously granted stock options. The accelerated
options were at exercise prices in excess of
71
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the closing price on May 4, 2005 of $10.28. The vesting was
accelerated to avoid future accounting charges under
SFAS No. 123R.
|
|
10. |
Employee Savings and Retirement Plan: |
IXYS has a 401(k) plan, known as the IXYS Corporation
and Subsidiary Employee Savings and Retirement Plan.
Eligibility to participate in the plan is subject to certain
minimum service requirements. Employees may voluntarily
contribute up to 20% of yearly compensation and IXYS may make
matching contributions as determined by the Board of Directors
in a resolution on or before the end of the fiscal year.
Employees are 100% vested immediately in any contributions by
IXYS. For the years ended March 31, 2005, 2004 and 2003,
IXYS contributed $407,000, $378,000 and $424,000, respectively.
|
|
11. |
Related Party Transactions: |
ABB, Ltd. was a principal stockholder of IXYS until December
2004. In fiscal years 2005, 2004 and 2003, IXYS generated
revenues of $3.6 million, $2.7 million and
$2.7 million, respectively, from sales of products to ABB
and ABBs affiliates for use as components in their
products. At March 31, 2005 and 2004 the accounts
receivable balances from these sales were $535,000 and $704,000
respectively.
Omni Microelectronics, a sales representative company majority
owned by S. Joon Lee, was paid sales commissions by Samsung
Electronics on $39.8 million and $21.8 million
received by Samsung Electronics from the Company in respect of
fiscal 2005 and fiscal 2004. Samsung Electronics serves as a
wafer foundry for the Company. Mr. Lee is a director of the
Company.
IXYS maintains two defined benefit pension plans: one for the
United Kingdom employees and one for German employees. These
plans cover most of the employees in the United Kingdom and
Germany. Benefits are based on years of service and the
employees compensation. The Company deposits funds for
these plans, consistent with the requirements of local law, with
investment management companies, insurance companies, trustees,
and/or accrues for the unfunded portion of the obligations. The
measurement date for the projected benefit obligations and the
plan assets is March 31, 2005.
The net periodic pension expense includes the following
components:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
|
(In thousands) | |
Service cost
|
|
$ |
878 |
|
|
$ |
750 |
|
|
$ |
750 |
|
Interest cost on projected benefit obligation
|
|
|
1,713 |
|
|
|
1,397 |
|
|
|
1,245 |
|
Expected return on plan assets
|
|
|
(1,166 |
) |
|
|
(762 |
) |
|
|
(957 |
) |
Recognized actuarial loss (gain)
|
|
|
118 |
|
|
|
181 |
|
|
|
63 |
|
|
|
|
|
|
|
|
|
|
|
Net periodic pension expense
|
|
$ |
1,543 |
|
|
$ |
1,566 |
|
|
$ |
1,101 |
|
|
|
|
|
|
|
|
|
|
|
72
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Change in benefit obligation
|
|
|
|
|
|
|
|
|
|
Projected benefit obligation at the beginning of the year
|
|
$ |
30,499 |
|
|
$ |
24,469 |
|
|
Service cost
|
|
|
878 |
|
|
|
750 |
|
|
Interest cost
|
|
|
1,713 |
|
|
|
1,397 |
|
|
Plan participants contribution
|
|
|
195 |
|
|
|
294 |
|
|
Actuarial (gain) loss
|
|
|
(96 |
) |
|
|
1,915 |
|
|
Benefits paid
|
|
|
(976 |
) |
|
|
(646 |
) |
|
Foreign currency translation adjustment
|
|
|
1,561 |
|
|
|
2,320 |
|
|
|
|
|
|
|
|
|
Projected benefit obligation at the end of the year
|
|
$ |
33,774 |
|
|
$ |
30,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Change in plan assets
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at the beginning of the year
|
|
$ |
13,452 |
|
|
$ |
10,480 |
|
|
Actual return on plan assets
|
|
|
1,553 |
|
|
|
2,559 |
|
|
Employer contribution
|
|
|
1,152 |
|
|
|
938 |
|
|
Plan participant contribution
|
|
|
195 |
|
|
|
294 |
|
|
Benefits paid
|
|
|
(668 |
) |
|
|
(322 |
) |
|
Foreign currency translation adjustment
|
|
|
2,351 |
|
|
|
(497 |
) |
|
|
|
|
|
|
|
|
Fair value of plan assets at the end of the year
|
|
$ |
18,035 |
|
|
$ |
13,452 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Status of plan
|
|
|
|
|
|
|
|
|
|
Plan obligations in excess of plan assets
|
|
$ |
(15,739 |
) |
|
$ |
(17,047 |
) |
|
Unrecognized actuarial loss
|
|
|
3,128 |
|
|
|
3,784 |
|
|
Net loss
|
|
|
381 |
|
|
|
1,204 |
|
|
|
|
|
|
|
|
|
Accrued benefit
|
|
$ |
(12,230 |
) |
|
$ |
(12,059 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
|
|
(In thousands) | |
Reconciliation of funded status
|
|
|
|
|
|
|
|
|
|
Accrued pension cost at the beginning of the year
|
|
$ |
(12,059 |
) |
|
$ |
(9,924 |
) |
|
Net period pension cost
|
|
|
(1,543 |
) |
|
|
(1,566 |
) |
|
Cash contribution
|
|
|
1,152 |
|
|
|
938 |
|
|
Benefits paid
|
|
|
976 |
|
|
|
646 |
|
|
Foreign currency translation adjustment
|
|
|
(756 |
) |
|
|
(2,153 |
) |
|
|
|
|
|
|
|
|
Accrued pension cost at the end of the year
|
|
$ |
(12,230 |
) |
|
$ |
(12,059 |
) |
|
|
|
|
|
|
|
73
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Assumptions
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
5.50 |
% |
|
|
5.50 |
% |
|
Expected long-term rate of return on assets
|
|
|
4.0- 7.0 |
% |
|
|
4.20- 7.40 |
% |
|
Salary scale
|
|
|
1.0- 4.4 |
% |
|
|
2.20- 4.40 |
% |
Approximately 70% of the accrued pension liability relates to
the German plan and 30% to the United Kingdom plan. The total
accumulated benefit obligation at March 31, 2005 was
approximately $30.7 million.
The investment policies and strategies for the assets of the
plans are determined by the respective plans trustees in
consultation with independent investment consultants and the
employer. The Companys practice is to fund these plans in
amounts at least sufficient to meet the minimum requirements of
local laws and regulations. The trustees are aware that the
nature of the liabilities of the plans will evolve as the age
profile and life expectancy of the membership changes. These
changing liability profiles lead to consultations about the
appropriate balance of investment assets to be used by the plans
(equity, debt, other), as well as timescales within which
required adjustments should be implemented. The plan assets in
the United Kingdom are held in pooled investment funds operated
by Fidelity Investments. The plan assets in Germany are held by
a separate legal entity. The plan assets do not include
securities of the Company. There is a near term objective to
increase the debt proportion of the assets to approximately 25%
of assets by 2007 by investing new contributions in debt and by
reducing equity investments.
The long term expected rate of return is a weighted average of
the returns expected for the underlying broad asset classes. The
expected returns for each asset class have regard to market
conditions on March 31, 2005 and past performance of the
asset classes generally.
IXYS expects to make contributions to the plans of approximately
$1.1 million in the fiscal year ended March 31, 2006.
This contribution is primarily contractual. The allocation of
the assets of the plans at the measurement dates was
approximately (in thousands):
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Equity securities
|
|
$ |
14,348 |
|
|
$ |
11,300 |
|
Debt securities
|
|
|
3,053 |
|
|
|
2,125 |
|
Other
|
|
|
634 |
|
|
|
27 |
|
|
|
|
|
|
|
|
|
|
$ |
18,035 |
|
|
$ |
13,452 |
|
|
|
|
|
|
|
|
IXYS expects to pay benefits in each of the next five fiscal
years and in the aggregate for the five fiscal years thereafter
of approximately (in thousands):
|
|
|
|
|
|
|
Benefit Payments | |
|
|
| |
Year ended March 31, 2006
|
|
$ |
860 |
|
Year ended March 31, 2007
|
|
|
935 |
|
Year ended March 31, 2008
|
|
|
1,024 |
|
Year ended March 31, 2009
|
|
|
1,108 |
|
Year ended March 31, 2010
|
|
|
1,185 |
|
Five fiscal years ended March 31, 2015
|
|
|
7,681 |
|
|
|
|
|
Total benefit payments for the ten fiscal years ended
March 31, 2015
|
|
$ |
12,793 |
|
|
|
|
|
74
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Income (loss) before income tax provision (benefit) consists of
the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
Domestic
|
|
$ |
14,829 |
|
|
$ |
(10,810 |
) |
|
$ |
(17,322 |
) |
International
|
|
|
10,952 |
|
|
|
4,737 |
|
|
|
(539 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
25,781 |
|
|
$ |
(6,073 |
) |
|
$ |
(17,861 |
) |
|
|
|
|
|
|
|
|
|
|
IXYSs provision for (benefit from) income taxes consists
of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$ |
(1,121 |
) |
|
$ |
(1,653 |
) |
|
$ |
|
|
|
State
|
|
|
429 |
|
|
|
25 |
|
|
|
30 |
|
|
Foreign
|
|
|
2,346 |
|
|
|
961 |
|
|
|
819 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,654 |
|
|
|
(667 |
) |
|
|
849 |
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
4,735 |
|
|
|
(1,740 |
) |
|
|
(6,458 |
) |
|
State
|
|
|
(36 |
) |
|
|
98 |
|
|
|
(546 |
) |
|
Foreign
|
|
|
3,186 |
|
|
|
668 |
|
|
|
439 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,885 |
|
|
|
(974 |
) |
|
|
(6,565 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Total income tax provision (benefit)
|
|
$ |
9,539 |
|
|
$ |
(1,641 |
) |
|
$ |
(5,716 |
) |
|
|
|
|
|
|
|
|
|
|
The Company evaluates the need for tax contingency reserves at
the end of each financial statement reporting period. During the
current period, the Company adjusted its tax contingency
reserves related to various tax jurisdictions.
IXYSs effective tax rate differed from the statutory
federal income tax rate for the years ended March 31, 2005,
2004 and 2003 as shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
Statutory federal income tax (benefit) rate
|
|
|
35 |
% |
|
|
(35 |
)% |
|
|
(35 |
)% |
State taxes, net of federal tax benefit
|
|
|
1 |
|
|
|
2 |
|
|
|
(4 |
) |
Foreign earnings taxed at different rates
|
|
|
(3 |
) |
|
|
6 |
|
|
|
7 |
|
R&D credit
|
|
|
(3 |
) |
|
|
|
|
|
|
|
|
Valuation allowance
|
|
|
12 |
|
|
|
|
|
|
|
|
|
Other
|
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
37 |
% |
|
|
(27 |
)% |
|
|
(32 |
)% |
|
|
|
|
|
|
|
|
|
|
75
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The components of net deferred income tax assets are as follows
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Deferred tax assets:
|
|
|
|
|
|
|
|
|
|
Reserves
|
|
$ |
6,765 |
|
|
$ |
7,696 |
|
|
Other liabilities and accruals
|
|
|
2,882 |
|
|
|
3,071 |
|
|
|
|
|
|
|
|
|
|
Total short term deferred tax assets
|
|
|
9,647 |
|
|
|
10,767 |
|
|
Depreciable assets
|
|
|
391 |
|
|
|
169 |
|
|
Net operating loss carryforward
|
|
|
50,621 |
|
|
|
55,602 |
|
|
Credits carryforward
|
|
|
2,316 |
|
|
|
1,609 |
|
|
Intangibles arising from acquisitions
|
|
|
(1,869 |
) |
|
|
(2,173 |
) |
|
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
$ |
61,106 |
|
|
$ |
65,974 |
|
|
Less: Valuation allowance
|
|
|
(51,670 |
) |
|
|
(48,702 |
) |
|
|
|
|
|
|
|
|
|
$ |
9,436 |
|
|
$ |
17,272 |
|
|
|
|
|
|
|
|
The Company has made no provision for U.S. income taxes on
undistributed earnings of certain foreign subsidiaries because
it is the Companys intention to permanently reinvest such
earnings in its foreign subsidiaries. If such earnings were
distributed, the Company would be subject to additional
U.S. income tax expense. Determination of the amount of
unrecognized deferred income tax liability related to these
earnings is not practicable. The deferred tax assets of
$9.4 million consists of current tax assets from timing
differences between U.S. accounting guidelines and tax laws
that more likely than not will be utilized in future reporting
periods.
As of March 31, 2005, the Company had net operating loss
carryforwards for income tax purposes of approximately
$134.5 million and $1.3 million for federal and state,
respectively. The Company had net operating loss carryforwards
for foreign income tax purposes of approximately
$9.9 million. If not utilized, the U.S. net operating
losses begin to expire in 2013 and 2012 for federal and state,
respectively. The Company has not recognized approximately
$113.9 million of the operating loss carryforwards, most of
which were obtained in acquisitions. Of the remaining
$20.6 million of U.S. operating loss carryforwards,
approximately $11.9 million were utilized in fiscal 2005
and the balance of $8.7 million is reflected in the
long-term deferred tax assets. The Companys
U.S. federal and state research and development tax credit
carryforwards for income tax purposes are approximately
$1.8 million and $0.7 million, respectively. If not
utilized, the federal tax credit carryforwards will begin to
expire in 2005.
A valuation allowance was recorded at March 31, 2005 to
reduce the deferred tax assets arising from a portion of the
Companys foreign operating loss carryforwards, to an
amount that is more likely than not to be realized. As of
March 31, 2005 and March 31, 2004, the Company had a
valuation allowance of $51.7 million and
$48.7 million, respectively. The difference of
$3.0 million primarily relates to an increase in foreign
net operating losses that are more likely than not to be
unrealized due to currently unprofitable operations. In
determining the amount of the valuation allowance, the Company
considers estimated future taxable income as well as feasible
tax planning strategies in each taxing jurisdiction in which it
operates. If the Company determines that it will not realize all
or a portion of the remaining deferred tax assets, it will
increase the valuation allowance with a charge to income tax
expense. Conversely, if the Company determines that it will
ultimately be able to utilize all or a portion of the deferred
tax assets for which a valuation allowance has been provided,
the related portion of the valuation allowance will be released
to income as a credit to income tax expense. Significant
management judgment is required in determining the
Companys provision for income taxes, its deferred tax
assets and liabilities, and any valuation allowance recorded
against net deferred tax
76
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
assets. In the event that actual results differ from these
estimates or the Company adjusts these estimates in future
periods, the Company may need to establish a valuation allowance
that could materially impact its financial position and results
of operations. The Companys ability to utilize its
deferred tax assets and the continuing need for a related
valuation allowance are monitored on an ongoing basis. The
valuation allowance recorded in fiscal 2005 is based on the
Companys assessment that a portion of the foreign net
operating losses would not be realizable.
Under the Tax Reform Act of 1986, the amounts of and benefits
from net operating loss carryforwards and credit carryforwards
may be impaired or limited in certain circumstances. Events
which may restrict utilization of a companys net operating
loss and credit carryforwards include, but are not limited to,
certain ownership change limitations and continuity of business
requirements as defined in Internal Revenue Code
Section 382 and similar state provisions. In the event the
Company has had a change of ownership, defined as a cumulative
ownership change of more than 50% over a three-year period,
utilization of carryforwards could be restricted to an annual
limitation. The annual limitation may result in the expiration
of net operating loss carryforwards and credit carryforwards
before utilization.
|
|
14. |
Computation of Net Income (Loss) Per Share: |
Basic and diluted earnings per share are calculated as follows
(in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares
|
|
|
33,093 |
|
|
|
32,434 |
|
|
|
30,889 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
16,242 |
|
|
$ |
(4,432 |
) |
|
$ |
(12,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share
|
|
$ |
0.49 |
|
|
$ |
(0.14 |
) |
|
$ |
(0.39 |
) |
|
|
|
|
|
|
|
|
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares
|
|
|
33,093 |
|
|
|
32,434 |
|
|
|
30,889 |
|
|
Common equivalent shares from stock options and warrants
|
|
|
1,992 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in per share calculation
|
|
|
35,085 |
|
|
|
32,434 |
|
|
|
30,889 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
16,242 |
|
|
$ |
(4,432 |
) |
|
$ |
(12,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share
|
|
$ |
0.46 |
|
|
$ |
(0.14 |
) |
|
$ |
(0.39 |
) |
|
|
|
|
|
|
|
|
|
|
In 2005, there were outstanding options to
purchase 619,000 shares at a weighted average price of
$19.38 that were not included in the computation of dilutive net
income per share since the exercise prices of the options
exceeded the market price of the common stock. These options
could dilute earnings per share in future periods. In 2004 and
2003, there were outstanding options to purchase 5,310,564
and 4,985,011 shares at weighted average prices of $6.29
and $6.11, respectively, which were not included in the
computation of net loss per share because their effect was
anti-dilutive.
77
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
15. |
Segment and Geographic Information: |
IXYS operates in a single industry segment and has a single
reporting unit comprised of semiconductor products used
primarily in power-related applications, including those in
motor drives, consumer products and power conversion (among
them, uninterruptible power supplies, switch mode power supplies
and medical electronics), and in the telecommunications
industry. IXYSs sales by major geographic area (based on
destination) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
North America
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
$ |
72,300 |
|
|
$ |
62,061 |
|
|
$ |
52,932 |
|
|
Canada
|
|
|
3,473 |
|
|
|
5,985 |
|
|
|
4,563 |
|
Europe and the Middle East
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany
|
|
|
28,821 |
|
|
|
24,631 |
|
|
|
19,071 |
|
|
Italy
|
|
|
7,220 |
|
|
|
6,954 |
|
|
|
6,468 |
|
|
United Kingdom
|
|
|
15,947 |
|
|
|
10,111 |
|
|
|
8,602 |
|
|
Other
|
|
|
33,281 |
|
|
|
29,578 |
|
|
|
19,428 |
|
Asia Pacific
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Korea
|
|
|
49,990 |
|
|
|
14,513 |
|
|
|
3,872 |
|
|
China
|
|
|
16,800 |
|
|
|
13,565 |
|
|
|
7,239 |
|
|
Japan
|
|
|
6,711 |
|
|
|
4,782 |
|
|
|
4,003 |
|
|
Other
|
|
|
17,619 |
|
|
|
11,301 |
|
|
|
7,970 |
|
Rest of the World
|
|
|
4,458 |
|
|
|
3,961 |
|
|
|
1,963 |
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
256,620 |
|
|
$ |
187,442 |
|
|
$ |
136,111 |
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth the revenues for each of
IXYSs product groups for fiscal 2005 and 2004:
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Power semiconductors
|
|
$ |
190,338 |
|
|
$ |
139,312 |
|
Integrated circuits
|
|
|
40,759 |
|
|
|
33,058 |
|
Systems and RF power semiconductors
|
|
|
25,523 |
|
|
|
15,072 |
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
256,620 |
|
|
$ |
187,442 |
|
|
|
|
|
|
|
|
During the year ended March 31, 2005, sales to one customer
represented 11.5% of net revenues. There was no single end user
customer providing more than 10% of IXYSs net revenues for
the years ended March 31, 2004 and 2003.
IXYSs foreign operations consist of those of its
subsidiaries, IXYS GmbH and IXYS Berlin in Germany, IXYS CH in
Switzerland and Westcode in the United Kingdom. At
March 31, 2005 all recorded
78
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Goodwill relates to acquired businesses based in the
U.S. The following table summarizes the net revenues, net
income (loss) and long-lived assets of IXYSs U.S. and
foreign operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
Net Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
|
|
$ |
99,442 |
|
|
$ |
86,533 |
|
|
$ |
64,977 |
|
|
IXYS U.S.
|
|
|
157,178 |
|
|
|
100,909 |
|
|
|
71,134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
256,620 |
|
|
$ |
187,442 |
|
|
$ |
136,111 |
|
|
|
|
|
|
|
|
|
|
|
Net Income(loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
|
|
$ |
6,504 |
|
|
$ |
3,206 |
|
|
$ |
(925 |
) |
|
IXYS U.S.
|
|
|
9,738 |
|
|
|
(7,638 |
) |
|
|
(11,220 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
16,242 |
|
|
$ |
(4,432 |
) |
|
$ |
(12,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, | |
|
|
| |
|
|
2005 | |
|
2004 | |
|
|
| |
|
| |
Property, Plant and Equipment:
|
|
|
|
|
|
|
|
|
|
Germany
|
|
$ |
13,880 |
|
|
$ |
12,668 |
|
|
Switzerland
|
|
|
1,207 |
|
|
|
1,713 |
|
|
IXYS U.S.
|
|
|
8,668 |
|
|
|
4,457 |
|
|
United Kingdom
|
|
|
4,059 |
|
|
|
7,531 |
|
|
|
|
|
|
|
|
|
|
Total Property plant and equipment
|
|
$ |
27,814 |
|
|
$ |
26,369 |
|
|
|
|
|
|
|
|
On May 6, 2005, IXYS purchased the 83,000 square foot
facility used by its Clare, Inc. subsidiary in Beverly,
Massachusetts for $9.0 million. In June 2005, IXYS
committed to purchase the 27,000 square foot facility used
by its Clare Micronix Integrated Systems, Inc. subsidiary in
Aliso Viejo, California for $5.1 million.
On June 10, 2005, IXYS Semiconductor GmbH, a German
subsidiary of IXYS, borrowed Euro 10.0 million, or about
$12.1 million, from IKB Deutsche Industriebank for a term
of 15 years.
The interest rate on the loan is determined by adding the then
effective Euribor rate and a margin. The margin can range from
70 basis points to 125 basis points, depending on the
calculation of a ratio of indebtedness to cash flow for the
German subsidiary. During the first five years of the loan, if
the Euribor rate exceeds 3.75%, the interest rate may not exceed
4.1%, and, if the Euribor rate falls below 2%, the interest rate
may not be lower than 3%. Thereafter, the interest rate is
recomputed annually.
Each fiscal quarter during the first five years of the loan, a
principal payment of Euro 167,000, or about $200,000, will be
required. Thereafter, the amount of the payment will be
recomputed.
Financial covenants for a ratio of indebtedness to cash flow and
a ratio of equity to total assets for the German subsidiary must
be satisfied for the loan to remain in good standing. The loan
may be prepaid in whole or in part at any time without penalty.
The loan is collateralized by a security interest in the
facility owned by IXYS in Lampertheim, Germany.
79
IXYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Selected Quarterly Financial Data (unaudited)
|
|
|
Fiscal Year Ended March 31, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended | |
|
|
| |
|
|
March 31, | |
|
December 31, | |
|
September 30, | |
|
June 30, | |
|
|
2005 | |
|
2004 | |
|
2004 | |
|
2004 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands, except per share amounts) | |
Net revenues
|
|
$ |
69,023 |
|
|
$ |
66,258 |
|
|
$ |
61,385 |
|
|
$ |
59,954 |
|
Gross profit
|
|
|
23,169 |
|
|
|
20,055 |
|
|
|
19,511 |
|
|
|
17,175 |
|
Operating income
|
|
|
9,043 |
|
|
|
7,051 |
|
|
|
6,289 |
|
|
|
3,246 |
|
Net income
|
|
$ |
5,789 |
|
|
$ |
4,749 |
|
|
$ |
3,841 |
|
|
$ |
1,863 |
|
Basic net income per share applicable to common stockholder
|
|
$ |
0.17 |
|
|
$ |
0.14 |
|
|
$ |
0.12 |
|
|
$ |
0.06 |
|
Diluted net income per share applicable to common stockholders
|
|
$ |
0.16 |
|
|
$ |
0.14 |
|
|
$ |
0.11 |
|
|
$ |
0.05 |
|
Weighted average shares used in per share calculation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
33,034 |
|
|
|
33,076 |
|
|
|
33,007 |
|
|
|
32,952 |
|
|
Diluted
|
|
|
35,297 |
|
|
|
35,012 |
|
|
|
34,484 |
|
|
|
35,049 |
|
|
|
|
Fiscal Year Ended March 31, 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended | |
|
|
| |
|
|
March 31, | |
|
December 31, | |
|
September 30, | |
|
June 30, | |
|
|
2004 | |
|
2003 | |
|
2003 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In thousands, except per share amounts) | |
Net revenues
|
|
$ |
53,676 |
|
|
$ |
50,744 |
|
|
$ |
42,926 |
|
|
$ |
40,096 |
|
Gross profit
|
|
|
7,871 |
|
|
|
12,045 |
|
|
|
11,237 |
|
|
|
12,341 |
|
Operating income (loss)
|
|
|
(6,077 |
) |
|
|
504 |
|
|
|
(65 |
) |
|
|
579 |
|
Net income (loss)
|
|
$ |
(5,152 |
) |
|
$ |
386 |
|
|
$ |
(109 |
) |
|
$ |
443 |
|
Basic net income (loss) per share applicable to common
stockholder
|
|
$ |
(0.16 |
) |
|
$ |
0.01 |
|
|
$ |
0.00 |
|
|
$ |
0.01 |
|
Diluted net income (loss) per share applicable to common
stockholder
|
|
$ |
(0.16 |
) |
|
$ |
0.01 |
|
|
$ |
0.00 |
|
|
$ |
0.01 |
|
Weighted average shares used in per share calculation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
32,858 |
|
|
|
32,772 |
|
|
|
32,213 |
|
|
|
31,972 |
|
|
Diluted
|
|
|
32,858 |
|
|
|
34,805 |
|
|
|
32,213 |
|
|
|
33,116 |
|
80
|
|
Item 9. |
Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure |
Not applicable.
|
|
Item 9A. |
Controls and Procedures |
Disclosure Controls and Procedures
An evaluation was carried out under the supervision and with the
participation of our Chief Executive Officer and our Chief
Financial Officer of the effectiveness of our disclosure
controls and procedures (as defined in Rule 13a-15(e)
under the Securities Exchange Act of 1934, as amended, or
Exchange Act) as of March 31, 2005. This evaluation
included various processes that were carried out in an effort to
ensure that information required to be disclosed in our
Securities and Exchange Commission, or SEC, reports is recorded,
processed, summarized and reported within the time periods
specified by the SEC. In this evaluation, the Chief Executive
Officer and the Chief Financial Officer considered whether our
disclosure controls and procedures were also effective to ensure
that information required to be disclosed in the reports that we
file or submit under the Exchange Act is accumulated and
communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, to allow timely decisions
regarding required disclosure. This evaluation also included
consideration of certain aspects of our internal controls and
procedures for the preparation of our financial statements. Our
Chief Executive Officer and Chief Financial Officer concluded
that, as of March 31, 2005, our disclosure controls and
procedures were not effective. Material weaknesses in internal
control over financial reporting that led to the conclusion are
discussed below.
Managements Report on Internal Control over Financial
Reporting
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting, as such term
is defined in Exchange Act Rules 13a-15(f) and 15d-15(f).
Under the supervision and with the participation of our
management, including our Chief Executive Officer and Chief
Financial Officer, we conducted an evaluation of the
effectiveness of our internal control over financial reporting
as of March 31, 2005. In making this assessment, our
management used the criteria set forth in Internal
Control-Integrated Framework, which was issued by the
Committee of Sponsoring Organizations of the Treadway
Commission. Our management has concluded that, as of
March 31, 2005, our internal control over financial
reporting was not effective.
In conducting its assessment, our management concluded that five
material weaknesses existed as of March 31, 2005:
|
|
|
|
|
deficiencies in the number of accounting personnel trained in
applying US GAAP and in reporting financial information in
accordance with the requirements of the SEC; |
|
|
|
deficiencies in our control over costing and valuation of
inventory; |
|
|
|
deficiencies in our control over the use of spreadsheets in our
operations; |
|
|
|
deficiencies in the review of the consolidation process; and |
|
|
|
inadequate segregation of duties in the purchasing cycle. |
The deficiencies in the number of accounting personnel have
resulted in a number of designed controls not operating
properly. The deficiencies in the number of accounting staff
during the initial year of Sarbanes-Oxley compliance placed an
extra burden upon the existing division controllers and their
accounting staff, which led to controls not being performed
properly.
The material weakness related to the costing and valuation of
inventory resulted from the incorrect calculation of inventory
yields and overhead absorption, causing erroneous production
variances, at our facility in Lampertheim, Germany, errors in
capitalized variances at our facilities in Chippenham, England
and Lampertheim, Germany and errors in calculating inventory
reserves in our facility in Fremont, California. The net effect
of the corrections of these errors on our financial statements
for the year ended March 31, 2005 was
81
an increase in cost of goods sold on our statement of operations
of $624,000, a decrease in inventory of $122,000 and $502,000
distributed over a number of other accounts.
The material weakness related to spreadsheets occurred when
division controllers made modifications to the template
spreadsheets for periodic reporting sent to them by corporate
accounting personnel, and the modifications and the impact of
the modifications were not identified by corporate accounting
personnel when accounting information was submitted by the
divisions. As a result of these items, reported income taxes and
miscellaneous other matters changed approximately $105,000 and
$332,000, respectively. In addition, the spreadsheets used to
compute key financial statement items did not have adequate
validation controls.
In part because a financial analyst resigned without notice,
our controls relating to review of consolidations, inputs,
foreign currency translations and recurring journal entries did
not function properly. As a consequence of the unexpected
departure of the financial analyst, our senior financial
analyst, who is responsible for our consolidation process, had
to do her work as well as that of the departed financial
analyst. Thus, a layer of control in the consolidation process
was eliminated. Due to a lack of personnel resources,
supervisory review of the senior financial analysts work
was inadequate. As a result of these deficiencies, our auditors
found differences in our reports requiring a reduction in
deferred tax assets and income tax payable of approximately
$8.2 million and adjustments to foreign exchange totaling
$145,000. These deficiencies were assessed to be a material
weakness.
We have determined that a number of duties have not been
segregated properly within our cycle of activities whereby we
purchase and pay for goods and services. In particular, at
several of our facilities, the same individual was able to
update vendor files, control purchase orders and process vendor
invoices. These deficiencies in segregation of duties
constituted a material weakness. The material weakness arises
from the limited number of accounting personnel at a number of
our facilities and our historical practice of only having
accounting personnel perform traditional accounting functions.
Our Audit Committee is aware of these material weaknesses.
Managements assessment of the effectiveness of our
internal control over financial reporting as of March 31,
2005 has been audited by BDO Seidman, LLP (BDO), an
independent registered public accounting firm, as stated in
their report, which is included elsewhere herein.
Changes in Internal Control over Financial Reporting
We plan to remedy the deficiencies in the number of accounting
personnel by filling a number of positions, some of which are
newly designated. We intend to employ another financial analyst
as a replacement for the individual who resigned. We plan to
hire an accountant trained in US GAAP at both our European and
Fremont, California facilities. We intend to employ a compliance
manager at the corporate level who will be responsible for
guiding the application of US GAAP and our SEC reporting. We
also intend to hire a corporate controller. We have engaged a
professional to oversee and further implement our internal
control over financial reporting. We believe that the material
weakness will be remediated when these positions are filled and
the new personnel are properly trained in their duties. We will
seek to fill these positions and complete training by
December 31, 2005.
Regarding the inventory material weakness at March 31,
2005, we have addressed the yield calculation error in
Lampertheim, Germany by changing the procedure to calculate
yield, and by the end of December 2005, we intend to conduct a
thorough review of the standard costs in Lampertheim, Germany to
verify that proper United States accounting practices are
followed. In addition, one of the accounting personnel hired
will be based in our Fremont facility and will provide
additional resources for the preparation of inventory costing
and valuation. His work will allow time for more supervisory
review by the division controller. We have issued a financial
policy regarding inventory valuation to all of our operating
entities. We plan to review and possibly supplement this policy
by the end of the third quarter of fiscal year 2006. We expect
that the implementation of the foregoing will remediate the
inventory material weakness that existed at March 31, 2005.
It is our objective to complete these remediation activities by
December 31, 2005.
82
In June 2005, we concluded that a material weakness in our
control over the use of spreadsheets existed at March 31,
2005. Our information technology steering committee is currently
reviewing alternatives to address the material weakness. We have
yet to determine the actions to be undertaken to mitigate or
remediate this material weakness. Consequently, we are not yet
able to assess when the material weakness will be adequately
addressed.
In remediation of the material weakness in our consolidation
process, we expect to hire a new financial analyst, as well as a
new corporate controller and a compliance manager for SEC
reporting and GAAP accounting. When these personnel are hired,
we will have the people necessary for appropriate review of the
consolidation process. We also expect to review the design of
our consolidation process controls for adequacy. Our goal is to
complete these remediation activities by December 31, 2005.
We expect to address our material weakness in segregation of
duties in our purchasing cycle through the aforementioned hiring
of additional accounting personnel, the redistribution of duties
among existing accounting personnel and the assignment of some
duties to non-accounting personnel. We expect that controls will
be redesigned to reflect the redistribution of duties and the
involvement of non-accounting personnel. Our objective is to
finish the actions in remediation of this material weakness by
December 31, 2005.
Our Audit Committee is currently reviewing our need to establish
an internal audit function, in part to enhance our monitoring of
remediation of these material weaknesses. The Audit Committee
intends to complete its review of internal audit requirements by
December 31, 2005.
In connection with its review of our financial statements for
the quarter ended December 31, 2004, BDO advised us of
several control deficiencies. BDO considered the internal
controls in order to complete its review of the financial
statements and not to provide assurance on internal controls.
Had BDO performed an attestation engagement of the internal
controls as of December 31, 2004, other control
deficiencies, possibly significant deficiencies or material
weaknesses, may have come to the attention of BDO. The control
deficiencies identified by BDO include the following:
|
|
|
|
|
untimely reconciliation and aging of accounts receivable at our
Santa Clara operation; |
|
|
|
untimely quarterly updating of inventory reserves; |
|
|
|
inconsistency in analyzing and appropriately capitalizing
production variances at each quarter end; |
|
|
|
lack of reconciliation of intercompany accounts; |
|
|
|
inadequate review of the consolidation and controls about
inputs, translation of foreign currency balances and recurring
journal entries; |
|
|
|
absence of consistent accounting policies across the company for
accounts receivable reserves and inventory reserves; and |
|
|
|
deficiencies in information technology controls together with
the absence of a company-wide information technology strategy
and organizational structure. |
We concluded that these control deficiencies, when taken
together, were a material weakness in internal control over
financial reporting. Our Chief Executive Officer, Chief
Financial Officer and Audit Committee have been aware of this
material weakness.
We have conducted additional training of personnel on the
accounting module recently implemented at our Santa Clara
location. We believe that this training remediates the control
deficiency relating to reconciliation and aging of accounts
receivable at our Santa Clara operation. We have employed
two cost accountants at our Santa Clara location. With
their addition, we believe that we have the personnel to timely
update inventory reserves. We believe that we have remediated
the control deficiency relating to the updating of inventory
reserves, which occurred in Santa Clara.
We have reinforced the existing procedures to be performed by
division controllers relating to the reconciliation of
intercompany accounts. We are monitoring on a regular basis to
confirm that the procedures are followed. We believe that we
have remediated the control deficiencies related to intercompany
accounts.
83
We have enhanced our policies on accounts receivable reserves
and have instituted regular monitoring of these reserves. We
believe that we have remediated the control deficiencies related
to our policies on accounts receivable reserves.
We have employed an information technology manager and have
formed an information technology steering committee that has
addressed our information technology control deficiencies and
will guide our information technology actions in the future. We
have instituted information technology controls, adopted an
information technology strategy and established an
organizational structure for our information technology efforts.
We believe that we have remediated the control deficiencies
related to our information technology controls and our absence
of a company-wide information technology strategy and
organizational structure.
As discussed elsewhere, a financial analyst, whose
responsibilities included consolidations and review of inputs,
foreign currency translation and recurring journal entries,
resigned without notice. Her position was not filled by
March 31, 2005 and, as a consequence, the control
deficiencies relating to consolidation and controls about
inputs, foreign currency translation and recurring journal
entries have not been remediated. We intend to employ another
financial analyst. We have adopted a new policy on foreign
currency translation and have conducted further training on
foreign currency translation. We expect that these control
deficiencies will be resolved after the employment of another
financial analyst and the establishment of appropriate review of
these matters.
The control deficiencies relating to production variances and
inventory reserves have not been remediated. We intend to
reinforce the existing procedures to be performed by division
controllers relating to analyzing and capitalizing production
variances and computing inventory reserves. We intend to monitor
on a regular basis to confirm that the procedures are followed.
The control deficiencies at December 31, 2004 that are, as
yet, unremediated have been identified as components of material
weaknesses existing at March 31, 2005. In future filings,
we will report the status of remediation efforts for these
control deficiencies as part of our disclosure of the efforts to
remediate the material weaknesses extant at March 31, 2005.
At March 31, 2004, we also had a material weakness. Certain
of our inventory processes were not reviewed by a supervisor in
sufficient detail, resulting in the following inaccurate
adjustments: standard cost revisions; incomplete updating of
costs included in the standards; journal entries recorded
without the proper supporting documentation; and reconciliation
of the general ledger balance to the perpetual records. A lack
of procedures to track inventory transactions related to cut-off
issues was also found.
The material weakness related to errors that occurred in
connection with a systematic update of standard costs at our
Santa Clara, California operation following a review of
standard costs. We review standard costs on an as-needed basis,
but no less frequently than annually. One review of standard
costs occurred in fiscal year 2004, during our fourth quarter.
Because the errors giving rise to the material weakness occurred
in connection with a systematic update of standard costs that
occurred only in the fourth quarter, the material weakness
related to the fourth quarter of fiscal year 2004 and not to
prior periods.
The net effect of the corrections of these errors on our
financial statements for the year ended March 31, 2004 was
a reduction in cost of goods sold on our statement of operations
of $823,000, an increase in inventory of $1,099,000 and an
increase in accrued expenses and other liabilities of $276,000.
We have implemented controls and procedures in our
Santa Clara operations to address the material weakness.
These controls and procedures include supervisory review of
standard costs and improved cycle count procedures. In addition,
we replaced the division controller and added two cost
accountants at our Santa Clara location.
We have documented our procedures for updating standard costs
and established uniform procedures for cost methodologies. We
are currently implementing manufacturing resource planning
software in Santa Clara that, among other things, will
monitor standard costs and inventory movement. We assessed the
operation of our controls and procedures relating to the
updating of standard costs in our Santa Clara operation and
determined that they operated effectively. We believe the
material weakness that existed as of March 31, 2004
84
has been remediated. In the future, we also intend to schedule
standard cost revisions for times other than when financial
statement closings are occurring.
As mitigation, we performed a regular review of the actual costs
of significant inventory components, in which we compared actual
costs to standard costs to ascertain that our standard costs
approximate actual costs. We also reviewed aggregate variances
each quarter for an indication of the appropriateness of
standard costs.
Inherent Limitations on Effectiveness of Controls
Our management, including our Chief Executive Officer and Chief
Financial Officer, does not expect that our procedures or our
internal controls will prevent or detect all error and all
fraud. An internal control system, no matter how well conceived
and operated, can provide only reasonable, not absolute,
assurance that the objectives of the control system are met.
Because of the inherent limitations in all control systems, no
evaluation of our controls can provide absolute assurance that
all control issues and instances of fraud, if any, have been
detected.
Report of Independent Registered Public Accounting Firm on
Internal Controls
To the Board of Directors and Stockholders of
IXYS Corporation:
We have audited managements assessment, included in the
accompanying Managements Report on Internal Control over
Financial Reporting, that IXYS Corporation (the
Company) did not maintain effective internal control
over financial reporting as of March 31, 2005, because of
the effect of material weaknesses identified in
managements assessment, based on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO). The Companys management is responsible
for maintaining effective internal control over financial
reporting and for its assessment of the effectiveness of
internal control over financial reporting. Our responsibility is
to express an opinion on managements assessment and an
opinion on the effectiveness of the Companys internal
control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, evaluating
managements assessment, testing and evaluating the design
and operating effectiveness of internal control, and performing
such other procedures as we considered necessary in the
circumstances. We believe that our audit provides a reasonable
basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
accounting principles generally accepted in the United States of
America. A companys internal control over financial
reporting includes those policies and procedures that
(1) pertain to the maintenance of records that, in
reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company;
(2) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial
statements in accordance with accounting principles generally
accepted in the United States of America, and that receipts and
expenditures of the company are being made only in accordance
with authorizations of management and directors of the company;
and (3) provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use, or
disposition of the companys assets that could have a
material effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
85
A material weakness is a control deficiency, or combination of
control deficiencies, that results in more than a remote
likelihood that a material misstatement of the annual or interim
financial statements will not be prevented or detected. The
following material weaknesses have been identified and included
in managements assessment.
|
|
|
1. There were insufficient accounting personnel trained in
applying United States generally accepted accounting principles
(US GAAP) and in reporting financial information in accordance
with the requirements of the Securities and Exchange Commission
(SEC) to ensure the correct application of US GAAP and SEC
requirements to amounts and disclosures within the financial
statements. |
|
|
2. Controls over the costing and valuation of inventory
were inadequate to prevent and detect errors in the accuracy of
standard costs, the capitalization of production variances and
the computation of excess and obsolete inventory reserves,
resulting in erroneous production variances in one facility,
errors in capitalized variances at two locations and errors in
calculating inventory reserves in a fourth facility. The
correction of these errors resulted in an increase in cost of
goods sold in the statement of operations of $624,000, a
decrease in inventory of $122,000 and $502,000 distributed over
a number of other accounts. |
|
|
3. There were inadequate access and validation controls in
spreadsheets used to compute key financial statement amounts and
disclosures to prevent and detect errors in both computation and
data entry. As a result of these items, reported income taxes
and other matters were corrected at March 31, 2005 by
approximately $105,000 and $332,000, respectively. |
|
|
4. Controls over the consolidation process, including the
review of inputs, foreign currency translation and recurring
journal entries, together with overall supervisory review of the
consolidation were inadequate to prevent and detect errors in
the consolidated financial statements. This deficiency resulted
in the draft reports requiring a reduction in both deferred tax
assets and income taxes payable of approximately
$8.2 million and adjustments to foreign exchange totaling
$145,000. |
|
|
5. Segregation of duties in the purchasing and payables
functions was inadequate to prevent and detect material
misstatements. In particular, at several Company facilities, the
same individual was able to update vendor files, control
purchase orders and process vendor invoices. |
These material weaknesses were considered in determining the
nature, timing, and extent of audit tests applied in our audit
of the 2005 financial statement, and this report does not affect
our report dated June 3, 2005 on those consolidated
financial statements.
In our opinion, managements assessment that the Company
did not maintain effective internal control over financial
reporting as of March 31, 2005, is fairly stated, in all
material respects, based on criteria established in Internal
Control Integrated Framework issued by COSO.
Also in our opinion, because of the effects of the material
weaknesses described above on the achievement of the objectives
of the control criteria, the Company has not maintained
effective internal control over financial reporting as of
March 31, 2005, based on the criteria established in
Internal Control Integrated Framework issued
by COSO.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
accompanying consolidated balance sheet of IXYS Corporation
as of March 31, 2005 and the related consolidated
statements of operations, stockholders equity,
comprehensive income, and cash flows for the year then ended,
and our report dated June 3, 2005 expressed an unqualified
opinion thereon.
We do not express an opinion or any other form of assurance on
managements statements regarding corrective actions taken
by the Company after March 31, 2005.
BDO Seidman, LLP
San Francisco, California
June 3, 2005
86
|
|
Item 9B. |
Other Information |
On May 4, 2005, the Compensation Committee of the Board of
Directors accelerated the vesting of all outstanding stock
options with vesting remaining and with exercise prices greater
than the closing price on that date, $10.28, causing such stock
options to be fully vested. The vesting was accelerated to avoid
future accounting charges under SFAS No. 123R. As a
consequence of the action, our Chief Executive Officer,
Dr. Nathan Zommer, was vested in the right to
purchase 127,500 shares of our common stock at
$10.63 per share earlier than he otherwise would have been
and each of our directors Donald Feucht, Samuel Kory and Joon
Lee was vested in the right to purchase 250 shares of
our common stock at $15.48 per share earlier than he
otherwise would have been.
PART III
|
|
Item 10. |
Directors and Executive Officers of the Registrant |
|
|
|
Identification of Directors |
Reference is made to the information regarding directors
appearing under the heading Proposal 1
Election of Directors in our Proxy Statement for the
stockholders meeting following the fiscal year ended
March 31, 2005 (the 2005 Proxy Statement),
which information is hereby incorporated by reference.
|
|
|
Identification of Executive Officers |
Reference is made to the information regarding executive
officers appearing under the heading Executive Officers of
the Registrant in Part I of this Annual Report on
Form 10-K, which information is hereby incorporated by
reference.
|
|
|
Identification of Audit Committee and Financial
Expert |
Reference is made to the information regarding directors
appearing under the heading Proposal 1
Election of Directors Audit Committee in our
2005 Proxy Statement, which information is hereby incorporated
by reference.
|
|
|
Material Changes to Procedures for Recommending
Directors |
Reference is made to the information regarding directors
appearing under the heading Proposal 1
Election of Directors in our 2005 Proxy Statement, which
information is hereby incorporated by reference.
|
|
|
Compliance with Section 16(a) of the Exchange
Act |
Reference is made to the information appearing under the heading
Section 16(a) Beneficial Ownership Reporting
Compliance in our 2005 Proxy Statement, which information
is hereby incorporated by reference.
Reference is made to the information appearing under the heading
Proposal 1 Election of
Directors Code of Ethics in our 2005 Proxy
Statement, which information is hereby incorporated by reference.
|
|
Item 11. |
Executive Compensation |
Reference is made to the information appearing under the heading
Executive Compensation in our 2005 Proxy Statement,
which information is hereby incorporated by reference.
87
|
|
Item 12. |
Security Ownership of Certain Beneficial Owners and
Management and Related Stockholder Matters |
Reference is made to information appearing in our 2005 Proxy
Statement under the heading Security Ownership of Certain
Beneficial Owners and Management and Equity
Compensation Plan Information, which information is hereby
incorporated by reference.
|
|
Item 13. |
Certain Relationships and Related Transactions |
Reference is made to information appearing in our 2005 Proxy
Statement under the heading Certain Transactions,
which information is hereby incorporated by reference.
|
|
Item 14. |
Principal Accounting Fees and Services |
Reference is made to the information appearing under the heading
Proposal 2Ratification of Selection of
Independent Auditors Fees Billed by the Independent
Auditors and Proposal 2
Ratification of Selection of Independent Auditors
Policy on Audit Committee Pre-Approval of Audit and Permissible
Non-Audit Services of Independent Auditors in our 2005
Proxy Statement, which information is hereby incorporated by
reference.
PART IV
|
|
Item 15. |
Exhibits, Financial Statement Schedules |
(a) The following documents are filed as part of this
report:
|
|
|
Report of Independent Registered Public Accounting Firm on
Consolidated Financial Statements |
|
|
Report of Independent Registered Public Accounting Firm |
|
|
Consolidated Balance Sheets as of March 31, 2005 and 2004 |
|
|
Consolidated Statement of Operations for the years ended
March 31, 2005, 2004 and 2003 |
|
|
Consolidated Statement of Comprehensive Income (Loss) for the
years ended March 31, 2005, 2004 and 2003 |
|
|
Consolidated Statement of Stockholders Equity for the
years ended March 31, 2005, 2004 and 2003 |
|
|
Consolidated Statements of Cash Flows for the years ended
March 31, 2005, 2004 and 2003 |
|
|
Notes to Consolidated Financial Statements |
|
|
|
(2) Financial statements schedules. All schedules are
omitted because they are not applicable or the required
information is shown in the financial statements or the notes
thereto. |
|
|
(3) Exhibits. |
|
|
|
|
|
Exhibit |
|
Title |
|
|
|
|
3 |
.1 |
|
Amended and Restated Certificate of Incorporation of the
Registrant, as filed with the Secretary of State for the State
of Delaware on March 23, 2001 (filed on June 28, 2001
as Exhibit 3.1 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
3 |
.2 |
|
Amended and Restated Bylaws of the Registrant (filed on
November 14, 2002 as Exhibit 3.2 to the Quarterly
Report on Form 10-Q (No. 000-26124) and incorporated
herein by reference). |
88
|
|
|
|
|
Exhibit |
|
Title |
|
|
|
|
10 |
.1* |
|
Second Amended Executive Employment Agreement, dated as of
February 1, 2004, by and between IXYS Corporation
(IXYS) and Nathan Zommer (filed on June 14,
2004 as Exhibit 10.1 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.2 |
|
Wafer Foundry Agreement, dated as of June 21, 1995, as
amended on March 28, 1996 and March 13, 1998, by and
between IXYS and Samsung Electronics Co. (filed on June 29,
1998 as Exhibit 10.3 to Amendment No. 1 the
Registration Statement on Form S-4 of Paradigm Technology,
Inc. (No. 333-57003) (Amendment No. 1 to the
Paradigm S-4) and incorporated herein by reference). |
|
10 |
.3* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Nathan Zommer (filed on June 28, 2001
as Exhibit 10.7 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.4* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Arnold Agbayani (filed on June 28, 2001 as
Exhibit 10.8 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.5* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Samuel Kory (filed on June 28, 2001 as
Exhibit 10.10 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.6* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Kevin McDonough (filed on June 28, 2001 as
Exhibit 10.11 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.7* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Peter Ingram (filed on June 28, 2001 as
Exhibit 10.12 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.8* |
|
Indemnity Agreement, dated August 4, 2000, by and between
IXYS and Donald L. Feucht (filed on June 28, 2001 as
Exhibit 10.13 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.9* |
|
Indemnity Agreement, dated August 4, 2000, by and between
IXYS and S. Joon Lee (filed on June 28, 2001 as
Exhibit 10.14 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.10* |
|
Indemnity Agreement, dated December 9, 2004, by and between
IXYS and Kenneth D. Wong (filed on February 11, 2005
as Exhibit 10.3 to the Quarterly Report on Form 10-Q
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.11* |
|
Indemnity Agreement, dated December 9, 2004, by and between
IXYS and Uzi Sasson (filed on February 11, 2005 as
Exhibit 10.2 to the Quarterly Report on Form 10-Q
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.12* |
|
Indemnity Agreement, dated December 9, 2004, by and between
IXYS and Kent P. Loose (filed on February 11, 2005 as
Exhibit 10.1 to the Quarterly Report on Form 10-Q
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.13* |
|
The Paradigm 1994 Stock Option Plan, as amended (filed on
February 16, 1999 as Exhibit 10.2 to the Quarterly
Report on Form 10-Q (No. 000-26124) and incorporated
herein by reference). |
|
10 |
.14* |
|
The IXYS 1999 Equity Incentive Plan (filed on July 8, 1999
as Exhibit 10.10 to the Annual Report on Form 10-K
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.15* |
|
The IXYS 1999 Employee Stock Purchase Plan (filed on
July 8, 1999 as Exhibit 10.11 to the Annual Report on
Form 10-K (No. 000-26124) and incorporated herein by
reference). |
|
10 |
.16* |
|
The IXYS 1999 Non-Employee Directors Equity Incentive Plan
(filed on July 8, 1999 as Exhibit 10.12 to the Annual
Report on Form 10-K (No. 000-26124) and incorporated
herein by reference). |
|
10 |
.17* |
|
Form of Stock Option Agreement for the 1999 Equity Incentive
Plan (filed on November 9, 2004 as Exhibit 10.3 to the
Quarterly Report on Form 10-Q (No. 000-26124) and
incorporated herein by reference). |
89
|
|
|
|
|
Exhibit |
|
Title |
|
|
|
|
10 |
.18* |
|
Form of Stock Option Agreement for the 1999 Non-Employee
Directors Equity Incentive Plan (filed on November 9,
2004 as Exhibit 10.1 to the Quarterly Report on
Form 10-Q (No. 000-26124) and incorporated herein by
reference). |
|
10 |
.19* |
|
Form of Stock Option Agreement for the 1999 Non-Employee
Directors Equity Incentive Plan (filed on November 9,
2004 as Exhibit 10.2 to the Quarterly Report on
Form 10-Q (No. 000-26124) and incorporated herein by
reference). |
|
10 |
.20* |
|
Amended and Restated Promissory Note, dated September 15,
2000, executed by Nathan Zommer and acknowledged and agreed to
by IXYS (filed on October 23, 2000 as Exhibit 10.1 to
Amendment No. 3 to the Registration Statement on
Form S-3 (No. 333-46028) (Amendment No. 3 to the
S-3) and incorporated herein by reference). |
|
10 |
.21* |
|
Amended and Restated Promissory Note, dated September 15,
2000, executed by Arnold P. Agbayani and acknowledged and agreed
to by IXYS (filed on October 23, 2000 as Exhibit 10.2
to Amendment No. 3 to the S-3 and incorporated herein by
reference). |
|
10 |
.22* |
|
Amended and Restated Pledge Agreement, dated September 15,
2000, by Nathan Zommer and acknowledged and agreed to by IXYS
(filed on October 23, 2000 as Exhibit 10.3 to
Amendment No. 3 to the S-3 and incorporated herein by
reference). |
|
10 |
.23* |
|
Amended and Restated Pledge Agreement, dated September 15,
2000, executed by Arnold P. Agbayani and acknowledged and
agreed to by IXYS (filed on October 23, 2000 as
Exhibit 10.4 to Amendment No. 3 to the S-3 and
incorporated herein by reference). |
|
10 |
.24* |
|
Recourse Promissory Note issued to IXYS by Samuel J. Kory,
effective as of August 30, 2002 and executed in April 2002
(filed on August 14, 2002 as Exhibit 10.29 to the
Quarterly Report on Form 10-Q (No. 000-26124) and
incorporated herein by reference). |
|
10 |
.25* |
|
Stock Pledge Agreement by Samuel J. Kory in favor of IXYS,
effective as of August 30, 2001 and executed in April 2002
(filed on August 14, 2002 as Exhibit 10.30 to the
Quarterly Report on Form 10-Q (No. 000-26124) and
incorporated herein by reference). |
|
10 |
.26* |
|
Description of Nathan Zommers cash bonuses. |
|
10 |
.27* |
|
Description of elements of Uzi Sassons compensation. |
|
10 |
.28* |
|
Summary of outside director compensation. |
|
21 |
.1 |
|
List of Subsidiaries. |
|
23 |
.1 |
|
Consent of BDO Seidman, LLP. |
|
23 |
.2 |
|
Consent of PricewaterhouseCoopers LLP. |
|
24 |
.1 |
|
Power of Attorney (included on the signature page) |
|
31 |
.1 |
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(a) of the Securities and Exchange Commission. |
|
31 |
.2 |
|
Certification of Chief Financial Officer pursuant to the
Rule 13a-14(a) of the Securities and Exchange Commission. |
|
32 |
.1 |
|
Certification required by Rule 13a-14(b) of the Securities
and Exchange Commission and Section 1350 of Chapter 63
of Title 18 of the United States Code (18 U.S.C. 1350). |
|
|
* |
Management contract or compensation plan or arrangement. |
90
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
Nathan Zommer |
|
President, Chief Executive Officer and Chairman |
|
(Principal Executive Officer) |
Dated: June 29, 2005
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose
signature appears below constitutes and appoints Nathan Zommer
and Uzi Sasson, and each or any one of them, his true and lawful
attorney-in-fact and agent, with full power of substitution and
resubstitution, for him and in his name, place and stead, in any
and all capacities, to sign any and all amendments (including
post-effective amendments) to this Report, and to file the same,
with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting
unto said attorneys-in-fact and agents, and each of them, full
power and authority to do and perform each and every act and
thing requisite and necessary to be done in connection
therewith, as fully to all intents and purposes as he might or
could do in person, hereby ratifying and confirming all that
said attorneys-in-fact and agents, or any of them, or their or
his substitutes or substitute, may lawfully do or cause to be
done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the Registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
|
/s/ Nathan Zommer
Nathan
Zommer |
|
President, Chief Executive Officer and Chairman (Principal
Executive Officer) and Director |
|
June 29, 2005 |
|
/s/ Uzi Sasson
Uzi
Sasson |
|
Vice President of Finance and Chief Financial Officer (Principal
Financial Officer and Principal Accounting Officer) |
|
June 29, 2005 |
|
/s/ Samuel Kory
Samuel
Kory |
|
Director |
|
June 29, 2005 |
|
/s/ Donald L. Feucht
Donald
L. Feucht |
|
Director |
|
June 29, 2005 |
|
/s/ S. Joon Lee
S.
Joon Lee |
|
Director |
|
June 29, 2005 |
|
/s/ Kenneth D. Wong
Kenneth
D. Wong |
|
Director |
|
June 29, 2005 |
91
Exhibit Index
|
|
|
|
|
Exhibit |
|
Title |
|
|
|
|
3 |
.1 |
|
Amended and Restated Certificate of Incorporation of the
Registrant, as filed with the Secretary of State for the State
of Delaware on March 23, 2001 (filed on June 28, 2001
as Exhibit 3.1 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
3 |
.2 |
|
Amended and Restated Bylaws of the Registrant (filed on
November 14, 2002 as Exhibit 3.2 to the Quarterly
Report on Form 10-Q (No. 000-26124) and incorporated herein by
reference). |
|
10 |
.1* |
|
Second Amended Executive Employment Agreement, dated as of
February 1, 2004, by and between IXYS Corporation
(IXYS) and Nathan Zommer (filed on June 14,
2004 as Exhibit 10.1 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.2 |
|
Wafer Foundry Agreement, dated as of June 21, 1995, as
amended on March 28, 1996 and March 13, 1998, by and
between IXYS and Samsung Electronics Co. (filed on June 29,
1998 as Exhibit 10.3 to Amendment No. 1 the
Registration Statement on Form S-4 of Paradigm Technology,
Inc. (No. 333-57003) (Amendment No. 1 to the Paradigm
S-4) and incorporated herein by reference). |
|
10 |
.3* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Nathan Zommer (filed on June 28, 2001 as
Exhibit 10.7 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.4* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Arnold Agbayani (filed on June 28, 2001 as
Exhibit 10.8 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.5* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Samuel Kory (filed on June 28, 2001 as
Exhibit 10.10 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.6* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Kevin McDonough (filed on June 28, 2001 as
Exhibit 10.11 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.7* |
|
Indemnity Agreement, dated November 20, 1999, by and
between IXYS and Peter Ingram (filed on June 28, 2001 as
Exhibit 10.12 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.8* |
|
Indemnity Agreement, dated August 4, 2000, by and between
IXYS and Donald L. Feucht (filed on June 28, 2001 as
Exhibit 10.13 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.9* |
|
Indemnity Agreement, dated August 4, 2000, by and between
IXYS and S. Joon Lee (filed on June 28, 2001 as
Exhibit 10.14 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.10* |
|
Indemnity Agreement, dated December 9, 2004, by and between
IXYS and Kenneth D. Wong (filed on February 11, 2005 as
Exhibit 10.3 to the Quarterly Report on Form 10-Q (No.
000-26124) and incorporated herein by reference). |
|
10 |
.11* |
|
Indemnity Agreement, dated December 9, 2004, by and between
IXYS and Uzi Sasson (filed on February 11, 2005 as
Exhibit 10.2 to the Quarterly Report on Form 10-Q (No.
000-26124) and incorporated herein by reference). |
|
10 |
.12* |
|
Indemnity Agreement, dated December 9, 2004, by and between
IXYS and Kent P. Loose (filed on February 11, 2005 as
Exhibit 10.1 to the Quarterly Report on Form 10-Q (No.
000-26124) and incorporated herein by reference). |
|
10 |
.13* |
|
The Paradigm 1994 Stock Option Plan, as amended (filed on
February 16, 1999 as Exhibit 10.2 to the Quarterly
Report on Form 10-Q (No. 000-26124) and incorporated herein by
reference). |
|
10 |
.14* |
|
The IXYS 1999 Equity Incentive Plan (filed on July 8, 1999
as Exhibit 10.10 to the Annual Report on Form 10-K (No.
000-26124) and incorporated herein by reference). |
|
10 |
.15* |
|
The IXYS 1999 Employee Stock Purchase Plan (filed on
July 8, 1999 as Exhibit 10.11 to the Annual Report on
Form 10-K (No. 000-26124) and incorporated herein by reference). |
92
|
|
|
|
|
Exhibit |
|
Title |
|
|
|
|
10 |
.16* |
|
The IXYS 1999 Non-Employee Directors Equity Incentive Plan
(filed on July 8, 1999 as Exhibit 10.12 to the Annual
Report on Form 10-K (No. 000-26124) and incorporated herein by
reference). |
|
10 |
.17* |
|
Form of Stock Option Agreement for the 1999 Equity Incentive
Plan (filed on November 9, 2004 as Exhibit 10.3 to the
Quarterly Report on Form 10-Q (No. 000-26124) and incorporated
herein by reference). |
|
10 |
.18* |
|
Form of Stock Option Agreement for the 1999 Non-Employee
Directors Equity Incentive Plan (filed on November 9,
2004 as Exhibit 10.1 to the Quarterly Report on Form 10-Q
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.19* |
|
Form of Stock Option Agreement for the 1999 Non-Employee
Directors Equity Incentive Plan (filed on November 9,
2004 as Exhibit 10.2 to the Quarterly Report on Form 10-Q
(No. 000-26124) and incorporated herein by reference). |
|
10 |
.20* |
|
Amended and Restated Promissory Note, dated September 15,
2000, executed by Nathan Zommer and acknowledged and agreed to
by IXYS (filed on October 23, 2000 as Exhibit 10.1 to
Amendment No. 3 to the Registration Statement on
Form S-3 (No. 333-46028) (Amendment No. 3 to the
S-3) and incorporated herein by reference). |
|
10 |
.21* |
|
Amended and Restated Promissory Note, dated September 15,
2000, executed by Arnold P. Agbayani and acknowledged and agreed
to by IXYS (filed on October 23, 2000 as Exhibit 10.2
to Amendment No. 3 to the S-3 and incorporated herein by
reference). |
|
10 |
.22* |
|
Amended and Restated Pledge Agreement, dated September 15,
2000, by Nathan Zommer and acknowledged and agreed to by IXYS
(filed on October 23, 2000 as Exhibit 10.3 to
Amendment No. 3 to the S-3 and incorporated herein by
reference). |
|
10 |
.23* |
|
Amended and Restated Pledge Agreement, dated September 15,
2000, executed by Arnold P. Agbayani and acknowledged and
agreed to by IXYS (filed on October 23, 2000 as
Exhibit 10.4 to Amendment No. 3 to the S-3 and
incorporated herein by reference). |
|
10 |
.24* |
|
Recourse Promissory Note issued to IXYS by Samuel J. Kory,
effective as of August 30, 2002 and executed in April 2002
(filed on August 14, 2002 as Exhibit 10.29 to the
Quarterly Report on Form 10-Q (No. 000-26124) and incorporated
herein by reference). |
|
10 |
.25* |
|
Stock Pledge Agreement by Samuel J. Kory in favor of IXYS,
effective as of August 30, 2001 and executed in April 2002
(filed on August 14, 2002 as Exhibit 10.30 to the
Quarterly Report on Form 10-Q (No. 000-26124) and incorporated
herein by reference). |
|
10 |
.26* |
|
Description of Nathan Zommers cash bonuses. |
|
10 |
.27* |
|
Description of elements of Uzi Sassons compensation. |
|
10 |
.28* |
|
Summary of outside director compensation. |
|
21 |
.1 |
|
List of Subsidiaries. |
|
23 |
.1 |
|
Consent of BDO Seidman, LLP. |
|
23 |
.2 |
|
Consent of PricewaterhouseCoopers LLP. |
|
24 |
.1 |
|
Power of Attorney (included on the signature page) |
|
31 |
.1 |
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(a) of the Securities and Exchange Commission. |
|
31 |
.2 |
|
Certification of Chief Financial Officer pursuant to the
Rule 13a-14(a) of the Securities and Exchange Commission. |
|
32 |
.1 |
|
Certification required by Rule 13a-14(b) of the Securities
and Exchange Commission and Section 1350 of Chapter 63
of Title 18 of the United States Code (18 U.S.C. 1350). |
|
|
* |
Management contract or compensation plan or arrangement. |
93